e10vk
SECURITIES AND EXCHANGE
COMMISSION
Washington, D.C.
20549
Form 10-K
|
|
|
(Mark One)
|
|
|
|
þ
|
|
ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934
|
|
|
FOR THE FISCAL YEAR ENDED
DECEMBER 31, 2008
|
or
|
o
|
|
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934
|
Commission File Number 1-31719
MOLINA HEALTHCARE,
INC.
(Exact name of registrant as
specified in its charter)
|
|
|
Delaware
|
|
13-4204626
|
(State or other jurisdiction
of
incorporation or organization)
|
|
(I.R.S. Employer
Identification No.)
|
200
Oceangate, Suite 100, Long Beach, California 90802
(Address
of principal executive offices)
(562) 435-3666
(Registrants
telephone number, including area code)
Securities registered pursuant to Section 12(b) of the
Act:
|
|
|
Title of Class
|
|
Name of Each Exchange on Which Registered
|
|
Common Stock, $0.001 Par Value
|
|
New York Stock Exchange
|
Securities registered pursuant to Section 12(g) of the
Act:
None
Indicate by check mark if the registrant is a well-known
seasoned issuer, as defined in Rule 405 of the Securities
Act. o Yes þ No
Indicate by check mark if the registrant is not required to file
reports pursuant to Section 13 or Section 15(d) of the
Act. o Yes þ No
Indicate by check mark whether the registrant (1) has filed
all reports required to be filed by Section 13 or 15(d) of
the Securities Exchange Act of 1934 during the preceding
12 months (or for such shorter period that the registrant
was required to file such reports), and (2) has been
subject to such filing requirements for the past 90 days.
þ Yes o No
Indicate by check mark if disclosure of delinquent filers
pursuant to Item 405 of
Regulation S-K
is not contained herein, and will not be contained, to the best
of Registrants knowledge, in definitive proxy or
information statements incorporated by reference in
Part III of this
Form 10-K
or any amendment to this
Form 10-K. o
Indicate by check mark whether the registrant is a large
accelerated filer, an accelerated filer, a non-accelerated
filer, or a smaller reporting company. See the definitions of
large accelerated filer, accelerated
filer and smaller reporting company in
Rule 12b-2
of the Exchange Act. (Check one):
|
|
|
|
Large
accelerated
filer o
|
Accelerated
filer þ
|
Non-accelerated
filer o
|
Smaller
reporting
company o
|
(Do not check if a smaller
reporting company)
Indicate by check mark whether the registrant is a shell company
(as defined in
Rule 12b-2
of the Exchange
Act). o Yes þ No
The aggregate market value of Common Stock held by
non-affiliates of the Registrant as of June 30, 2008, the
last business day of our most recently completed second fiscal
quarter, was approximately $300 million (based upon the
closing price for shares of the Registrants Common Stock
as reported by the New York Stock Exchange, Inc. on
June 30, 2008).
As of March 13, 2009, approximately 26,066,000 shares
of the Registrants Common Stock, $0.001 par value per
share, were outstanding.
DOCUMENTS
INCORPORATED BY REFERENCE
Portions of the Registrants Proxy Statement for the 2009
Annual Meeting of Stockholders to be held on April 28, 2009
are incorporated by reference into Part III of this
Form 10-K.
MOLINA
HEALTHCARE, INC.
Table of
Contents
Form 10-K
PART I
Overview
We are a multi-state managed care organization that arranges for
the delivery of health care services to persons eligible for
Medicaid, Medicare, and other government-sponsored programs for
low-income families and individuals. We conduct our business
primarily through 10 licensed health plans in the states of
California, Florida, Michigan, Missouri, Nevada, New Mexico,
Ohio, Texas, Utah, and Washington. The health plans are locally
operated by our respective wholly owned subsidiaries in those
10 states, each of which is licensed as a health
maintenance organization. Our revenues are derived primarily
from premium revenues paid to our health plans by the relevant
state Medicaid authority, which revenues are jointly financed by
the federal government and the states. Increasingly, we also
derive revenues from the federal Centers for Medicare and
Medicaid Services, or CMS, in connection with our Medicare
services.
The payments made to our health plans generally represent an
agreed upon amount per member per month, or a
capitation amount, which is paid regardless of
whether the member utilizes any medical services in that month
or whether the member utilizes medical services in excess of the
capitation amount. Each of our health plans (with the exception
of our Utah plan whose Medicaid business was not capitated in
2008) is thus financially at risk for the
medical care of its members. Each health plan arranges for
health care services for its members by contracting with health
care providers in the relevant communities or states, including
contracting with primary care physicians, specialist physicians,
physician groups, hospitals, and other medical care providers.
Our California health plan also operates 17 of its own primary
care community clinics. Various core administrative functions of
our health plans primarily claims processing,
information systems, and finance are centralized at
our corporate parent in Long Beach, California. As of
December 31, 2008, approximately 1,256,000 members were
enrolled in our ten health plans.
Dr. C. David Molina founded our company in 1980 under the
name Molina Medical Centers as a provider
organization serving the Medicaid population in Southern
California through a network of primary care clinics. Since
then, we have increased our membership through the
start-up
development of new health plan operations, the acquisition of
existing health plans, and internal or organic growth. In 1997,
we established our Utah health plan as a
start-up
operation. In 1999, we incorporated in California as the parent
company of our California and Utah health plan subsidiaries
under the name American Family Care, Inc. In late
1999, we acquired our Michigan and Washington health plans. In
March 2000, we changed our name to Molina Healthcare, Inc. In
June 2003, we reincorporated from California to Delaware, and in
July 2003 we completed our initial public offering of common
stock and listed our shares for trading on the New York Stock
Exchange under the trading symbol, MOH. In July 2004, we
acquired our New Mexico health plan. Our
start-up
health plan in Ohio began operations in December 2005. On
January 1, 2006, our health plans in California, Michigan,
Utah, and Washington began operating Medicare Advantage Special
Needs Plans in their respective states. In May 2006, we acquired
Cape Health Plan in Michigan, merging it into our Michigan
health plan effective December 31, 2006. Our
start-up
health plan in Texas began operations in September 2006. On
January 1, 2007, our health plans in California, Michigan,
Nevada, New Mexico, Texas, Utah, and Washington began enrolling
members in Medicare Advantage plans with prescription drug
coverage, or MA-PD plans. In June 2007, we organized a health
plan in Nevada that serves only Medicare members. In November
2007, we acquired Alliance For Community Health LLC, doing
business as Mercy CarePlus, a licensed health plan in Missouri.
In January 2008, our health plans in New Mexico and Texas also
began operating Medicare Advantage Special Needs Plans. In late
December 2008, we began enrolling members in our Florida health
plan.
Our members have distinct social and medical needs and come from
diverse cultural, ethnic, and linguistic backgrounds. From our
inception, we have focused exclusively on serving financially
vulnerable individuals enrolled in government-sponsored health
care programs. Our success has resulted from our extensive
experience with meeting the needs of our members, including over
28 years of experience in operating community-based primary
care clinics, our cultural and linguistic expertise, our
education and outreach programs, our expertise in working with
government agencies, and our focus on operational and
administrative efficiencies.
1
Our principal executive offices are located at 200 Oceangate,
Suite 100, Long Beach, California 90802, and our telephone
number is
(562) 435-3666.
Our website is www.molinahealthcare.com.
Information contained on our website or linked to our website is
not incorporated by reference into, or as part of, this annual
report. Unless the context otherwise requires, references to
Molina Healthcare, the Company,
we, our, and us herein refer
to Molina Healthcare, Inc. and its subsidiaries. Our annual
reports on
Form 10-K,
quarterly reports on
Form 10-Q,
current reports on
Form 8-K,
and all amendments to these reports, are available free of
charge on our website, www.molinahealthcare.com, as soon
as reasonably practicable after such reports are electronically
filed with or furnished to the Securities and Exchange
Commission, or SEC. Information regarding our officers and
directors, and copies of our Code of Business Conduct and
Ethics, Corporate Governance Guidelines, and our Audit,
Compensation, and Corporate Governance and Nominating Committee
Charters, are also available on our website. Such information is
also available in print upon the request of any stockholder to
our Investor Relations Department at the address of our
executive offices set forth above. In accordance with New York
Stock Exchange (NYSE) rules, on June 9, 2008,
we filed the annual certification by our Chief Executive Officer
certifying that he was unaware of any violation by us of the
NYSEs corporate governance listing standards at the time
of the certification.
Our
Industry
The Medicaid and CHIP Programs. Established in
1965, the Medicaid program is an entitlement program funded
jointly by the federal and state governments and administered by
the states. The Medicaid program provides health care benefits
to low-income families and individuals. Each state establishes
its own eligibility standards, benefit packages, payment rates,
and program administration within broad federal statutory and
regulatory guidelines. The most common state-administered
Medicaid program is the Temporary Assistance for Needy Families
program, or TANF (often pronounced TAN-if). TANF is
the successor to the Aid to Families with Dependent Children
program, or AFDC, and most enrolled members are mothers and
their children. Another common state-administered Medicaid
program is for the aged, blind, or disabled, or ABD Medicaid
members, who do not qualify under other Medicaid coverage
categories. Although state programs must meet minimum federal
standards, states have significant flexibility in determining
eligibility thresholds, the amount of covered services, and
payment rates for providers.
In addition, the Childrens Health Insurance Program, known
widely by the acronym, CHIP, is a joint federal and state
matching program that provides health care coverage to children
whose families earn too much to qualify for Medicaid coverage,
but not enough to afford commercial health insurance. States
have the option of administering CHIP through their Medicaid
programs.
The federal government pays a portion of the costs that states
incur to provide services to Medicaid enrollees. The proportion
of states costs that the federal government pays is based
on the federal medical assistance percentage, or
FMAP. The percentage for each state is determined through a
formula that assigns a higher federal reimbursement rate to
states that have lower income per capita (and vice versa)
relative to the national average. The average matching rate that
the federal government pays is 57 percent nationwide;
states contribute the remaining 43 percent. The federal
matching rates have both a floor (50 percent) and a ceiling
(83 percent). The matching rates for CHIP are approximately
one-third higher than those under Medicaid. Generally, states
have more programmatic flexibility in CHIP than in Medicaid.
As part of the American Recovery and Reinvestment Act of 2009
enacted on February 17, 2009, states will receive
approximately $87 billion in assistance for their Medicaid
programs through a temporary increase in the FMAP match rate.
The funding is effective retroactively from October 1, 2008
to December 31, 2010. Under the American Recovery and
Reinvestment Act of 2009, every state will receive a minimum
FMAP increase of 6.2 percent. The balance of funding is
based on unemployment rates in the states. In order to receive
this additional FMAP increase, states may not reduce Medicaid
eligibility levels below the eligibility levels that were in
place on July 1, 2008. Medicaid is classified as an
entitlement, and therefore there is no limit on the federal
funds that may be expended. Federal payments for Medicaid are
limited only by the amount states are willing and able to spend.
Nevertheless, budgetary constraints at both the federal and
state levels may limit the benefits paid and the number of
members served by Medicaid. CHIP, however, is a capped
allotment. Pursuant to the Childrens Health Insurance
2
Program Reauthorization Act of 2009 enacted on February 4,
2009, CHIP was reauthorized and expanded to cover up to a total
of 11 million children by 2011. The legislation also
provides an additional $32.8 billion in funding over the
next four and a half years, and allows states to expand coverage
up to 300 percent of the federal poverty level. CHIP will
continue to be funded at an enhanced match, with the minimum
federal amount being 65 percent.
Medicaid Managed Care. Under traditional
fee-for-service Medicaid programs, health care services are made
available to beneficiaries in an uncoordinated manner. These
beneficiaries typically have minimal access to preventive care
such as immunizations, and access to primary care physicians is
limited. As a consequence, treatment is often postponed until
medical conditions become more severe, leading to higher
utilization of costly emergency room services. In addition,
because providers are paid on a fee-for-service basis where
additional services rendered result in additional revenues, they
lack incentives to monitor utilization and control costs.
In an effort to improve quality and provide more uniform and
more cost-effective care, many states have implemented Medicaid
managed care programs. Such programs seek to improve access to
coordinated health care services, including preventive care, and
to control health care costs. Under Medicaid managed care
programs, a health plan receives a predetermined payment per
enrollee or member (commonly referred to as
capitation) for the covered health care services.
The health plan is thus financially at risk for its
members medical services. The health plan, in turn,
arranges for the provision of the covered health care services
by contracting with a network of providers, including both
physicians and hospitals, who agree to provide the covered
services to the health plans members. The health plan also
monitors quality of care and implements preventive programs,
thereby striving to improve access to care while more
effectively controlling costs.
Over the past decade, the federal government has expanded the
ability of state Medicaid agencies to explore and, in many
cases, to mandate the use of managed care for Medicaid
beneficiaries. If Medicaid managed care is not mandatory,
individuals entitled to Medicaid may choose either the
fee-for-service Medicaid program or a managed care plan, if
available. All states in which we operate have mandatory
Medicaid managed care programs.
Medicare Advantage Plans. During 2008, each of
our health plans in California, Michigan, Nevada, New Mexico,
Texas, Utah, and Washington operated Medicare Advantage plans,
each of which included a mandatory Part D prescription drug
benefit. Our Medicare Advantage special needs plans, or SNPs,
operate under the trade name, Molina Medicare Options Plus, and
serve those beneficiaries who are dually eligible for both
Medicare and Medicaid such as low-income seniors and people with
disabilities. Our Medicare Advantage Prescription Drug plans, or
MA-PDs, operate under the trade name, Molina Medicare Options.
Although our MA-PD benefit plans do not exclusively enroll dual
eligible beneficiaries, the plans benefit structure is
designed to appeal to lower income beneficiaries. We believe
offering these Medicaid plans is consistent with our historical
mission of serving low-income and medically underserved families
and individuals. None of our health plans operate a Medicare
Advantage private fee-for-service plan. Total enrollment in our
Medicare Advantage plans at December 31, 2008 was
approximately 8,000 members. Our 2008 premium revenues from
Medicare across all health plans represented approximately 3.1%
of our total premium revenues.
Other Government Programs for Low Income
Individuals. In certain instances, states have
elected to provide medical benefits to individuals and families
who do not qualify for Medicaid. Such programs are often
administered in a manner similar to Medicaid and CHIP, but
without federal matching funds. At December 31, 2008, our
Washington health plan served approximately 26,000 such members
under one such program, that states Basic Health
Plan.
3
Our
Approach
We focus on serving financially vulnerable families and
individuals who receive health care benefits through
government-sponsored programs within a managed care model. These
families and individuals generally represent diverse cultures
and ethnicities. Many have had limited educational opportunities
and do not speak English as their first language. Lack of
adequate transportation is common. We believe we are
well-positioned to capitalize on the growth opportunities in
serving these members. Our approach to managed care is based on
the following key attributes:
Experience. For over 28 years we have
focused on serving Medicaid beneficiaries as both a health plan
and as a provider. We have developed and forged strong
relationships with the constituents whom we serve
members, providers, and government agencies. Our ability to
deliver quality care and to establish and maintain provider
networks, as well as our administrative efficiency, has allowed
us to compete successfully for government contracts. We have a
strong record of obtaining and renewing contracts and have
developed significant expertise as a government contractor.
Administrative Efficiency. We have centralized
and standardized various functions and practices across all of
our health plans to increase administrative efficiency. The
steps we have taken include centralizing claims processing and
information services onto a single platform. We have
standardized medical management programs, pharmacy benefits
management contracts, and health education programs. In
addition, we have designed our administrative and operational
infrastructure to be scalable for cost-effective expansion into
new and existing markets.
Proven Expansion Capability. We have
successfully replicated our business model through the
acquisition of health plans, the
start-up
development of new operations, and the transition of members
from other health plans. The successful integration of our New
Mexico and Missouri health plans demonstrated our ability to
expand into states in which we had not previously had any
presence. The establishment of our health plans in Utah, Ohio,
and Texas reflects our ability to replicate our business model
on a
start-up
basis in new states, while contract acquisitions in California,
Michigan, and Washington have demonstrated our ability to expand
our operations within states in which we were already operating.
Flexible Care Delivery Systems. Our systems
for delivery of health care services are diverse and readily
adaptable to different markets and changing conditions. We
arrange health care services through contracts with providers
that include independent physicians and medical groups,
hospitals, ancillary providers and, in California, our own
clinics. Our systems support multiple contracting models, such
as fee-for-service, capitation, per diem, case rates, and
diagnostic related groups, or DRGs. Our provider network
strategy is to contract with providers that are best-suited,
based on expertise, proximity, cultural sensitivity, and
experience, to provide services to the members we serve.
Our California health plan operates 17 company-owned
primary care clinics in California. In addition, on July 1,
2008, our unlicensed subsidiary in Virginia began to manage the
Fairfax County Community Health Care Network. This network
consists of three county-owned clinics, providing comprehensive
medical services to over 12,000 of Fairfax Countys
uninsured residents. We believe that our clinics serve a useful
role in providing certain communities with access to primary
care and providing us with insights into physician practice
patterns, first-hand knowledge of the needs of our members, and
a platform to pilot new programs.
Cultural and Linguistic Expertise. We have
over 28 years of experience developing targeted health care
programs for culturally diverse Medicaid members, and believe we
are well-qualified to successfully serve these populations. We
contract with a diverse network of community-oriented providers
who have the capabilities to address the linguistic and cultural
needs of our members. We educate employees and providers about
the differing needs among our members. We develop member
education materials in a variety of media and languages and
ensure that the literacy level is appropriate for our target
audience.
Medical Management. We believe that our
experience as a health care provider has helped us to improve
medical outcomes for our members while at the same time
enhancing the cost-effectiveness of care. We carefully monitor
day-to-day medical management to provide appropriate care to our
members, contain costs, and ensure an efficient delivery
network. We have developed disease management and health
education programs that address the
4
particular health care needs of our members. We have established
pharmacy management programs and policies that have allowed us
to manage our pharmaceutical costs effectively. For example, our
staff pharmacists educate our providers on the use of generic
drugs rather than brand drugs.
Our
Strategy
Our objective is to be an innovative health care leader
providing quality care and accessible services in an efficient
and caring manner to Medicaid, CHIP, Medicare, and other
financially vulnerable members. To achieve this objective, we
intend to:
Focus On Serving Financially Vulnerable Families And
Individuals. We believe that the Medicaid and
low-income Medicare population, which is characterized by
significant ethnic diversity, requires unique services to meet
its health care needs. Our more than 28 years of experience
in serving this population has provided us significant expertise
in meeting the unique needs of our members.
Increase Our Membership. We have grown our
membership through a combination of acquisitions,
start-up
health plans, serving new populations, and internal or organic
growth. Increasing our membership provides the opportunity to
grow and diversify our revenues, increase profits, enhance
economies of scale, and strengthen our relationships with
providers and government agencies. We will continue to seek to
grow our membership by expanding within existing markets and
entering new strategic markets.
|
|
|
|
|
Expand within existing markets. We expect to
grow in existing markets by expanding our service areas and
provider networks, increasing awareness of the Molina brand
name, extending our services to new populations, maintaining
positive provider relationships, and integrating members from
other health plans.
|
|
|
|
Enter new strategic markets. We intend to
enter new markets by acquiring existing businesses or building
our own operations. We will focus our expansion in markets with
competitive provider communities, supportive regulatory
environments, significant size and, where possible, mandated
Medicaid managed care enrollment.
|
Provide quality cost-effective care. We will
use our information systems, strong provider networks, and
first-hand provider experience to further develop and utilize
effective medical management and other programs that address the
distinct needs of our members. While improving the quality of
care, these programs also facilitate the cost-effective delivery
of that care. To document our commitment to quality, each Molina
Healthcare health plan has adopted goals: (1) to achieve or
continue accreditation by the National Committee for Quality
Assurance, or NCQA, and (2) to achieve scores under the
Healthcare Effectiveness Data and Information Set (HEDIS) at the
75th percentile for Medicaid plans. It is our goal to be
the health plan of choice, recognized for the quality and
accessibility of our services. Financially vulnerable families
and individuals covered by government programs have
traditionally faced long-standing barriers to accessing care
that include language, culture, and literacy. We want to be
known for our ability to help others overcome these barriers.
Among physicians, hospitals, and other providers, we want to be
known for prompt and accurate payment of claims and sound
medical decisions.
Leverage operational efficiencies. Our
centralized administrative infrastructure, flexible information
systems, and dedication to controlling administrative costs
provide economies of scale. We believe our administrative
infrastructure has significant expansion capacity, allowing us
to integrate new members from expansion within existing markets
and entry into new markets.
5
Our
Health Plans
As of December 31, 2008, our health plans were located in
California, Florida, Michigan, Missouri, Nevada, New Mexico,
Ohio, Texas, Utah, and Washington. Additionally, we operate
three county primary care clinics in Virginia. An overview of
our health plans and their principal governmental program
contracts with the relevant state authority as of
December 31, 2008 is provided below:
|
|
|
|
|
State
|
|
Expiration Date
|
|
Contract Description or Covered Program
|
|
California
|
|
3-31-10
|
|
Subcontract with Health Net for services to Medi-Cal members
under Health Nets Los Angeles County Two-Plan Model
Medi-Cal contract with the California Department of Health
Services (DHS).
|
California
|
|
12-31-12
|
|
Medi-Cal contract for Sacramento Geographic Managed Care Program
with California Department of Health Services (DHS).
|
California
|
|
3-31-11
|
|
Two Plan Model Medi-Cal contract for Riverside and
San Bernardino Counties (Inland Empire) with California
Department of Health Services (DHS).
|
California
|
|
6-30-09
|
|
Medi-Cal contract for San Diego Geographic Managed Care
Program with California Department of Health Services (DHS).
|
California
|
|
6-30-09
|
|
Healthy Families contract (Californias CHIP program) with
California Managed Risk Medical Insurance Board (MRMIB).
|
Florida
|
|
8-31-09
|
|
Medicaid contract with the Florida Agency for Health Care
Administration.
|
Michigan
|
|
9-30-09
|
|
Medicaid contract with State of Michigan.
|
Missouri
|
|
9-30-09
|
|
Medicaid contract with the Missouri Department of Social
Services.
|
Nevada
|
|
12-31-09
|
|
Medicare Advantage contract with CMS.
|
New Mexico
|
|
6-30-09
|
|
Salud! Medicaid Managed Care Program contract (including CHIP)
with New Mexico Human Services Department (HSD).
|
Ohio
|
|
6-30-09
|
|
Medicaid contract with Ohio Department of Job and Family
Services (ODJFS).
|
Texas
|
|
8-31-10
|
|
Medicaid contract with Texas Health and Human Services
Commission (HHSC).
|
Utah
|
|
6-30-09
|
|
Medicaid contract with Utah Department of Health.
|
Washington
|
|
12-31-09
|
|
Basic Health Plan and Basic Health Plus Programs contract with
Washington State Health Care Authority (HCA).
|
Washington
|
|
12-31-09
|
|
Healthy Options Program (including Medicaid and CHIP) contract
with State of Washington Department of Social and Health
Services.
|
In addition to the foregoing, our health plans in California,
Michigan, Nevada, New Mexico, Texas, Utah, and Washington have
entered into a standardized form of contract with CMS with
respect to their operation of a MA SNP, and our health plans in
California, Michigan, Nevada, New Mexico, Texas, Utah, and
Washington have also entered into a standardized form of
contract with CMS with respect to their operations of an MA-PD
plan. These contracts are renewed annually and were most
recently renewed as of January 1, 2009.
Our health plan subsidiaries have generally been successful in
obtaining the renewal by amendment of their contracts in each
state prior to the actual expiration of their contracts.
However, there can be no assurance that these contracts will
continue to be renewed. For example, our Indiana plans
contract with the state of Indiana expired without being renewed
effective December 31, 2006.
Our contracts with state and local governments determine the
type and scope of health care services that we arrange for our
members. Generally, our contracts require us to arrange for
preventive care, office visits, inpatient and outpatient
hospital and medical services, and pharmacy benefits. We are
usually paid a negotiated amount per member per month, with the
amount varying from contract to contract. Generally, that amount
is higher in states where we are required to offer more
extensive health benefits. We are also paid an additional amount
for each newborn delivery in Michigan, Missouri, New Mexico,
Ohio, Texas and Washington. Since July 2002, our Utah health
plan has been reimbursed by the state for all medical costs
incurred by its Medicaid members plus a 9%
6
administrative fee. Effective as of January 1, 2009, that
administrative fee was reduced to 8%. In general, either party
may terminate our state contracts with or without cause upon
30 days to nine months prior written notice. In addition,
most of these contracts contain renewal options that are
exercisable by the state.
California. As of December 31, 2008, our
California health plan served 322,000 members. We arrange health
care services for our members either as a direct contractor to
the state or through subcontracts with other health plans. Our
plan serves the counties of Los Angeles, Riverside,
San Bernardino, San Diego, Sacramento, and Yolo. Our
Medi-Cal members in Los Angeles County are served pursuant to a
subcontract we have entered into with Health Net, with Health
Net in turn contracting with the state. Our California health
plan also operates 17 of its own primary care community clinics.
Florida. In August 2008, we announced our
intention to acquire Florida NetPASS, LLC (NetPASS),
a provider of care management and administrative services at
that time to approximately 55,000 Florida MediPass members in
South and Central Florida. In October 2008, we announced that
our wholly owned subsidiary, Molina Healthcare of Florida, Inc.,
was awarded a Medicaid managed care contract by the state of
Florida. The term of the contract commenced on December 1,
2008, at which time Molina Healthcare of Florida began its
initial enrollment of NetPASS Medicaid members, with the full
transition of NetPASS members expected to be completed by the
third quarter of 2009. As of March 1, 2009, our Florida
plan served approximately 17,000 members.
Michigan. As of December 31, 2008, our
Michigan health plan served 206,000 members, and operated in 42
of the states 83 counties, including the Detroit
metropolitan area.
Missouri. As of December 31, 2008, our
Missouri health plan served 77,000 members, and operated in 57
of the states 114 counties. Our Missouri health plan was
acquired effective November 1, 2007.
Nevada. As of December 31, 2008, our
Nevada health plan served approximately 700 Medicare members,
and had no Medicaid enrollment. Our Nevada health plan became
operational on June 1, 2007.
New Mexico. As of December 31, 2008, our
New Mexico health plan served 84,000 members, and operated in
all of New Mexicos 33 counties.
Ohio. As of December 31, 2008, our Ohio
health plan served 176,000 members, and operated in 50 of the
states 88 counties.
Texas. As of December 31, 2008, our Texas
health plan served 31,000 members, serving STAR and CHIP members
in 6 counties and STAR PLUS members in 13 counties. STAR stands
for State of Texas Access Reform, and is Texas Medicaid
managed care program. STAR PLUS is the Texas Medicaid managed
care program serving the aged, blind or disabled and includes a
long-term care component.
Utah. As of December 31, 2008, our Utah
health plan served 61,000 members (including 2,400 Medicare
Advantage SNP members). Our Utah health plan serves Medicaid
members in 26 of the states 29 counties, including the
Salt Lake City metropolitan area, and CHIP members in all 29
counties.
Virginia. On July 1, 2008, Molina
Healthcare of Virginia, Inc. began to operate the Fairfax County
Community Health Care Network. This network consists of three
county clinics, providing comprehensive medical services to over
12,000 of the countys uninsured residents.
Washington. As of December 31, 2008, our
Washington health plan served 299,000 members, and operated in
32 of the states 39 counties.
Provider
Networks
We arrange health care services for our members through
contracts with providers that include independent physicians and
groups, hospitals, ancillary providers, and our own clinics. Our
strategy is to contract with providers in those geographic areas
and medical specialties necessary to meet the needs of our
members. We also strive to ensure that our providers have the
appropriate cultural and linguistic experience and skills.
7
The following table shows the total approximate number of
primary care physicians, specialists, and hospitals
participating in our network as of December 31, 2008:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Primary Care
|
|
|
|
|
|
|
|
|
|
Physicians
|
|
|
Specialists
|
|
|
Hospitals
|
|
|
California
|
|
|
2,833
|
|
|
|
7,162
|
|
|
|
81
|
|
Florida
|
|
|
226
|
|
|
|
85
|
|
|
|
8
|
|
Michigan
|
|
|
2,103
|
|
|
|
4,319
|
|
|
|
66
|
|
Missouri
|
|
|
1,828
|
|
|
|
4,282
|
|
|
|
97
|
|
Nevada
|
|
|
706
|
|
|
|
2,091
|
|
|
|
27
|
|
New Mexico
|
|
|
1,511
|
|
|
|
5,799
|
|
|
|
60
|
|
Ohio
|
|
|
1,682
|
|
|
|
10,585
|
|
|
|
123
|
|
Texas
|
|
|
1,329
|
|
|
|
3,939
|
|
|
|
58
|
|
Utah
|
|
|
1,101
|
|
|
|
3,178
|
|
|
|
35
|
|
Washington
|
|
|
2,710
|
|
|
|
5,815
|
|
|
|
87
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
|
16,029
|
|
|
|
47,255
|
|
|
|
642
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Physicians. We contract with both primary care
physicians and specialists, many of whom are organized into
medical groups or independent practice associations. Primary
care physicians provide office-based primary care services.
Primary care physicians may be paid under capitation or
fee-for-service contracts and may receive additional
compensation by providing certain preventive services. Our
specialists care for patients for a specific episode or
condition, usually upon referral from a primary care physician,
and are usually compensated on a fee-for-service basis. When we
contract with groups of physicians on a capitated basis, we
monitor their solvency.
Hospitals. We generally contract with
hospitals that have significant experience dealing with the
medical needs of the Medicaid population. We reimburse hospitals
under a variety of payment methods, including fee-for-service,
per diems, diagnostic-related groups, or DRGs, capitation, and
case rates.
Primary Care Clinics. Our California health
plan operates 17 company-owned primary care clinics in
California staffed by our physicians, physician assistants, and
nurse practitioners. These clinics are located in neighborhoods
where our members live, and provide us a first-hand opportunity
to understand the special needs of our members. The clinics
assist us in developing and implementing community education,
disease management, and other programs. The clinics also give us
direct clinic management experience that enables us to better
understand the needs of our contracted providers. In addition,
we have a non-licensed subsidiary in Virginia which manages
three health care clinics for Fairfax County.
Medical
Management
Our experience in medical management extends back to our roots
as a provider organization. Primary care physicians are the
focal point of the delivery of health care to our members,
providing routine and preventive care, coordinating referrals to
specialists, and assessing the need for hospital care. This
model has proven to be an effective method for coordinating
medical care for our members. The underlying challenge we face
is to coordinate health care so that our members receive timely
and appropriate care from the right provider at the appropriate
cost. In support of this goal, and to ensure medical management
consistency among our various state health plans, we
continuously refine and upgrade our medical management efforts
at both the corporate and subsidiary levels.
We seek to ensure quality care for our members on a
cost-effective basis through the use of certain key medical
management and cost control tools. These tools include
utilization management, case and health management, and provider
network and contract management.
Utilization Management. We continuously review
utilization patterns with the intent to optimize quality of care
and ensure that only appropriate services are rendered in the
most cost-effective manner. Utilization management, along with
our other tools of medical management and cost control, is
supported by a centralized corporate medical informatics
function which utilizes third-party software and data
warehousing tools to convert
8
data into actionable information. We use a predictive modeling
capability that supports a proactive case and health management
approach both for us and our affiliated physicians.
Case and Health Management. We seek to
encourage quality, cost-effective care through a variety of case
and health management programs, including disease management
programs, educational programs, and pharmacy management programs.
Disease Management Programs. We develop
specialized disease management programs that address the
particular health care needs of our members. motherhood
matters!sm
is a comprehensive program designed to improve pregnancy
outcomes and enhance member satisfaction. breathe with
ease!sm
is a multi-disciplinary disease management program that provides
intensive health education resources and case management
services to assist physicians caring for asthmatic members
between the ages of three and fifteen. Healthy Living with
Diabetessm
is a diabetes disease management program. Heart Health
Living is a cardiovascular disease management program
for members who have suffered from congestive heart failure,
angina, heart attack, or high blood pressure.
Educational Programs. Educational programs are
an important aspect of our approach to health care delivery.
These programs are designed to increase awareness of various
diseases, conditions, and methods of prevention in a manner that
supports our providers while meeting the unique needs of our
members. For example, we provide our members with information to
guide them through various episodes of care. This information,
which is available in several languages, is designed to educate
parents on the use of primary care physicians, emergency rooms,
and nurse call centers.
Pharmacy Management Programs. Our pharmacy
management programs focus on physician education regarding
appropriate medication utilization and encouraging the use of
generic medications. Our pharmacists and medical directors work
with our pharmacy benefits manager to maintain a formulary that
promotes both improved patient care and generic drug use. We
employ full-time pharmacists and pharmacy technicians who work
with physicians to educate them on the uses of specific drugs,
the implementation of best practices, and the importance of
cost-effective care.
Provider Network and Contract Management. The
quality, depth, and scope of our provider network are essential
if we are to ensure quality, cost-effective care for our
members. In partnering with quality, cost-effective providers,
we utilize clinical and financial information derived by our
medical informatics function, as well as the experience we have
gained in serving Medicaid members to gain insight into the
needs of both our members and our providers. As we grow in size,
we seek to strengthen our ties with high-quality, cost-effective
providers by offering them greater patient volume.
Plan
Administration and Operations
Management Information Systems. All of our
health plan information technology and systems operate on a
single platform. This approach avoids the costs associated with
maintaining multiple systems, improves productivity, and enables
medical directors to compare costs, identify trends, and
exchange best practices among our plans. Our single platform
also facilitates our compliance with current and future
regulatory requirements.
The software we use is based on client-server technology and is
scalable. We believe the software is flexible, easy to use, and
allows us to accommodate anticipated enrollment growth and new
contracts. The open architecture of the system gives us the
ability to transfer data from other systems without the need to
write a significant amount of computer code, thereby
facilitating the integration of new plans and acquisitions.
We have designed our corporate website with a focus on ease of
use and visual appeal. Our website has a secure ePortal which
allows providers, members, and trading partners to access
individualized data. The ePortal allows the following
self-services:
|
|
|
|
|
Provider Self Services. Providers have the
ability to access information regarding their members and
claims. Key functionalities include Check Member Eligibility,
View Claim, and View/Submit Authorizations.
|
9
|
|
|
|
|
Member Self Services. Members can access
information regarding their personal data, and can perform the
following key functionalities: View Benefits, Request New ID
Card, Print Temporary ID Card, and Request Change of Address/PCP.
|
|
|
|
File Exchange Services. Various trading
partners such as service partners, providers,
vendors, management companies, and individual IPAs
are able to exchange data files (HIPAA or any other proprietary
format) with us using the file exchange functionality.
|
Best Practices. We continuously seek to
promote best practices. Our approach to quality is broad,
encompassing traditional medical management and the improvement
of our internal operations. We have staff assigned full-time to
the development and implementation of a uniform, efficient, and
quality-based medical care delivery model for our health plans.
These employees coordinate and implement Company-wide programs
and strategic initiatives such as preparation of the Health
Employer Data and Information Set (HEDIS) and accreditation by
the National Committee on Quality Assurance, or NCQA. We use
measures established by the NCQA in credentialing the physicians
in our network. We routinely use peer review to assess the
quality of care rendered by providers. At December 31,
2008, six of our ten health plans were accredited by the NCQA.
In January 2009, our Ohio health plan received its NCQA
accreditation. Our Texas health plan expects to apply for NCQA
accreditation review in 2009. Our Missouri plan will undergo
NCQA review in 2010, and our Nevada plan expects to apply for
NCQA review as soon as it is eligible.
Claims Processing. All of our health plans
operate on a single managed care platform for claims processing
(the QNXT 3.4 system), with the exception of our Missouri plan
which we expect will be migrated to the Molina standard platform
in the fourth quarter of 2009.
Compliance. Our health plans have established
high standards of ethical conduct. Our compliance programs are
modeled after the compliance guidance statements published by
the Office of the Inspector General of the U.S. Department
of Health and Human Services. Our uniform approach to compliance
makes it easier for our health plans to share information and
practices and reduces the potential for compliance errors and
any associated liability.
Disaster Recovery. We have established a
disaster recovery and business resumption plan, with
back-up
operating sites, to be deployed in the case of a major
disruptive event.
Competition
We operate in a highly competitive
environment. The Medicaid managed care industry
is fragmented and currently subject to significant changes as a
result of business consolidations, new strategic alliances
entered into by other managed care organizations, and the entry
into the industry of large commercial health plans. We compete
with a large number of national, regional, and local Medicaid
service providers, principally on the basis of size, location,
and quality of provider network, quality of service, and
reputation. Below is a general description of our principal
competitors for state contracts, members, and providers:
|
|
|
|
|
Multi-Product Managed Care Organizations
National and regional managed care organizations
that have Medicaid members in addition to numerous commercial
health plan and Medicare members.
|
|
|
|
Medicaid HMOs National and regional managed
care organizations that focus principally on providing health
care services to Medicaid beneficiaries, many of which operate
in only one city or state.
|
|
|
|
Prepaid Health Plans Health plans that
provide less comprehensive services on an at-risk basis or that
provide benefit packages on a non-risk basis.
|
|
|
|
Primary Care Case Management Programs
Programs established by the states through
contracts with primary care providers to provide primary care
services to Medicaid beneficiaries, as well as to provide
limited oversight of other services.
|
We will continue to face varying levels of competition. Health
care reform proposals may cause organizations to enter or exit
the market for government sponsored health programs. However,
the licensing requirements and bidding and contracting
procedures in some states may present partial barriers to entry
into our industry.
10
We compete for government contracts, renewals of those
government contracts, members, and providers. State agencies
consider many factors in awarding contracts to health plans.
Among such factors are the health plans provider network,
medical management, degree of member satisfaction, timeliness of
claims payment, and financial resources. Potential members
typically choose a health plan based on a specific provider
being a part of the network, the quality of care and services
available, accessibility of services, and reputation or name
recognition of the health plan. We believe factors that
providers consider in deciding whether to contract with a health
plan include potential member volume, payment methods,
timeliness and accuracy of claims payment, and administrative
service capabilities.
Regulation
Our health plans are regulated by both state and federal
government agencies. Regulation of managed care products and
health care services is an evolving area of law that varies from
jurisdiction to jurisdiction. Regulatory agencies generally have
discretion to issue regulations and interpret and enforce laws
and rules. Changes in applicable laws and rules occur frequently.
To operate a health plan in a given state, we must apply for and
obtain a certificate of authority or license from that state.
Our 10 operating health plans are licensed to operate as health
maintenance organizations, or HMOs, in each of California,
Florida, Michigan, Missouri, Nevada, New Mexico, Ohio, Texas,
Utah, and Washington. In those states we are regulated by the
agency with responsibility for the oversight of HMOs which, in
most cases, is the state department of insurance. In California,
however, the agency with responsibility for the oversight of
HMOs is the Department of Managed Health Care. Licensing
requirements are the same for us as they are for health plans
serving commercial or Medicare members. We must demonstrate that
our provider network is adequate, that our quality and
utilization management processes comply with state requirements,
and that we have adequate procedures in place for responding to
member and provider complaints and grievances. We must also
demonstrate that we can meet requirements for the timely
processing of provider claims, and that we can collect and
analyze the information needed to manage our quality improvement
activities. In addition, we must prove that we have the
financial resources necessary to pay our anticipated medical
care expenses and the infrastructure needed to account for our
costs.
Each of our health plans is required to report quarterly on its
operating results to the appropriate state regulatory agencies,
and to undergo periodic examinations and reviews by the state in
which it operates. The health plans generally must obtain
approval from the state before declaring dividends in excess of
certain thresholds. Each health plan must maintain its net worth
at an amount determined by statute or regulation. Any
acquisition of another plans members must also be approved
by the state, and our ability to invest in certain financial
securities may be prescribed by statute.
In addition, we are also regulated by each states
department of health services or the equivalent agency charged
with oversight of Medicaid and CHIP. These agencies typically
require demonstration of the same capabilities mentioned above
and perform periodic audits of performance, usually annually.
Medicaid. Medicaid was established under the
U.S. Social Security Act to provide medical assistance to
the poor. Although both the federal and state governments
jointly fund it, Medicaid is a state-operated and
state-implemented program. Our contracts with the state Medicaid
programs impose various requirements on us in addition to those
imposed by applicable federal and state laws and regulations.
Within broad guidelines established by the federal government,
each state:
|
|
|
|
|
establishes its own member eligibility standards;
|
|
|
|
determines the type, amount, duration, and scope of services;
|
|
|
|
sets the rate of payment for health care services; and
|
|
|
|
administers its own program.
|
We obtain our Medicaid contracts in different ways. Some states,
such as Washington, award contracts to any applicant
demonstrating that it meets the states requirements. Other
states, such as California, engage in a competitive bidding
process. In all cases, we must demonstrate to the satisfaction
of the state Medicaid program that
11
we are able to meet the states operational and financial
requirements. These requirements are in addition to those
required for a license and are targeted to the specific needs of
the Medicaid population. For example:
|
|
|
|
|
We must measure provider access and availability in terms of the
time needed to reach the doctors office using public
transportation;
|
|
|
|
Our quality improvement programs must emphasize member education
and outreach and include measures designed to promote
utilization of preventive services;
|
|
|
|
We must have linkages with schools, city or county health
departments, and other community-based providers of health care,
to demonstrate our ability to coordinate all of the sources from
which our members may receive care;
|
|
|
|
We must be able to meet the needs of the disabled and others
with special needs;
|
|
|
|
Our providers and member service representatives must be able to
communicate with members who do not speak English or who are
deaf; and
|
|
|
|
Our member handbook, newsletters, and other communications must
be written at the prescribed reading level, and must be
available in languages other than English.
|
In addition, we must demonstrate that we have the systems
required to process enrollment information, to report on care
and services provided, and to process claims for payment in a
timely fashion. We must also have the financial resources needed
to protect the state, our providers, and our members against the
insolvency of one of our health plans.
Once awarded, our contracts generally have terms of one to four
years, with renewal options at the discretion of the states. Our
contracts generally set forth the requirements for operating in
the Medicaid sector, and include provisions relating to:
eligibility; enrollment and disenrollment processes; covered
services; eligible providers; subcontractors; record-keeping and
record retention; periodic financial and informational
reporting; quality assurance; marketing; financial standards;
timeliness of claims payments; health education and wellness and
prevention programs; safeguarding of member information; fraud
and abuse detection and reporting; grievance procedures; and
organization and administrative systems. A health plans
compliance with these requirements is subject to monitoring by
state regulators. A health plan is subject to periodic
comprehensive quality assurance evaluation by the insurance
department of the jurisdiction that licenses the health plan,
and must submit periodic utilization reports and other
information to state or county Medicaid authorities. Health
plans are not permitted to enroll members directly, and are
permitted to market only in accordance with strict guidelines.
Most health plans must also submit quarterly and annual
statutory financial statements and utilization reports, as well
as many other reports in accordance with individual state
requirements.
Our health plans have generally been successful in obtaining the
renewal by amendment of their contracts in each state prior to
the actual expiration of their contracts. However, there can be
no assurance that these contracts will continue to be renewed.
The Medicaid managed care contracts of our Michigan and Missouri
health plans are each the subject of a new Request for Proposal,
or RFP, during 2009.
HIPAA. In 1996, Congress enacted the Health
Insurance Portability and Accountability Act of 1996, or HIPAA.
All health plans are subject to HIPAA, including ours. HIPAA
generally requires health plans to:
|
|
|
|
|
Establish the capability to receive and transmit electronically
certain administrative health care transactions, like claims
payments, in a standardized format,
|
|
|
|
Afford privacy to patient health information, and
|
|
|
|
Protect the privacy of patient health information through
physical and electronic security measures.
|
The American Recovery and Reinvestment Act of 2009 further
expands the coverage of HIPAA by, among other things, extending
the privacy and security provisions, mandating new regulations
around electronic medical records, expanding enforcement
mechanisms, allowing the state Attorneys General to bring
enforcement actions and increasing penalties for violations.
12
Fraud and Abuse Laws. Federal and state
governments have made investigating and prosecuting health care
fraud and abuse a priority. Fraud and abuse prohibitions
encompass a wide range of activities, including kickbacks for
referral of members, billing for unnecessary medical services,
improper marketing, and violations of patient privacy rights.
Companies involved in public health care programs such as
Medicaid are often the subject of fraud and abuse
investigations. The regulations and contractual requirements
applicable to participants in these public-sector programs are
complex and subject to change. Although we believe that our
compliance efforts are adequate, we will continue to devote
significant resources to support our compliance efforts.
Employees
As of December 31, 2008, we had approximately
2,500 employees. Our employee base is multicultural and
reflects the diverse Medicaid and Medicare membership we serve.
We believe we have good relations with our employees. None of
our employees is represented by a union.
RISK
FACTORS
This annual report on
Form 10-K
and the documents we incorporate by reference in this report
contain forward-looking statements within the meaning of
Section 27A of the Securities Act of 1933, as amended (the
Securities Act), and Section 21E of the
Securities Exchange Act of 1934, as amended (the Exchange
Act). Other than statements of historical fact, all
statements that we include in this report and in the documents
we incorporate by reference may be deemed to be forward-looking
statements for purposes of the Securities Act and the Exchange
Act. Such forward-looking statements may be identified by words
such as anticipates, believes,
could, estimates, expects,
guidance, intends, may,
outlook, plans, projects,
seeks, will, or similar words or
expressions.
Investing in our securities involves a high degree of risk.
Before making an investment decision, you should carefully read
and consider the following risk factors, as well as the other
information we include or incorporate by reference in this
report and the information in the other reports we file with the
SEC. Such risk factors should be considered not only with regard
to the information contained in this annual report, but also
with regard to the information and statements in the other
periodic or current reports we file with the SEC, as well as our
press releases, presentations to securities analysts or
investors, or other communications made by or with the approval
of one of our executive officers. We cannot guarantee that we
will actually achieve the results contemplated or disclosed in
our forward-looking statements. Such statements may turn out to
be wrong due to the inherent uncertainties associated with
future events. Accordingly, you should not place undue reliance
on our forward-looking statements, which reflect
managements analyses, judgments, beliefs, or expectations
only as of the date they are made.
If any of the events described in the following risk factors
actually occur, our business, results of operations, financial
condition, cash flows, or prospects could be materially
adversely affected. The risks and uncertainties described below
are those that we currently believe may materially affect us.
Additional risks and uncertainties that we are unaware of or
that we currently deem immaterial may also become important
factors that may materially affect us. Except to the extent
otherwise required by federal securities laws, we do not
undertake to address or update forward-looking statements in
future filings or communications regarding our business or
operating results, and do not undertake to address how any of
these factors may have caused results to differ from discussions
or information contained in previous filings or
communications.
Our
profitability depends on our ability to accurately predict and
effectively manage our medical care costs.
Our profitability depends to a significant degree on our ability
to accurately predict and effectively manage our medical care
costs. Historically, our medical care cost ratio, meaning our
medical care costs as a percentage of our premium revenue, has
fluctuated substantially, and has also varied across our state
health plans. Because the premium payments we receive are
generally fixed in advance and we operate with a narrow profit
margin, relatively small changes in our medical care cost ratio
can create significant changes in our overall financial results.
For
13
example, if our overall medical care ratio for 2008 of 84.8% had
been one percentage point higher, or 85.8%, our earnings for
2008 would have been $1.60 per diluted share rather than our
actual 2008 earnings of $2.25 per diluted share, a 29% reduction
in our earnings.
Factors that may affect our medical care costs include the level
of utilization of health care services, increases in hospital
costs, an increased incidence or acuity of high dollar claims
related to catastrophic illnesses or medical conditions such as
hemophilia for which we do not have adequate reinsurance
coverage, increased maternity costs, payment rates that are not
actuarially sound, changes in state eligibility certification
methodologies, unexpected patterns in the annual flu season,
relatively low levels of hospital and specialty provider
competition in certain geographic areas, increases in the cost
of pharmaceutical products and services, changes in health care
regulations and practices, epidemics, new medical technologies,
and other various external factors. Many of these factors are
beyond our control and could reduce our ability to accurately
predict and effectively manage the costs of providing health
care services. The inability to forecast and manage our medical
care costs or to establish and maintain a satisfactory medical
care cost ratio, either with respect to a particular state
health plan or across the consolidated entity, could have a
material adverse effect on our business, financial condition,
cash flows, or results of operations. For additional information
regarding this risk, see Item 7. Managements
Discussion and Analysis of Financial Condition and Results of
Operations Critical Accounting Policies.
A
failure to accurately estimate incurred but not reported medical
care costs may negatively impact our results of
operations.
Because of the time lag between when medical services are
actually rendered by our providers and when we receive, process,
and pay a claim for those medical services, we must continually
estimate our medical claims liability at particular points in
time, and establish claims reserves related to such estimates.
Our estimated reserves for such incurred but not
paid, or IBNP medical care costs, are based on numerous
assumptions. We estimate our medical claims liabilities using
actuarial methods based on historical data adjusted for claims
receipt and payment experience (and variations in that
experience), changes in membership, provider billing practices,
health care service utilization trends, cost trends, product
mix, seasonality, prior authorization of medical services,
benefit changes, known outbreaks of disease or increased
incidence of illness such as influenza, provider contract
changes, changes to Medicaid fee schedules, and the incidence of
high dollar or catastrophic claims. Our ability to accurately
estimate claims for our newer health plans in Florida and
Missouri is impacted by the more limited claims payment history
of those health plans. Likewise, our ability to accurately
estimate claims for our newer lines of business or populations,
such as with respect to Medicare Advantage or aged, blind or
disabled Medicaid members, is impacted by the more limited
experience we have had with those populations. Finally, with
regard to the new Medicaid and CHIP members we expect to enroll
in 2009 through organic growth due primarily to the recession,
new members may be disproportionately costly due to high
utilization in their first several months of Medicaid or CHIP
membership as a result of their previously having been uninsured
and therefore not seeking or deferring medical treatment.
The IBNR estimation methods we use and the resulting reserves
that we establish are reviewed and updated, and adjustments, if
deemed necessary, are reflected in the current period. Given the
numerous uncertainties inherent in such estimates, our actual
claims liabilities for a particular quarter or other period
could differ significantly from the amounts estimated and
reserved for that quarter or period. Our actual claims
liabilities have varied and will continue to vary from our
estimates, particularly in times of significant changes in
utilization, medical cost trends, and populations and markets
served.
If our actual liability for claims payments is higher than
estimated, our earnings per share in any particular quarter or
annual period could be negatively affected. Our estimates of
IBNP may be inadequate in the future, which would negatively
affect our results of operations for the relevant time period.
Furthermore, if we are unable to accurately estimate IBNP, our
ability to take timely corrective actions may be limited,
further exacerbating the extent of the negative impact on our
results. For additional information regarding this risk, see
Item 7. Managements Discussion and Analysis of
Financial Condition and Results of Operations
Critical Accounting Policies.
14
The
2008-09 recession and resulting pressures on state budgets
may result in funding for Medicaid or CHIP that does not keep
pace with the growth in member enrollment.
As a result of the current recession and rising unemployment
levels, overall Medicaid enrollment and Medicaid costs are
projected to increase in 2009. In addition, the federal
government recently approved a significant expansion of the CHIP
program, which should lead to increased CHIP enrollment and
costs.
However, most state governments are currently facing significant
budget shortfalls for their 2009 and 2010 fiscal years. These
budget pressures have already caused many states to cut their
spending, to tap into their budget reserves, and to seek to
raise revenues in order to balance their budgets. Because
governmental health care programs account for such a large
portion of state budgets, efforts to contain overall government
spending and to achieve a balanced budget often result in
significant political pressure being directed at the funding for
these health care programs. With the exception of the relatively
small portion of our revenues which come from Medicare, nearly
all of our premium revenues are derived from the joint federal
and state funding of the Medicaid and CHIP programs. Thus, the
completeness of the funding under our various state contracts,
or the rate increases we expect to receive during the course of
a year, can be jeopardized during times of state budget crises.
All of the states in which we currently operate our health
plans with the sole exception of Texas
are currently facing significant budgetary pressures.
In recognition of this problem and to help ease the pressure
caused by shortfalls in state budgets, the federal government
enacted on February 17, 2009 the American Recovery and
Reinvestment Act of 2009. As part of this legislation, the
federal government increased the amount of funding for federal
Medicaid matching by approximately $87 billion for the
period between October 1, 2008 and December 31, 2010.
The actual matching percentage is computed from a formula that
takes into account the average per capita income for each state
relative to the national average, and a states
unemployment rate. As a result of the passage of this
legislation, the share of Medicaid costs that are paid for by
the federal government will go up, and the share of costs that
are paid for by the states will go down.
However, in order for states to receive these increased federal
matching funds, they must first budget for and actually spend
their own state dollars to cover their additional Medicaid and
CHIP members. Medicaid spending will therefore be driven by
states available revenues. State governments may have
insufficient funds in order to fully fund these programs or
provide for expanded enrollment. As a result, states may seek to
cut or revise health care programs, optional benefits,
eligibility criteria, or provider rates, causing the funding of
one or more of our state contracts to be curtailed or cut off.
In addition, the timing of payments we receive may be impacted
by state budget shortfalls. As an example, during 2008 some
monthly payments made by the state of California to our
California health plan were several months late, which may occur
again during 2009. Any of these events could have a material
adverse effect on our business, financial condition, cash flows,
or results of operations.
There
are numerous risks associated with the growth and operation of
our Ohio health plan.
Membership at our Ohio health plan has grown rapidly, and the
medical care ratio of our Ohio health plan has been
substantially higher than that historically experienced by the
Company as a whole. At the beginning of 2008, we had projected
that the medical care ratio of our Ohio plan would be 88% for
the full year. The actual medical care ratio of our Ohio health
plan for full year 2008 was 91.1%. For full year 2009, as the
result of risk adjustment payments we expect to receive with
respect to our Ohio ABD members, the expected benefits from our
in-sourcing of behavioral health, and the expected savings
derived from our provider re-contracting efforts, we have
projected that we can lower the medical care ratio of our Ohio
health plan to approximately 87%. In the event these efforts are
unsuccessful, the predicted savings are not realized, or we are
otherwise unable to lower the medical care ratio of our Ohio
health plan, the higher-than-expected medical care ratio of that
plan could negatively impact the financial performance of the
Company as a whole.
In addition, the lower amount of experience of our Ohio Medicaid
and ABD members in accessing managed care and of our local
providers in coordinating managed care services for their
patients may also contribute to a higher than average medical
care ratio. Further, as our Ohio plan continues to grow, we will
be required to increase the amount of regulatory capital we
contribute to it. In 2008, we were required to contribute
$18.4 million in additional regulatory capital to our Ohio
plan. If we are required to contribute additional capital in the
future, our
15
existing cash balances or cash from operations may not be
sufficient to cover such payments, in which case we would be
required to draw down on our credit facility or obtain
additional financing from another source and thereby incur
additional indebtedness. In the event we are unable to lower our
medical care ratio in Ohio, or if the Ohio plan requires a
disproportionate investment of corporate resources or is
otherwise unsuccessful, the poor performance of that health plan
could detrimentally impact the financial performance of the
Company as a whole.
If our
government contracts are not renewed or are terminated, or if
the responsive bids of our health plans for new Medicaid
contracts are not successful, including the 2009 bids of our
Michigan and Missouri health plans, our premium revenues could
be materially reduced and our operating results could be
negatively impacted.
Our government contracts generally run for periods of one year
to four years, and may be successively extended by amendment for
additional periods if the relevant state agency so elects. Our
current contracts expire on various dates over the next several
years. There is no guarantee that any of our government
contracts will be renewed or extended. Moreover, our contracts
may be subject to periodic competitive bidding. As an example,
the Medicaid contracts of our Michigan and Missouri health plans
both expire on September 30, 2009. These health plans will
be required to submit bids in response to the requests for
proposals of the Medicaid authorities in each of Michigan and
Missouri. In the event the responsive bids of our health plans
are not successful, we will lose our Medicaid contract in the
applicable state, and our premium revenues could be materially
reduced as a result. Alternatively, even if our responsive bids
are successful, they may be based upon assumptions regarding
enrollment, utilization, medical costs, or other factors which
could result in the Medicaid contract being less profitable than
we had expected or had previously been the case.
In addition, all of our contracts may be terminated for cause if
we breach a material provision of the contract or violate
relevant laws or regulations. Our contracts with the states are
also subject to cancellation by the state in the event of
unavailability of state or federal funding. In some
jurisdictions, such cancellation may be immediate and in other
jurisdictions a notice period is required. In addition, most
contracts are terminable without cause. We may face increased
competition as other plans, many with greater financial
resources and greater name recognition, attempt to enter our
markets through the contracting process. If we are unable to
renew, successfully re-bid, or compete for any of our government
contracts, or if any of our contracts are terminated or renewed
on less favorable terms, our business, financial condition, cash
flows, or results of operations could be adversely affected.
We
derive our premium revenues from a relatively small number of
state health plans.
We currently derive our premium revenues from ten state health
plans. If we were unable to continue to operate in any of those
ten states and in particular in the plans we operate
in the states of Washington, Ohio, Michigan, California, or
New Mexico or if our current operations in any
portion of the states we are in were significantly curtailed,
our revenues could decrease materially. Our reliance on
operations in a limited number of states could cause our revenue
and profitability to change suddenly and unexpectedly depending
on significant rate reductions, a loss of a material contract,
legislative actions, changes in Medicaid eligibility
methodologies, catastrophic claims, an epidemic or an unexpected
increase in utilization, general economic conditions, and
similar factors in those states. Our inability to continue to
operate in any of the states in which we currently operate, or a
significant change in the nature of our existing operations,
could adversely affect our business, financial condition, cash
flows, or results of operations.
Portions
of our premium revenue are subject to accounting estimates or
retroactive adjustment.
Certain elements of the premium revenue earned by our New
Mexico, Ohio, Texas, and Utah health plans, and by our Medicare
Advantage plans, are subject to accounting estimates. Such
estimates may subsequently prove to be inaccurate or may require
adjustment based upon factual developments. If our accounting
estimates with respect to our anticipated premiums are
inaccurate or previously recognized premiums require retroactive
adjustment, the change in our revenues could have a material
adverse effect on our business, financial condition, cash flows,
or results of operations. For additional information regarding
this risk, see Item 7. Managements Discussion
and Analysis of Financial Condition and Results of
Operations Revenue.
16
Our
business may be negatively affected by major governmental health
care reform proposals.
In response to dramatically escalating health care costs and the
large and growing number of uninsured Americans, legislative
proposals that would reform the health care system have been
advanced by Congress and state legislatures and are currently
pending at the federal and state levels. These changes include
policy changes that would fundamentally change the dynamics of
the health care industry, such as having the federal government
assume a larger role in the health care industry, or effecting a
fundamental restructuring of the Medicare or Medicaid programs.
These proposals may also affect certain aspects of our business,
including contracting with providers, provider reimbursement
methods and payment rates, coverage determinations, mandated
benefits, minimum medical expenditures, claims payment and
processing, drug utilization and patient safety efforts,
collection, use, disclosure, maintenance, and disposal of
individually identifiable health information or personal health
records.
We cannot predict if any of these initiatives will ultimately
become law, or, if enacted, what their terms or the regulations
promulgated pursuant to such laws will be, but their enactment
could increase our costs, expose us to expanded liability and
require us to revise the ways in which we conduct business or
put us at risk for loss of business. In addition, our operating
results could be adversely affected by such changes even if we
correctly predict their occurrence.
In the
event the grandfathering of the Medicaid managed care
organization provider tax in the states of California, Missouri,
and Ohio is not extended past September 30, 2009 or
replacement state programs are not enacted, the Medicaid funds
available for managed care organization in those states,
including for our health plans, could be materially
reduced.
Section 1903(w) of the Social Security Act permits states
to receive federal matching Medicaid funds for revenues
collected through health care-related taxes. Some states use
these taxes to fund increased payment rates to providers,
thereby effectively increasing the states federal matching
rates. The statute defines the term tax to include
any licensing fee, assessment, or other payment mandated by the
state. Prior to the enactment of the Deficit Reduction Act of
2005 (the Deficit Reduction Act), the law had
permitted a state to define the class of items provided by
managed care organizations to mean only revenues received for
Medicaid services. However, the Deficit Reduction Act
effectively eliminated the future use of such a tax by requiring
states to apply the tax broadly to revenue received by health
plans for all services provided, including services provided by
commercial health plans to commercial health plan members. But
for eight states that previously had had managed care
organization provider taxes in place targeting only Medicaid
health plan services, the Deficit Reduction Act delayed the
effective date of this change to October 1, 2009. Included
among those eight grandfathered states were four states in which
we currently operate health plans: California, Michigan,
Missouri, and Ohio. Since the adoption of the Deficit Reduction
Act, those four states have continued to collect a provider tax
on Medicaid managed care organizations, which has resulted in
additional federal Medicaid matching funds being available in
those states for distribution to Medicaid managed care
organizations. These states depend upon revenues raised through
their Medicaid managed care organization provider tax to help
them fund their Medicaid programs.
The affected states are now considering how to comply with the
expiration of the Deficit Reduction Act grandfather clause on
September 30, 2009. One option would be for them to
eliminate the managed care organization provider tax and replace
the lost funds with increases in other Medicaid provider taxes.
Another option would be to modify the existing managed care
organization provider tax to meet the requirements for a
broad-based tax that is imposed on both Medicaid and
non-Medicaid covered services. One of the affected states
Michigan has recently enacted a law
which, effective as of April 1, 2009, repeals the existing
managed care organization provider tax and introduces a new use
tax on entities that have a contract to provide Medicaid
services, thus effectively resolving the issue in that state. In
the event Congress does not further grandfather the Medicaid
managed care organization provider tax in the states of
California, Missouri, and Ohio to support their Medicaid
programs, or if local state programs are not adopted in its
place, the loss of state and federal matching Medicaid funds in
those states starting in October 2009 could materially reduce
the revenues of our California, Missouri, and Ohio health plans,
thereby negatively affecting our business, financial condition,
cash flows, or results of operations.
17
A
sustained drop in the rate of interest earned on our invested
balances could adversely affect our revenues.
Our revenues from invested balances in 2008 were
$21.1 million, whereas our revenues from invested balances
in 2007 were $30.1 million. If the rate of return on our
invested balances in 2008 had matched the rate of return
experienced in 2007, our year-over-year earnings would have
increased by 23% rather than the 10% increase actually
experienced. Thus, prevailing interest rates during the year can
have a significant impact on our revenues and earnings. We have
projected that, on average in fiscal year 2009, our invested
balances will earn interest at the rate of at least 2%. Our
invested balances earned an average of 3.0% in 2008. In the
event the interest earned on our invested balances throughout
2009 averages less than 2% per annum, our business, financial
condition, cash flows, or results of operations could be
adversely affected.
If we
are unable to achieve our projected growth in Medicare members
or our projected medical care ratio with respect to our Medicare
program, our results of operations could be adversely
affected.
Our business strategy includes increasing enrollment for our
members who are dually eligible under both the Medicaid and
Medicare programs, as well as increasing the number of our
members eligible under Medicare alone. Our experience with the
Medicare program and with Medicare members is much more limited
than our experience with Medicaid. The administrative processes,
programmatic requirements, and regulations pertaining to the
Medicare program differ significantly from those of the Medicaid
program. Likewise, the Medicare population has many
characteristics and behavior patterns which differ from the
Medicaid population with which we are familiar. Finally,
Medicare providers, provider networks, and provider relations
also differ from those of Medicaid.
During 2009, we intend to continue to invest in the
infrastructure necessary to grow our Medicare program. We have
projected that we will have enrolled 12,000 Medicare members by
the end of 2009. In the event we are unable to enroll as many
Medicare members as we project or if we are unable to quickly
develop our Medicare expertise and adapt to the differing
requirements and needs of the Medicare program and Medicare
members, our business strategy may be unsuccessful and our
business, financial condition, cash flows, or results of
operations could be adversely affected.
Failure
to attain profitability in any new
start-up
operations could negatively affect our results of
operations.
Start-up
costs associated with a new business can be substantial. For
example, to obtain a certificate of authority to operate as a
health maintenance organization in most jurisdictions, we must
first establish a provider network, have infrastructure and
required systems in place, and demonstrate our ability to obtain
a state contract and process claims. Often we are also required
to contribute significant capital to fund mandated net worth
requirements, performance bonds or escrows, or contingency
guaranties. If we were unsuccessful in obtaining the certificate
of authority, winning the bid to provide services, or attracting
members in sufficient numbers to cover our costs, any new
business of ours would fail. We also could be required by the
state to continue to provide services for some period of time
without sufficient revenue to cover our ongoing costs or to
recover our significant
start-up
costs.
Even if we are successful in establishing a profitable health
plan in a new state, increasing membership, revenues, and
medical costs will trigger increased mandated net worth
requirements which could substantially exceed the net income
generated by the health plan. Rapid growth in an existing state
will also create increased net worth requirements. In such
circumstances we may not be able to fund on a timely basis or at
all the increased net worth requirements with our available cash
resources. The expenses associated with starting up a health
plan in a new state or expanding a health plan in an existing
state could have a significant adverse impact on our business,
financial condition, cash flows, or results of operations.
Difficulties
in executing our acquisition strategy could adversely affect our
business.
The acquisitions of other health plans and the assignment and
assumption of Medicaid contract rights of other health plans
have accounted for a significant amount of our growth over the
last several years. Although we cannot predict with certainty
our rate of growth as the result of acquisitions, we believe
that additional acquisitions of all sizes will be important to
our future growth strategy. Many of the other potential
purchasers of these assets
18
particularly operators of large commercial health
plans have significantly greater financial resources
than we do. Also, many of the sellers may insist on selling
assets that we do not want, such as commercial lines of
business, or may insist on transferring their liabilities to us
as part of the sale of their companies or assets. Even if we
identify suitable targets, we may be unable to complete
acquisitions on terms favorable to us or obtain the necessary
financing for these acquisitions. Further, to the extent we
complete an acquisition, we may be unable to realize the
anticipated benefits from such acquisition because of
operational factors or difficulty in integrating the acquisition
with our existing business. This may include problems involving
the integration of:
|
|
|
|
|
additional employees who are not familiar with our operations or
our corporate culture,
|
|
|
|
new provider networks which may operate on terms different from
our existing networks,
|
|
|
|
additional members who may decide to transfer to other health
care providers or health plans,
|
|
|
|
disparate information, claims processing, and record keeping
systems,
|
|
|
|
internal controls and accounting policies, including those which
require the exercise of judgment and complex estimation
processes, such as estimates of claims incurred but not
reported, accounting for goodwill, intangible assets,
stock-based compensation, and income tax matters, and
|
|
|
|
new regulatory schemes, relationships, practices, and compliance
requirements.
|
Also, we are generally required to obtain regulatory approval
from one or more state agencies when making acquisitions. In the
case of an acquisition of a business located in a state in which
we do not already operate, we would be required to obtain the
necessary licenses to operate in that state. In addition,
although we may already operate in a state in which we acquire a
new business, we would be required to obtain regulatory approval
if, as a result of the acquisition, we will operate in an area
of that state in which we did not operate previously. We may be
unable to obtain the necessary governmental approvals or comply
with these regulatory requirements in a timely manner, if at
all. For all of the above reasons, we may not be able to
consummate our proposed acquisitions as announced from time to
time to sustain our pattern of growth or to realize benefits
from completed acquisitions.
Restrictions
and covenants in our credit facility may limit our ability to
make certain acquisitions or reduce our liquidity and capital
resources.
To provide liquidity, we have a $200 million senior secured
credit facility that matures in May 2012. As of
December 31, 2008, we had no outstanding indebtedness under
our credit facility. Our credit facility imposes numerous
restrictions and covenants, including prescribed consolidated
leverage and fixed charge coverage ratios, net worth
requirements, and acquisition limitations that restrict our
financial and operating flexibility, including our ability to
make certain acquisitions above specified values and declare
dividends without lender approval. As a result of the
restrictions and covenants imposed under our credit facility,
our growth strategy may be negatively impacted by our inability
to act with complete flexibility, or our inability to use our
credit facility in the manner intended.
If we are in default at a time when funds under the credit
facility are required to finance an acquisition, or if a
proposed acquisition does not satisfy the pro forma financial
requirements under our credit facility, we may be unable to use
the credit facility in the manner intended. In addition, if we
were to draw down on our credit facility, or incur other
additional debt in the future, it could have an adverse effect
on our business and future operations. For example, it could:
|
|
|
|
|
require us to dedicate a substantial portion of cash flow from
operations to pay principal and interest on our debt, which
would reduce funds available to fund future working capital,
capital expenditures, and other general operating requirements;
|
|
|
|
increase our vulnerability to general adverse economic and
industry conditions or a downturn in our business; or
|
|
|
|
place us at a competitive disadvantage compared to our
competitors that have less debt.
|
19
In addition, the financial institutions which form the lending
syndicate under our credit facility have recently experienced
significant losses. As a result, such financial institutions may
be unable to fund a loan under our credit facility. In the event
we default under our credit facility or our lenders are unable
to fund a loan request under our credit facility, our
operations, liquidity, and capital resources could be materially
adversely affected.
Adverse
credit market conditions may have a material adverse affect on
our liquidity or our ability to obtain credit on acceptable
terms.
The securities and credit markets have been experiencing extreme
volatility and disruption over the past year. The availability
of credit, from virtually all types of lenders, has been
severely restricted. Such conditions may persist throughout 2009
and beyond. In the event we need access to additional capital to
pay our operating expenses, make payments on our indebtedness,
pay capital expenditures, or fund acquisitions, our ability to
obtain such capital may be limited and the cost of any such
capital may be significant, particularly if we are unable to
access our existing credit facility.
Our access to additional financing will depend on a variety of
factors such as prevailing economic and credit market
conditions, the general availability of credit, the overall
availability of credit to our industry, our credit ratings and
credit capacity, and perceptions of our financial prospects.
Similarly, our access to funds may be impaired if regulatory
authorities or rating agencies take negative actions against us.
If a combination of these factors were to occur, our internal
sources of liquidity may prove to be insufficient, and in such
case, we may not be able to successfully obtain additional
financing on favorable terms or at all. While we have not
attempted to access the credit markets recently, we believe that
if credit could be obtained, the terms and costs of such credit
would be significantly less favorable to us than what was
obtained in our most recent financings.
Ineffective
management of our growth may negatively affect our business,
financial condition, or results of operations.
Depending on acquisitions and other opportunities, we expect to
continue to grow our membership and to expand into other
markets. In fiscal year 2005, we had total premium revenue of
$1.6 billion. In fiscal year 2008, we had total premium
revenue of $3.0 billion, an increase of 88% over a
four-year span. Continued rapid growth could place a significant
strain on our management and on other Company resources. Our
ability to manage our growth may depend on our ability to
strengthen our management team and attract, train, and retain
skilled employees, and our ability to implement and improve
operational, financial, and management information systems on a
timely basis. If we are unable to manage our growth effectively,
our financial condition and results of operations could be
materially and adversely affected. In addition, due to the
initial substantial costs related to acquisitions, rapid growth
could adversely affect our short-term profitability and
liquidity.
Any
changes to the laws and regulations governing our business, or
the interpretation and enforcement of those laws or regulations,
could cause us to modify our operations and could negatively
impact our operating results.
Our business is extensively regulated by the federal government
and the states in which we operate. The laws and regulations
governing our operations are generally intended to benefit and
protect health plan members and providers rather than managed
care organizations. The government agencies administering these
laws and regulations have broad latitude in interpreting and
applying them. These laws and regulations, along with the terms
of our government contracts, regulate how we do business, what
services we offer, and how we interact with members and the
public. For instance, some states mandate minimum medical
expense levels as a percentage of premium revenues. These laws
and regulations, and their interpretations, are subject to
frequent change. The interpretation of certain contract
provisions by our governmental regulators may also change.
Changes in existing laws or regulations, or their
interpretations, or the enactment of new laws or regulations,
could reduce our profitability by imposing additional capital
requirements, increasing our liability, increasing our
administrative and other costs, increasing mandated benefits,
forcing us to restructure our relationships with providers, or
requiring us to implement additional or different programs and
systems. Changes in the interpretation of our contracts could
also reduce our profitability if we have detrimentally relied on
a prior interpretation.
20
Funding
under our contracts is subject to regulatory and programmatic
adjustments and reforms for which we may not be appropriately
compensated.
The federal government and the governments of the states in
which we operate frequently consider legislative and regulatory
proposals regarding Medicaid reform and programmatic changes.
Such proposals involve, among other things, changes in
reimbursement or payment levels based on certain parameters or
member characteristics, changes in eligibility for Medicaid, and
changes in benefits covered such as pharmacy, behavioral health,
or vision. Any of these changes could be made effective
retroactively. If our cost increases resulting from these
changes are not matched by commensurate increases in our
revenue, we would be unable to make offsetting adjustments, such
as supplemental premiums or changes in our benefit plans, as
would a commercial health plan. Any such regulatory or
programmatic reforms at either the federal or state level could
have a material adverse effect on our business, financial
condition, cash flows, or results of operations.
We
face periodic routine and non-routine reviews, audits, and
investigations by government agencies, and these reviews and
audits could have adverse findings, which could negatively
impact our business.
We are subject to various routine and non-routine governmental
reviews, audits, and investigations. Violation of the laws,
regulations, or contract provisions governing our operations, or
changes in interpretations of those laws, could result in the
imposition of civil or criminal penalties, the cancellation of
our contracts to provide managed care services, the suspension
or revocation of our licenses, the exclusion from participation
in government sponsored health programs, or the revision and
recoupment of past payments made based on audit findings. If we
become subject to material fines or if other sanctions or other
corrective actions were imposed upon us, we might suffer a
substantial reduction in profitability, and might also lose one
or more of our government contracts and as a result lose
significant numbers of members and amounts of revenue. In
addition, government receivables are subject to government audit
and negotiation, and government contracts are vulnerable to
disagreements with the government. For instance, CMS announced
in 2008 that it will perform audits of selected Medicare health
plans each year to validate the coding practices of and
supporting documentation maintained by care providers. These
audits involve a review of medical records maintained by
providers, including those in and out of network, and may result
in retrospective or prospective adjustments to payments made to
health plans pursuant to CMS Medicare contracts. The final
amounts we ultimately receive under government contracts may be
different from the amounts we initially recognize in our
financial statements.
Our
business depends on our information and medical management
systems, and our inability to effectively integrate, manage, and
keep secure our information and medical management systems, or
to successfully migrate our main data processing facility to the
new facility we are constructing in New Mexico, could disrupt
our operations.
Our business is dependent on effective and secure information
systems that assist us in, among other things, processing
provider claims, monitoring utilization and other cost factors,
supporting our medical management techniques, and providing data
to our regulators. Our providers also depend upon our
information systems for membership verifications, claims status,
and other information. If we experience a reduction in the
performance, reliability, or availability of our information and
medical management systems, our operations and ability to
produce timely and accurate reports could be adversely affected.
In addition, if the licensor or vendor of any software which is
integral to our operations were to become insolvent or otherwise
fail to support the software sufficiently, our operations could
be negatively affected.
Our information systems and applications require continual
maintenance, upgrading, and enhancement to meet our operational
needs. Moreover, our acquisition activity requires transitions
to or from, and the integration of, various information systems.
Our policy is to upgrade and expand our information systems
capabilities. If we experience difficulties with the transition
to or from information systems or are unable to properly
implement, maintain, upgrade or expand our system, we could
suffer from, among other things, operational disruptions, loss
of members, difficulty in attracting new members, regulatory
problems, and increases in administrative expenses.
We are currently constructing a new health information
technology center in Albuquerque, New Mexico. During 2009, we
anticipate migrating our main data processing functions from our
current facility in Long Beach,
21
California to that new facility. In the event that transition to
New Mexico is disrupted for any reason, or if the information
technology equipment in our new facility malfunctions, our
claims processing, utilization management, or other data
processing functions could be disrupted which would adversely
affect all of our business operations. In addition, we intend
during 2009 to migrate the claims processing functions of our
Missouri health plan to our centralized platform. In the event
that migration is unsuccessful, the business operations of our
Missouri health plan could be adversely affected.
Our business requires the secure transmission of confidential
information over public networks. Advances in computer
capabilities, new discoveries in the field of cryptography, or
other events or developments could result in compromises or
breaches of our security systems and member data stored in our
information systems. Anyone who circumvents our security
measures could misappropriate our confidential information or
cause interruptions in services or operations. The internet is a
public network, and data is sent over this network from many
sources. In the past, computer viruses or software programs that
disable or impair computers have been distributed and have
rapidly spread over the internet. Computer viruses could be
introduced into our systems, or those of our providers or
regulators, which could disrupt our operations, or make our
systems inaccessible to our members, providers, or regulators.
We may be required to expend significant capital and other
resources to protect against the threat of security breaches or
to alleviate problems caused by breaches. Because of the
confidential health information we store and transmit, security
breaches could expose us to a risk of regulatory action,
litigation, possible liability and loss. Our security measures
may be inadequate to prevent security breaches, and our business
operations would be negatively impacted by cancellation of
contracts and loss of members if they are not prevented.
Because
our corporate headquarters are located in Southern California,
our business operations may be significantly disrupted as a
result of a major earthquake.
Our corporate headquarters is located in Long Beach, California.
In addition, until our centralized claims processing and
information technology support functions are migrated to New
Mexico, those facilities will remain in Long Beach, California.
Southern California is exposed to a statistically greater risk
of a major earthquake than most other parts of the country. If a
major earthquake were to strike the Los Angeles and Long Beach
area, our corporate functions and claims processing could be
significantly impaired for a substantial period of time.
Although we have established a disaster recovery and business
resumption plan with
back-up
operating sites to be deployed in the case of such a major
disruptive event, there can be no assurances that the business
operations of all our health plans, including those that are
remote from any such event, would not be substantially impacted
by a major Southern California earthquake.
If we
are unable to maintain good relations with the physicians,
hospitals, and other providers with whom we contract, or if we
are unable to enter into cost-effective contracts with such
providers, our profitability could be adversely
affected.
We contract with physicians, hospitals, and other providers as a
means to assure access to health care services for our members,
to manage health care costs and utilization, and to better
monitor the quality of care being delivered. In any particular
market, providers could refuse to contract with us, demand
higher payments, or take other actions which could result in
higher health care costs, disruption to provider access for
current members, a decline in our growth rate, or difficulty in
meeting regulatory or accreditation requirements.
In some markets, certain providers, particularly hospitals,
physician/hospital organizations, and some specialists, may have
significant market positions or even monopolies. If these
providers refuse to contract with us or utilize their market
position to negotiate favorable contracts which are
disadvantageous to us, our profitability in those areas could be
adversely affected.
Some providers that render services to our members are not
contracted with our plans. In those cases, there is no
pre-established understanding between the provider and our plan
about the amount of compensation that is due to the provider. In
some states, the amount of compensation is defined by law or
regulation, but in most instances it is either not defined or it
is established by a standard that is not clearly translatable
into dollar terms. In such instances, providers may believe they
are underpaid for their services and may either litigate or
arbitrate their dispute with our
22
plan. The uncertainty of the amount to pay and the possibility
of subsequent adjustment of the payment could adversely affect
our business, financial position, cash flows, or results of
operations.
Regulatory
actions and negative publicity regarding Medicaid managed care
and Medicare Advantage may lead to programmatic changes and
intensified regulatory scrutiny and regulatory
burdens.
Several of our health care competitors have recently been
involved in governmental investigations and regulatory actions
which have resulted in significant volatility in the price of
their stock. In addition, there has been negative publicity and
proposed programmatic changes regarding Medicare Advantage
private fee-for-service plans, a part of the Medicare Advantage
program in which the Company does not participate. Because of
the limited number of health care companies competing in our
market space, these actions and the resulting negative publicity
could become associated with or imputed to the Company,
regardless of the Companys actual regulatory compliance or
programmatic participation. Such an association, as well as any
perception of a recurring pattern of abuse among the health plan
participants in government programs and the diminished
reputation of the managed care sector as a whole, could result
in public distrust, political pressure for changes in the
programs in which the Company does participate, intensified
scrutiny by regulators, additional regulatory requirements and
burdens, increased stock volatility due to speculative trading,
and heightened barriers to new managed care markets and
contracts, all of which could have a material adverse effect on
our business, financial condition, cash flows, or results of
operations.
If a
state fails to renew its federal waiver application for mandated
Medicaid enrollment into managed care or such application is
denied, our membership in that state will likely
decrease.
States may only mandate Medicaid enrollment into managed care
under federal waivers or demonstrations. Waivers and programs
under demonstrations are approved for two-year periods and can
be renewed on an ongoing basis if the state applies. We have no
control over this renewal process. If a state does not renew its
mandated program or the federal government denies the
states application for renewal, our business would suffer
as a result of a likely decrease in membership.
We
face claims related to litigation which could result in
substantial monetary damages.
We are subject to a variety of legal actions, including medical
malpractice actions, provider disputes, employment related
disputes, and breach of contract actions. In the event we incur
liability materially in excess of the amount for which we have
insurance coverage, our profitability would suffer. In addition,
our providers involved in medical care decisions are exposed to
the risk of medical malpractice claims. Providers at the 17
primary care clinics we operate in California are employees of
our California health plan. As a direct employer of physicians
and ancillary medical personnel and as an operator of primary
care clinics, our California plan is subject to liability for
negligent acts, omissions, or injuries occurring at one of its
clinics or caused by one of its employees. We maintain medical
malpractice insurance for our clinics in the amount of
$1 million per occurrence, and an annual aggregate limit of
$3 million, errors and omissions insurance in the amount of
$10 million per occurrence and in aggregate for each policy
year, and such other lines of coverage as we believe are
reasonable in light of our experience to date. However, given
the significant amount of some medical malpractice awards and
settlements, this insurance may not be sufficient or available
at a reasonable cost to protect us from damage awards or other
liabilities. Even if any claims brought against us were
unsuccessful or without merit, we would have to defend ourselves
against such claims. The defense of any such actions may be
time-consuming and costly, and may distract our
managements attention. As a result, we may incur
significant expenses and may be unable to effectively operate
our business.
Furthermore, claimants often sue managed care organizations for
improper denials of or delays in care, and in some instances
improper authorizations of care. Also, Congress and several
state legislatures have considered legislation that would permit
managed care organizations to be held liable for negligent
treatment decisions or benefits coverage determinations. If this
or similar legislation were enacted, claims of this nature could
result in substantial damage awards against us and our providers
that could exceed the limits of any applicable medical
malpractice insurance coverage. Successful malpractice or tort
claims asserted against us, our providers, or our employees
could adversely affect our financial condition and profitability.
23
We cannot predict the outcome of any lawsuit with certainty.
While we currently have insurance coverage for some of the
potential liabilities relating to litigation, other such
liabilities may not be covered by insurance, the insurers could
dispute coverage, or the amount of insurance could be
insufficient to cover the damages awarded. In addition,
insurance coverage for all or certain types of liability may
become unavailable or prohibitively expensive in the future or
the deductible on any such insurance coverage could be set at a
level which would result in us effectively self-insuring cases
against us.
Although we establish reserves for litigation as we believe
appropriate, we cannot assure you that our recorded reserves
will be adequate to cover such costs. Therefore, the litigation
to which we are subject could have a material adverse effect on
our business, financial condition, cash flows, or results of
operations, and could prompt us to change our operating
procedures.
We are
subject to competition which negatively impacts our ability to
increase penetration in the markets we serve.
We operate in a highly competitive environment and in an
industry that is currently subject to significant changes from
business consolidations, new strategic alliances, and aggressive
marketing practices by other managed care organizations. We
compete for members principally on the basis of size, location,
and quality of provider network, benefits supplied, quality of
service, and reputation. A number of these competitive elements
are partially dependent upon and can be positively affected by
the financial resources available to a health plan. Many other
organizations with which we compete, including large commercial
plans, have substantially greater financial and other resources
than we do. For these reasons, we may be unable to grow our
membership, or may lose members to other health plans.
If
state regulators do not approve payments of dividends and
distributions by our subsidiaries, it may negatively affect our
business strategy.
We are a corporate parent holding company and hold most of our
assets at, and conduct most of our operations through, direct
and indirect subsidiaries. As a holding company, our results of
operations depend on the results of operations of our
subsidiaries. Moreover, we are dependent on dividends or other
intercompany transfers of funds from our subsidiaries to meet
our debt service and other obligations. The ability of our
subsidiaries to pay dividends or make other payments or advances
to us will depend on their operating results and will be subject
to applicable laws and restrictions contained in agreements
governing the debt of such subsidiaries. In addition, our health
plan subsidiaries are subject to laws and regulations that limit
the amount of dividends and distributions that they can pay to
us without prior approval of, or notification to, state
regulators. In California, our health plan may dividend, without
notice to or approval of the California Department of Managed
Health Care, amounts by which its tangible net equity exceeds
130% of the tangible net equity requirement. Our other health
plans must give thirty days advance notice and the opportunity
to disapprove extraordinary dividends to the
respective state departments of insurance for amounts over the
lesser of (a) ten percent of surplus or net worth at the
prior year end or (b) the net income for the prior year.
The discretion of the state regulators, if any, in approving or
disapproving a dividend is not clearly defined. Health plans
that declare non-extraordinary dividends must usually provide
notice to the regulators ten or fifteen days in advance of the
intended distribution date of the non-extraordinary dividend.
The aggregate amounts our health plan subsidiaries could have
paid us at December 31, 2008, 2007, and 2006 without
approval of the regulatory authorities were approximately
$7.6 million, $18.7 million, and $6.9 million,
respectively. If the regulators were to deny or significantly
restrict our subsidiaries requests to pay dividends to us,
the funds available to our company as a whole would be limited,
which could harm our ability to implement our business strategy.
For example, we could be hindered in our ability to make debt
service payments under our credit facility
and/or our
senior convertible notes.
Unforeseen
changes in regulations or pharmaceutical market conditions may
impact our revenues and adversely affect our results of
operations.
A significant category of our health care costs relate to
pharmaceutical products and services. Evolving regulations and
state and federal mandates regarding coverage may impact the
ability of our health plans to continue to receive existing
price discounts on pharmaceutical products for our members.
Other factors affecting our
24
pharmaceutical costs include, but are not limited to, the price
of pharmaceuticals, geographic variation in utilization of new
and existing pharmaceuticals, and changes in discounts. The
unpredictable nature of these factors may have an adverse effect
on our business, financial condition, cash flows, or results of
operations.
Failure
to maintain effective internal controls over financial reporting
could have a material adverse effect on our business, operating
results, and stock price.
The Sarbanes-Oxley Act of 2002 requires, among other things,
that we maintain effective internal control over financial
reporting. In particular, we must perform system and process
evaluation and testing of our internal controls over financial
reporting to allow management to report on, and our independent
registered public accounting firm to attest to, our internal
controls over financial reporting as required by
Section 404 of the Sarbanes-Oxley Act of 2002. Our future
testing, or the subsequent testing by our independent registered
public accounting firm, may reveal deficiencies in our internal
controls over financial reporting that are deemed to be material
weaknesses. Our compliance with Section 404 will continue
to require that we incur substantial accounting expense and
expend significant management time and effort. Moreover, if we
are not able to continue to comply with the requirements of
Section 404 in a timely manner, or if we or our independent
registered public accounting firm identifies deficiencies in our
internal control over financial reporting that are deemed to be
material weaknesses, the market price of our stock could decline
and we could be subject to sanctions or investigations by the
NYSE, SEC or other regulatory authorities, which would require
additional financial and management resources.
Volatility
of our stock price could adversely affect
stockholders.
Since our initial public offering in July 2003, the sales price
of our common stock has ranged from a low of $16.12 to a high of
$53.23. A number of factors will continue to influence the
market price of our common stock, including:
|
|
|
|
|
changes in expectations as to our future financial performance
or changes in financial estimates, if any, of public market
analysts,
|
|
|
|
announcements relating to our business or the business of our
competitors,
|
|
|
|
state and federal budget decreases,
|
|
|
|
adverse publicity regarding health maintenance organizations and
other managed care organizations,
|
|
|
|
government action regarding member eligibility,
|
|
|
|
changes in government payment levels,
|
|
|
|
changes in state mandatory programs,
|
|
|
|
conditions generally affecting the managed care industry or our
provider networks,
|
|
|
|
the success of our operating or acquisition strategy,
|
|
|
|
the operating and stock price performance of other comparable
companies in the health care industry,
|
|
|
|
the termination of our Medicaid or CHIP contracts with state or
county agencies, or subcontracts with other Medicaid managed
care organizations that contract with such state or county
agencies,
|
|
|
|
regulatory or legislative change, and
|
|
|
|
general economic conditions, including unemployment rates,
inflation, and interest rates.
|
Our stock may not trade at the same levels as the stock of other
health care companies or the market in general. Also, if the
trading market for our stock does not continue to develop,
securities analysts may not initiate or maintain research
coverage of our company and our shares, and this could depress
the market for our shares.
25
Members
of the Molina family own a majority of our capital stock,
decreasing the influence of other stockholders on stockholder
decisions.
Members of the Molina family, either directly or as trustees or
beneficiaries of Molina family trusts, in the aggregate own or
are entitled to receive upon certain events approximately 56% of
our capital stock. Our president and chief executive officer, as
well as our chief financial officer, are members of the Molina
family, and they are also on our board of directors. Because of
the amount of their shareholdings, Molina family members, if
they were to act as a group with the trustees of their family
trusts, have the ability to significantly influence all matters
submitted to stockholders for approval, including the election
and removal of directors, amendments to our charter, and any
merger, consolidation, or sale of our Company. A significant
concentration of share ownership can also adversely affect the
trading price for our common stock because investors often
discount the value of stock in companies that have controlling
stockholders. Furthermore, the concentration of share ownership
in the Molina family could delay or prevent a merger or
consolidation, takeover, or other business combination that
could be favorable to our stockholders. Finally, the interests
and objectives of the Molina family may be different from those
of our company or our other stockholders, and they may vote
their common stock in a manner that is contrary to the vote of
our other stockholders.
It may
be difficult for a third party to acquire our company, which
could inhibit stockholders from realizing a premium on their
stock price.
We are subject to the Delaware anti-takeover laws regulating
corporate takeovers. These provisions may prohibit stockholders
owning 15% or more of our outstanding voting stock from merging
or combining with us.
Our certificate of incorporation and bylaws also contain
provisions that could have the effect of delaying, deferring, or
preventing a change in control of our company that stockholders
may consider favorable or beneficial. These provisions could
discourage proxy contests and make it more difficult for our
stockholders to elect directors and take other corporate
actions. These provisions could also limit the price that
investors might be willing to pay in the future for shares of
our common stock. These provisions include:
|
|
|
|
|
a staggered board of directors, so that it would take three
successive annual meetings to replace all directors,
|
|
|
|
prohibition of stockholder action by written consent, and
|
|
|
|
advance notice requirements for the submission by stockholders
of nominations for election to the board of directors and for
proposing matters that can be acted upon by stockholders at a
meeting.
|
In addition, changes of control are often subject to state
regulatory notification, and in some cases, prior approval.
We do
not anticipate paying any cash dividends in the foreseeable
future.
We have not declared or paid any dividends since our initial
public offering in July 2003. While we have in the past and may
again use our available cash to repurchase our securities, we do
not anticipate declaring or paying any cash dividends in the
foreseeable future.
Changes
in accounting may affect our results of
operations.
U.S. generally accepted accounting principles
(GAAP) and related implementation guidelines and
interpretations can be highly complex and involve subjective
judgments. Changes in these rules or their interpretation, the
adoption of new pronouncements or the application of existing
pronouncements to our business could significantly affect our
results of operations.
In October 2007, we completed our offering of $200 million
aggregate principal amount of 3.75% Convertible Senior
Notes due 2014. In May 2008, the Financial Accounting
Standards Board (FASB) issued FASB Staff
Position APB 14-1,
Accounting for Convertible Debt Instruments That May Be
Settled in Cash upon Conversion (Including Partial Cash
Settlement) (the FSP). The FSP requires the
proceeds from the issuance of such convertible debt instruments
to be allocated between a liability component and an equity
component. The resulting debt discount is amortized over the
period the convertible debt is expected to be outstanding, as
additional
non-cash
26
interest expense. The change in accounting treatment is
effective for fiscal years beginning after December 15,
2008, and shall be applied retrospectively to prior periods. The
FSP changes the accounting treatment for our
3.75% Convertible Senior Notes. The impact of this new
accounting treatment will result in an increase to
non-cash
interest expense beginning in fiscal year 2009 for
financial statements covering past and future periods. The
incremental impact of the FSP to our results of operations in
2009 will be approximately $3.1 million, or
$0.12 per diluted share, net of tax. This estimate
does not include the impact of our repurchase of
$13 million face amount of the 3.75% Convertible Senior
Notes in February 2009. We estimate the retroactive adjustment
for prior periods will be approximately $627,000, or
$0.02 per diluted share, net of tax, for 2007, and
$2.9 million, or $0.11 per diluted share, net of
tax, for 2008.
Our
investments in auction rate securities are subject to risks that
may cause losses and have a material adverse effect on our
liquidity.
As of December 31, 2008, $70.5 million par value (fair
value of $58.2 million) of our investments consisted of
auction rate securities, all of which were securities
collateralized by student loan portfolios, guaranteed by the
U.S. government. We continued to earn interest on
substantially all of these auction rate securities as of
December 31, 2008. Due to events in the credit markets, the
auction rate securities held by us experienced failed auctions
beginning in the first quarter of 2008. As such, quoted prices
in active markets were not readily available during the majority
of 2008. We used pricing models to estimate the fair value of
these securities. These pricing models included factors such as
the collateral underlying the securities, the creditworthiness
of the counterparty, the timing of expected future cash flows,
and the expectation of the next time the security would be
expected to have a successful auction. The estimated values of
these securities were also compared, when possible, to valuation
data with respect to similar securities held by other parties.
We concluded that these estimates, given the lack of market
available pricing, provided a reasonable basis for determining
fair value of the auction rate securities as of
December 31, 2008.
As of December 31, 2008, we held $42.5 million par value
(fair value of $34.9 million) auction rate securities with
a certain investment securities firm. In November 2008, we
entered into a rights agreement with this firm that
(1) allows us to exercise rights (the Rights)
to sell the eligible auction rate securities at par value to
this firm between June 30, 2010 and July 2, 2012, and
(2) gives the investment securities firm the right to
purchase the auction rate securities from us any time after the
agreement date as long as we receive the par value.
We have accounted for the Rights as a freestanding financial
instrument and have elected to record the value of the Rights
under the fair value option of SFAS 159, The Fair Value
Option for Financial Assets and Financial Liabilities. In
the fourth quarter of 2008, this resulted in the recognition of
a $6.9 million non-current asset, with a corresponding
increase to pretax income for the value of the Rights. To
determine the fair value estimate of the Rights, we used a
discounted cash-flow model that was based on the expectation
that the auction rate securities will be put back to the
investment securities firm at par on June 30, 2010, as
permitted by the Rights agreement.
Simultaneous to the recognition of the $6.9 million rights
agreement, we recorded an other-than-temporary impairment of the
underlying auction rate securities, and prior unrealized losses
on the auction rate securities that had been recorded to other
comprehensive loss through November 2008 were charged to income,
totaling $7.2 million. Also, at the time of the execution
of the Rights agreement and pursuant to SFAS 115, we
elected to transfer the underlying auction rate securities from
available-for-sale to trading securities. For the month of
December 2008, we recorded additional losses of $399,000 on
these auction rate securities. We expect that the future changes
in the fair value of the Rights will be substantially offset by
the fair value movements in the underlying auction rate
securities.
As of December 31, 2008, the remainder of our auction rate
securities, which are still designated as available-for-sale,
amounted to $28.0 million par value (fair value of
$23.3 million). As a result of the decline in fair value of
these auction rate securities, we recorded unrealized losses of
$4.7 million to accumulated other comprehensive (loss)
income for the year ended December 31, 2008. We have deemed
these unrealized losses to be temporary and attribute the
decline in value to liquidity issues, as a result of the failed
auction market, rather than to credit issues. Any future
fluctuation in fair value related to these instruments that we
deem to be temporary, including any recoveries of previous
write-downs, would be recorded to accumulated other
comprehensive (loss) income. If we
27
determine that any future valuation adjustment was
other-than-temporary, we would record a charge to earnings as
appropriate.
The
value of our investments is influenced by varying economic and
market conditions, and a decrease in value could have an adverse
effect on our results of operations, liquidity and financial
condition.
Our investments consist solely of investment-grade debt
securities. The unrestricted portion of this portfolio is
designated primarily as available-for-sale. Our non-current
restricted investments are designated as held-to-maturity.
Available-for-sale investments are carried at fair value, and
the unrealized gains or losses are included in accumulated other
comprehensive loss as a separate component of stockholders
equity, unless the decline in value is deemed to be
other-than-temporary and we do not have the intent and ability
to hold such securities until their full cost can be recovered.
Trading securities are carried at fair value and any realized
gains or losses are included as a component of earnings. For our
available-for-sale investments and held-to-maturity investments,
if a decline in value is deemed to be other-than-temporary and
we do not have the intent and ability to hold such security
until its full cost can be recovered, the security is deemed to
be other-than-temporarily impaired and it is written down to
fair value and the loss is recorded as an expense.
In accordance with applicable accounting standards, we review
our investment securities to determine if declines in fair value
below cost are other-than-temporary. This review is subjective
and requires a high degree of judgment. We conduct this review
on a quarterly basis, using both quantitative and qualitative
factors, to determine whether a decline in value is
other-than-temporary. Such factors considered include the length
of time and the extent to which market value has been less than
cost, the financial condition and near term prospects of the
issuer, recommendations of investment advisors and forecasts of
economic, market or industry trends. This review process also
entails an evaluation of our ability and intent to hold
individual securities until they mature or full cost can be
recovered.
The current economic environment and recent volatility of the
securities markets increase the difficulty of assessing
investment impairment and the same influences tend to increase
the risk of potential impairment of these assets. During the
year ended December 31, 2008, we recorded an
other-than-temporary impairment of certain auction rate
securities as described above, totaling $7.2 million. Over
time, the economic and market environment may further
deteriorate or provide additional insight regarding the fair
value of certain securities, which could change our judgment
regarding impairment. This could result in realized losses
relating to other-than-temporary declines or losses related to
our trading securities to be recorded as an expense. Given the
current market conditions and the significant judgments
involved, there is continuing risk that further declines in fair
value may occur and material other-than-temporary impairments or
trading security losses may result in realized losses in future
periods which could have an adverse effect on our business,
financial condition, cash flows, or results of operations.
An
unauthorized disclosure of sensitive or confidential member
information could have an adverse effect on our
business.
As part of our normal operations, we collect, process and retain
confidential member information. We are subject to various
federal and state laws and rules regarding the use and
disclosure of confidential member information, including HIPAA
and the Gramm-Leach-Bliley Act. The American Recovery and
Reinvestment Act of 2009 further expands the coverage of HIPAA
by, among other things, extending the privacy and security
provisions, mandating new regulations around electronic medical
records, expanding enforcement mechanisms, allowing the state
Attorneys General to bring enforcement actions and increasing
penalties for violations. Despite the security measures we have
in place to ensure compliance with applicable laws and rules,
our facilities and systems, and those of our third party service
providers, may be vulnerable to security breaches, acts of
vandalism, computer viruses, misplaced or lost data, programming
and/or human
errors or other similar events. Any security breach involving
the misappropriation, loss or other unauthorized disclosure or
use of confidential member information, whether by us or a third
party, could have a material adverse effect on our business,
financial condition, cash flows, or results of operations.
28
We are
dependent on our executive officers and other key
employees.
Our operations are highly dependent on the efforts of our
executive officers. The loss of their leadership, knowledge, and
experience could negatively impact our operations. Replacing
many of our executive officers might be difficult or take an
extended period of time because a limited number of individuals
in the managed care industry have the breadth and depth of
skills and experience necessary to operate and expand
successfully a business such as ours. Our success is also
dependent on our ability to hire and retain qualified
management, technical, and medical personnel. We may be
unsuccessful in recruiting and retaining such personnel which
could negatively impact our operations.
A
pandemic, such as a worldwide outbreak of a new influenza virus,
could materially and adversely affect our ability to control
health care costs.
An outbreak of a pandemic disease, such as the H5N1 avian flu,
could materially and adversely affect our business and operating
results. The impact of a flu pandemic on the United States would
likely be substantial. Estimates of the contagion and mortality
rate of any mutated avian flu virus that can be transmitted from
human to human are highly speculative. A significant global
outbreak of avian flu among humans could have a material adverse
effect on our results of operations and financial condition as a
result of increased inpatient and outpatient hospital costs and
the cost of anti-viral medication to treat the virus.
Conversion
of our senior convertible notes may dilute the ownership
interest of existing stockholders.
Our convertible notes are convertible into cash and, under
certain circumstances, shares of our common stock. The
conversion of some or all of our convertible notes may dilute
the ownership interests of existing stockholders. Any sales in
the public market of our common stock issuable upon such
conversion could adversely affect prevailing market prices of
our common stock. In addition, the anticipated conversion of the
convertible notes into cash and shares of our common stock could
depress the price of our common stock.
|
|
Item 1B:
|
Unresolved
Staff Comments
|
We have not received any comments from the staff of the
Securities and Exchange Commission which remain unresolved.
We lease a total of 51 facilities, including our corporate
headquarters at 200 Oceangate in Long Beach, California, and 16
of our 17 California medical clinics. We also own a
32,000 square-foot office building in Long Beach,
California, the 26,000 square-foot data center nearing
completion of construction in Albuquerque, New Mexico, and one
of our medical clinics in Pomona, California. We believe our
current facilities are adequate to meet our operational needs
for the foreseeable future.
|
|
Item 3:
|
Legal
Proceedings
|
The health care industry is subject to numerous laws and
regulations of federal, state, and local governments. Compliance
with these laws and regulations can be subject to government
review and interpretation, as well as regulatory actions unknown
and unasserted at this time. Penalties associated with
violations of these laws and regulations include significant
fines and penalties, exclusion from participating in
publicly-funded programs, and the repayment of previously billed
and collected revenues.
We are involved in legal actions in the ordinary course of
business, some of which seek monetary damages, including claims
for punitive damages, which are not covered by insurance. The
outcome of such legal actions is inherently uncertain.
Nevertheless, we believe that these actions, when finally
concluded and determined, are not likely to have a material
adverse effect on our consolidated financial position, results
of operations, or cash flows.
|
|
Item 4:
|
Submission
of Matters to a Vote of Security Holders
|
None.
29
Executive
Officers of the Registrant
J. Mario Molina, M.D., 50, has served as President and
Chief Executive Officer since succeeding his father and company
founder, Dr. C. David Molina, in 1996. He has also served
as Chairman of the Board since 1996. Prior to that, he served as
Medical Director from 1991 through 1994 and was Vice President
responsible for provider contracting and relations, member
services, marketing and quality assurance from 1994 to 1996. He
earned an M.D. from the University of Southern California and
performed his medical internship and residency at the Johns
Hopkins Hospital. Dr. Molina is the brother of John C.
Molina.
John C. Molina, J.D., 44, has served in the role of Chief
Financial Officer since 1995. He also has served as a director
since 1994. Mr. Molina has been employed by us for over
28 years in a variety of positions. Mr. Molina is a
past president of the California Association of Primary Care
Case Management Plans. He earned a Juris Doctorate from the
University of Southern California School of Law. Mr. Molina
is the brother of J. Mario Molina, M.D.
Mark L. Andrews, Esq., 51, has served as Chief Legal
Officer and General Counsel since 1998. He also has served as a
member of the Executive Committee of our company since 1998.
Before joining our company, Mr. Andrews was a partner at
Wilke, Fleury, Hoffelt, Gould & Birney of Sacramento,
California, where he chaired that firms health care and
employment law departments and represented Molina as outside
counsel from 1994 through 1997. Mr. Andrews holds a Juris
Doctorate degree from Hastings College of the Law.
Terry P. Bayer, 58, has served as our Chief Operating Officer
since November 2005. She had formerly served as our Executive
Vice President, Health Plan Operations since January 2005.
Ms. Bayer has 25 years of health care management
experience, including staff model clinic administration,
provider contracting, managed care operations, disease
management, and home care. Prior to joining us, her professional
experience included regional responsibility at FHP, Inc. and
multi-state responsibility as Regional Vice-President at
Maxicare; Partners National Health Plan, a joint venture of
Aetna Life Insurance Company and Voluntary Hospital Association
(VHA); and Lincoln National. She has also served as Executive
Vice President of Managed Care at Matria Healthcare, President
and Chief Operating Officer of Praxis Clinical Services, and as
Western Division President of AccentCare. She holds a Juris
Doctorate from Stanford University, a Masters degree in
Public Health from the University of California, Berkeley, and a
Bachelors degree in Communications from Northwestern
University.
James W. Howatt, 62, has served as our Chief Medical Officer
since May 2008. Dr. Howatt formerly served as the chief
medical officer of Molina Healthcare of Washington. Prior to
joining Molina Healthcare in February 2006, Dr. Howatt was
Western Regional Medical Director for Humana, where he was
responsible for the coordination and oversight of quality,
utilization management, credentialing, and accreditation for
Humanas activities west of Kansas City. Previously, he was
Vice President and CMO of Humana Arizona, where he was
responsible for leading a variety of medical management
functions and worked closely with the companys sales
division to develop customer-focused benefit structures.
Dr. Howatt also served as CMO for Humana TRICARE, where he
oversaw a $2.5 billion health care operation that served
three million beneficiaries and comprised a professional network
of 40,000 providers, 800 institutions, and 13 medical directors.
Dr. Howatt received B.S. and M.D. degrees from the
University of California, San Francisco, and also holds a
Master of Business Administration degree with an emphasis in
Health Management from the University of Phoenix. He interned
and completed his residency program in family practice at
Ventura County Hospital in Ventura, California. Dr. Howatt
is a board-certified family physician and a member of the
American College of Managed Care Medicine.
30
PART II
|
|
Item 5:
|
Market
for Registrants Common Equity, Related Stockholder Matters
and Issuer Purchases of Equity Securities
|
Our common stock is listed on the New York Stock Exchange under
the trading symbol MOH. The high and low sales
prices of our common stock for specified periods are set forth
below:
|
|
|
|
|
|
|
|
|
Date Range
|
|
High
|
|
|
Low
|
|
|
2008
|
|
|
|
|
|
|
|
|
First Quarter
|
|
$
|
44.94
|
|
|
$
|
23.46
|
|
Second Quarter
|
|
$
|
30.50
|
|
|
$
|
22.68
|
|
Third Quarter
|
|
$
|
42.61
|
|
|
$
|
24.08
|
|
Fourth Quarter
|
|
$
|
32.45
|
|
|
$
|
16.12
|
|
2007
|
|
|
|
|
|
|
|
|
First Quarter
|
|
$
|
34.76
|
|
|
$
|
28.88
|
|
Second Quarter
|
|
$
|
34.92
|
|
|
$
|
28.72
|
|
Third Quarter
|
|
$
|
38.41
|
|
|
$
|
28.15
|
|
Fourth Quarter
|
|
$
|
41.21
|
|
|
$
|
34.01
|
|
As of March 10, 2009, there were approximately 112 holders
of record of our common stock.
We did not declare or pay any dividends in 2008, 2007, or 2006.
While we have in the past and may again in the future use our
cash to repurchase our securities, we do not anticipate
declaring or paying any cash dividends in the foreseeable future.
Moreover, our ability to pay dividends to stockholders is
dependent on cash dividends being paid to us by our
subsidiaries. Laws of the states in which we operate or may
operate our health plans, as well as requirements of the
government sponsored health programs in which we participate,
limit the ability of our health plan subsidiaries to pay
dividends to us. In addition, the terms of our credit facility
limit our ability to pay dividends.
Securities Authorized for Issuance Under Equity Compensation
Plans (as of December 31, 2008)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of Securities
|
|
|
|
|
|
|
|
|
|
Remaining Available for
|
|
|
|
Number of Securities to be
|
|
|
Weighted Average
|
|
|
Future Issuance
|
|
|
|
Issued Upon Exercise of
|
|
|
Exercise Price of
|
|
|
Under Equity Compensation
|
|
|
|
Outstanding Options,
|
|
|
Outstanding Options,
|
|
|
Plans (Excluding Securities
|
|
|
|
Warrants and Rights
|
|
|
Warrants and Rights
|
|
|
Reflected in Column (a))
|
|
Plan Category
|
|
(a)
|
|
|
(b)
|
|
|
(c)
|
|
|
Equity compensation plans approved by security holders
|
|
|
665,339
|
(1)
|
|
$
|
30.29
|
|
|
|
3,887,414
|
(2)
|
|
|
|
(1) |
|
Options to purchase shares of our common stock issued under the
2000 Omnibus Stock and Incentive Plan and the 2002 Equity
Incentive Plan. Further grants under the 2000 Omnibus Stock and
Incentive Plan have been suspended. |
|
(2) |
|
Includes only shares remaining available to issue under the 2002
Equity Incentive Plan (the 2002 Incentive Plan) and
the 2002 Employee Stock Purchase Plan (the ESPP).
The 2002 Incentive Plan initially allowed for the issuance of
1.6 million shares of common stock. Beginning
January 1, 2004, shares available for issuance under the
2002 Incentive Plan automatically increase by the lesser of
400,000 shares or 2% of total outstanding capital stock on
a fully diluted basis, unless the board of directors
affirmatively acts to nullify the automatic increase. The
400,000 share increase on January 1, 2008 increased
the total number of shares reserved for issuance under the 2002
Incentive Plan to 3,600,000 shares. The ESPP initially
allowed for the issuance of 600,000 shares of common stock.
Beginning December 31, 2003, and each year until the
2.2 million maximum aggregate number of shares reserved for
issuance is reached, shares reserved for issuance under the ESPP
automatically increase by 1% of total outstanding capital stock.
Through the automatic increase effective |
31
|
|
|
|
|
December 31, 2008, the total number of shares reserved for
issuance under the ESPP has increased to 2.2 million shares. |
Purchases
of Equity Securities by the Issuer
As publicly announced on July 23, 2008, our board of
directors authorized the repurchase of up to one million shares
of our common stock. The repurchase plan terminated on
December 31, 2008. Purchases of common stock made by or on
behalf of the Company during the quarter ended December 31,
2008 are set forth below:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Number of
|
|
|
|
|
|
|
|
|
|
|
|
|
Shares Purchased as
|
|
|
Approximate Dollar Value
|
|
|
|
Total Number
|
|
|
|
|
|
Part of Publicly
|
|
|
of Shares That May Yet Be
|
|
|
|
of Shares
|
|
|
Average Price
|
|
|
Announced Plans or
|
|
|
Purchased Under the Plans
|
|
|
|
Purchased
|
|
|
Paid per Share
|
|
|
Programs
|
|
|
or Programs
|
|
|
Oct. 1 - Oct. 31, 2008
|
|
|
721,561
|
|
|
$
|
23.9222
|
|
|
|
721,561
|
|
|
$
|
|
|
Nov. 1 - Nov. 30, 2008
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Dec. 1 - Dec. 31, 2008
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
|
721,561
|
|
|
$
|
23.9222
|
|
|
|
721,561
|
|
|
$
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
32
STOCK
PERFORMANCE GRAPH
The following discussion shall not be deemed to be
soliciting material or to be filed with
the SEC nor shall this information be incorporated by reference
into any future filing under the Securities Act or the Exchange
Act, except to the extent that the Company specifically
incorporates it by reference into a filing.
The following line graph compares the percentage change in the
cumulative total return on our common stock against the
cumulative total return of the Standard & Poors
Corporation Composite 500 Index (the S&P 500)
and a peer group index for the five-year period from
December 31, 2003 to December 31, 2008. The graph
assumes an initial investment of $100 in Molina Healthcare, Inc.
common stock and in each of the indices.
The peer group index consists of Amerigroup Corporation (AGP),
Centene Corporation (CNC), Coventry Health Care, Inc. (CVH),
Health Net, Inc. (HNT), Humana, Inc. (HUM), UnitedHealth Group
Incorporated (UNH), and WellPoint, Inc. (WLP).
COMPARISON
OF FIVE-YEAR CUMULATIVE TOTAL RETURN
Among
Molina Healthcare, Inc, The S&P 500 Index
And A Peer Group
|
|
* |
$100 invested on 12/31/03 in stock & index-including
reinvestment of dividends. Fiscal year ending December 31.
|
33
|
|
Item 6.
|
Selected
Financial Data
|
SELECTED
FINANCIAL DATA
We derived the following selected consolidated financial data
(other than the data under the caption Operating
Statistics) for the five years ended December 31,
2008 from our audited consolidated financial statements. You
should read the data in conjunction with our consolidated
financial statements, related notes and other financial
information included herein. All dollars are in thousands,
except per share data. The data under the caption
Operating Statistics has not been audited.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended December 31,
|
|
|
|
2008
|
|
|
2007(1)
|
|
|
2006(2)
|
|
|
2005
|
|
|
2004(3)
|
|
|
Statements of Income Data:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Revenue:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Premium revenue
|
|
$
|
3,091,240
|
|
|
$
|
2,462,369
|
|
|
$
|
1,985,109
|
|
|
$
|
1,639,884
|
|
|
$
|
1,171,038
|
|
Investment income
|
|
|
21,126
|
|
|
|
30,085
|
|
|
|
19,886
|
|
|
|
10,174
|
|
|
|
4,230
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total revenue
|
|
|
3,112,366
|
|
|
|
2,492,454
|
|
|
|
2,004,995
|
|
|
|
1,650,058
|
|
|
|
1,175,268
|
|
Expenses:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Medical care costs
|
|
|
2,621,312
|
|
|
|
2,080,083
|
|
|
|
1,678,652
|
|
|
|
1,424,872
|
|
|
|
984,686
|
|
General and administrative expenses
|
|
|
344,761
|
|
|
|
285,295
|
|
|
|
229,057
|
|
|
|
163,342
|
|
|
|
94,150
|
|
Loss contract charge
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
939
|
|
|
|
|
|
Impairment charge on purchased software(4)
|
|
|
|
|
|
|
782
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Depreciation and amortization
|
|
|
33,688
|
|
|
|
27,967
|
|
|
|
21,475
|
|
|
|
15,125
|
|
|
|
8,869
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total expenses
|
|
|
2,999,761
|
|
|
|
2,394,127
|
|
|
|
1,929,184
|
|
|
|
1,604,278
|
|
|
|
1,087,705
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating income
|
|
|
112,605
|
|
|
|
98,327
|
|
|
|
75,811
|
|
|
|
45,780
|
|
|
|
87,563
|
|
Total other income (expense), net
|
|
|
(8,714
|
)
|
|
|
(4,631
|
)
|
|
|
(2,353
|
)
|
|
|
(1,929
|
)
|
|
|
122
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income before income taxes
|
|
|
103,891
|
|
|
|
93,696
|
|
|
|
73,458
|
|
|
|
43,851
|
|
|
|
87,685
|
|
Provision for income taxes
|
|
|
41,493
|
|
|
|
35,366
|
|
|
|
27,731
|
|
|
|
16,255
|
|
|
|
31,912
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income
|
|
$
|
62,398
|
|
|
$
|
58,330
|
|
|
$
|
45,727
|
|
|
$
|
27,596
|
|
|
$
|
55,773
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income per share:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic
|
|
$
|
2.25
|
|
|
$
|
2.06
|
|
|
$
|
1.64
|
|
|
$
|
1.00
|
|
|
$
|
2.07
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Diluted
|
|
$
|
2.25
|
|
|
$
|
2.05
|
|
|
$
|
1.62
|
|
|
$
|
0.98
|
|
|
$
|
2.04
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted average number of common shares outstanding
|
|
|
27,676,000
|
|
|
|
28,275,000
|
|
|
|
27,966,000
|
|
|
|
27,711,000
|
|
|
|
26,965,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted average number of common shares and potential dilutive
common shares outstanding
|
|
|
27,772,000
|
|
|
|
28,419,000
|
|
|
|
28,164,000
|
|
|
|
28,023,000
|
|
|
|
27,342,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating Statistics:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Medical care ratio(5)
|
|
|
84.8
|
%
|
|
|
84.5
|
%
|
|
|
84.6
|
%
|
|
|
86.9
|
%
|
|
|
84.1
|
%
|
General and administrative expense ratio(6)
|
|
|
11.1
|
%
|
|
|
11.5
|
%
|
|
|
11.4
|
%
|
|
|
9.9
|
%
|
|
|
8.0
|
%
|
General and administrative expense ratio, excluding premium taxes
|
|
|
8.0
|
%
|
|
|
8.2
|
%
|
|
|
8.4
|
%
|
|
|
7.1
|
%
|
|
|
5.9
|
%
|
Members(7)
|
|
|
1,256,000
|
|
|
|
1,149,000
|
|
|
|
1,077,000
|
|
|
|
893,000
|
|
|
|
788,000
|
|
34
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
As of December 31,
|
|
|
|
2008
|
|
|
2007(1)
|
|
|
2006(2)
|
|
|
2005
|
|
|
2004(3)
|
|
|
Balance Sheet Data:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash and cash equivalents
|
|
$
|
387,162
|
|
|
$
|
459,064
|
|
|
$
|
403,650
|
|
|
$
|
249,203
|
|
|
$
|
228,071
|
|
Total assets
|
|
|
1,149,186
|
|
|
|
1,171,305
|
|
|
|
864,475
|
|
|
|
659,927
|
|
|
|
533,859
|
|
Long-term debt (including current maturities)
|
|
|
200,000
|
|
|
|
200,000
|
|
|
|
45,000
|
|
|
|
|
|
|
|
1,894
|
|
Total liabilities
|
|
|
638,522
|
|
|
|
680,827
|
|
|
|
444,309
|
|
|
|
297,077
|
|
|
|
203,237
|
|
Stockholders equity
|
|
|
510,664
|
|
|
|
490,478
|
|
|
|
420,166
|
|
|
|
362,850
|
|
|
|
330,622
|
|
|
|
|
(1) |
|
The balance sheet and operating results of the MCP (Mercy
CarePlus) acquisition have been included since November 1,
2007, the effective date of the acquisition. |
|
(2) |
|
The balance sheet and operating results of the HCLB (Cape Health
Plan) acquisition have been included since May 15, 2006,
the effective date of the acquisition. |
|
(3) |
|
The balance sheet and operating results of the New Mexico HMO
have been included since July 1, 2004, the effective date
of the acquisition. |
|
(4) |
|
Amount represents an impairment charge related to commercial
software no longer used for operations. |
|
(5) |
|
Medical care ratio represents medical care costs as a percentage
of premium revenue. The medical care ratio is a key operating
indicator used to measure our performance in delivering
efficient and cost effective health care services. Changes in
the medical care ratio from period to period result from changes
in Medicaid funding by the states, our ability to effectively
manage costs, and changes in accounting estimates related to
incurred but not reported claims. See Managements
Discussion and Analysis of Financial Condition and Results of
Operations for further discussion. |
|
(6) |
|
General and administrative expense ratio represents such
expenses as a percentage of total revenue. |
|
(7) |
|
Number of members at end of period. |
35
|
|
Item 7.
|
Managements
Discussion and Analysis of Financial Condition and Results of
Operations
|
The following discussion of our financial condition and results
of operations should be read in conjunction with the
Selected Financial Data and the accompanying
consolidated financial statements and the notes to those
statements appearing elsewhere in this report. This discussion
contains forward-looking statements that involve known and
unknown risks and uncertainties, including those set forth under
Item 1A Risk Factors, above.
Overview
Molina Healthcare, Inc. is a multi-state managed care
organization participating exclusively in government-sponsored
health care programs for low-income persons, such as the
Medicaid program and the Childrens Health Insurance
Program, or CHIP. We also serve a small number of low-income
Medicare members. We conduct our business primarily through 10
licensed health plans in the states of California, Florida,
Michigan, Missouri, Nevada, New Mexico, Ohio, Texas, Utah, and
Washington. The health plans are locally operated by our
respective wholly owned subsidiaries in those states, each of
which is licensed as a health maintenance organization, or HMO.
Our financial performance for 2008, 2007 and 2006 is briefly
summarized below (dollars in thousands, except per- share data):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended December 31,
|
|
|
|
2008
|
|
|
2007
|
|
|
2006
|
|
|
Earnings per diluted share
|
|
$
|
2.25
|
|
|
$
|
2.05
|
|
|
$
|
1.62
|
|
Premium revenue
|
|
$
|
3,091,240
|
|
|
$
|
2,462,369
|
|
|
$
|
1,985,109
|
|
Operating income
|
|
$
|
112,605
|
|
|
$
|
98,327
|
|
|
$
|
75,811
|
|
Net income
|
|
$
|
62,398
|
|
|
$
|
58,330
|
|
|
$
|
45,727
|
|
Medical care ratio
|
|
|
84.8
|
%
|
|
|
84.5
|
%
|
|
|
84.6
|
%
|
G&A expenses as a percentage of total revenue
|
|
|
11.1
|
%
|
|
|
11.5
|
%
|
|
|
11.4
|
%
|
Total ending membership
|
|
|
1,256,000
|
|
|
|
1,149,000
|
|
|
|
1,077,000
|
|
Revenue
Premium revenue is fixed in advance of the periods covered and,
except as described below, is not generally subject to
significant accounting estimates. For the year ended
December 31, 2008, we received approximately 92% of our
premium revenue as a fixed amount per member per month, or PMPM,
pursuant to our Medicaid contracts with state agencies, our
Medicare contracts with the Centers for Medicare and Medicaid
Services (CMS), and our contracts with other managed care
organizations for which we operate as a subcontractor. These
premium revenues are recognized in the month that members are
entitled to receive health care services. The state Medicaid
programs and the federal Medicare program periodically adjust
premium rates.
The amount of the premiums paid to us may vary substantially
between states and among various government programs. PMPM
premiums for members of the Childrens Health Insurance
Program (CHIP) are generally among our lowest, with rates as low
as approximately $80 PMPM in California and Utah. Premium
revenues for Medicaid members are generally higher. Among the
Temporary Aid for Needy Families (TANF) Medicaid
population the Medicaid group that includes most
mothers and children PMPM premiums range between
approximately $100 in California to $300 in New Mexico. Among
our Medicaid Aged, Blind or Disabled (ABD) membership, PMPM
premiums range from approximately $450 in California and Texas
to over $1,000 in New Mexico and Ohio. Medicare premiums are
approximately $1,100 PMPM, with Medicare revenue totaling
$95.1 million, $49.3 million and $27.2 million
for the years ended December 31, 2008, 2007 and 2006,
respectively.
Approximately 3% of our premium revenue for the year ended
December 31, 2008 was realized under a Medicaid cost-plus
reimbursement agreement that our Utah plan has with that state.
For the year ended December 31, 2008, we also received
approximately 5% of our premium revenue in the form of
birth income a one-time payment for the
delivery of a child from the Medicaid programs in
Michigan, Missouri, Ohio, Texas, and Washington. Such payments
are recognized as revenue in the month the birth occurs.
36
Certain components of premium revenue are subject to accounting
estimates. Chief among these are (1) that portion of
premium revenue paid to our New Mexico health plan by the state
of New Mexico that may be refunded to the state if certain
minimum amounts are not expended on defined medical care costs,
or if administrative costs or profit (as defined) exceed certain
amounts, (2) that portion of the revenue of our Ohio health
plan that is at risk if certain performance measures are not
met, (3) the additional premium revenue our Utah health
plan is entitled to receive from the state of Utah as an
incentive payment for saving the state of Utah money in relation
to
fee-for-service
Medicaid, (4) the profit-sharing agreement between our
Texas health plan and the state of Texas, where we pay a rebate
to the state of Texas if our Texas health plan generates pretax
income above a certain specified percentage, according to a
tiered rebate schedule, and (5) that portion of our
Medicare revenue that is subject to retroactive adjustment for
member risk adjustment and recoupment of pharmacy related
revenue.
Our contract with the state of New Mexico requires that we spend
a minimum percentage of premium revenue on certain explicitly
defined medical care costs (the medical cost floor). Our
contract is for a three-year period, and the medical cost floor
is based on premiums and medical care costs over the entire
contract period. During the six months ended June 30, 2008,
we recorded adjustments totaling $12.9 million to increase
premium revenue associated with this requirement. The revenue
resulted from a reversal of previously recorded amounts due the
state of New Mexico when we were below the minimum percentage,
because we exceeded the minimum percentage for the six months
ended June 30, 2008.
Effective July 1, 2008, our New Mexico health plan entered
into a new three year contract that, in addition to retaining
the medical cost floor, added certain limits on the amount our
New Mexico health plan can: (1) expend on administrative
costs; and (2) retain as profit. At December 31, 2008,
there was no liability recorded under the terms of these
contract provisions. Any changes to the terms of these
provisions, including revisions to the definitions of premium
revenue, medical care costs, administrative costs or profit, the
period of time over which performance is measured or the manner
of its measurement, or the percentages used in the calculations,
may trigger a change in the amounts owed. If the state of New
Mexico disagrees with our interpretation of the existing
contract terms, an adjustment to the amounts owed may be
required.
Under our contract with the state of Ohio, up to 1% of our Ohio
health plans revenue may be refundable to the state if
certain performance measures are not met. At December 31,
2008, we had recorded a liability of approximately
$1.6 million under the terms of this contract provision.
In prior years, we estimated amounts we believed were
recoverable under our savings sharing agreement with the state
of Utah based on available information and our interpretation of
our contract with the state. The state may not agree with our
interpretation or our application of the contract language, and
it may also not agree with the manner in which we have processed
and analyzed our member claims and encounter records. Thus, the
ultimate amount of savings sharing revenue that we realize from
prior years may be subject to negotiation with the state. During
2007, as a result of an ongoing disagreement with the state of
Utah, we wrote off the entire receivable, totaling
$4.7 million. Our Utah health plan continues to work with
the state to assure an appropriate determination of amounts due
to us under the savings share agreement. When additional
information is known, or agreement is reached with the state
regarding the appropriate savings sharing payment amount for
prior years, we will adjust the amount of savings sharing
revenue recorded in our financial statements as appropriate in
light of such new information or agreement.
As of December 31, 2008, we had a liability of
approximately $619,000 accrued pursuant to our profit-sharing
agreement with the state of Texas for the 2008 contract year
(ending August 31, 2008) and the 2009 contract year
(ending August 31, 2009). During 2008, we paid the state of
Texas $10.1 million relating to the 2007 and 2008 contract
years, and the 2007 contract year is now closed. Because the
final settlement calculations include a claims run-out period of
nearly one year, the amounts recorded, based on our estimates,
may be adjusted. We believe that the ultimate settlement will
not differ materially from our estimates.
Medicare revenue paid to us is subject to retroactive adjustment
for both member risk scores and member pharmacy cost experience.
Based on member encounter data that we submit to the Centers for
Medicare and Medicaid Services (CMS), our Medicare revenue is
subject to adjustment for up to two years after the original
year of service. This adjustment takes into account the acuity
of each members medical needs relative to what was
anticipated when premiums were originally set for that member.
In the event that our membership (measured on an
37
individual by individual basis) requires less acute medical care
than was anticipated by the original premium amount, CMS may
recover premium from us. In the event that our membership
requires more acute medical care than was anticipated by the
original premium amount, CMS may pay us additional retroactive
premium. A similar retroactive reconciliation is undertaken by
CMS for our Medicare members pharmacy utilization. That
analysis is similar to the process for the adjustment of member
risk scores, but is further complicated by member pharmacy cost
sharing provisions attached to the Medicare pharmacy benefit
that do not apply to the services measured by the member risk
adjustment process. We estimate the amount of Medicare revenue
that will ultimately be realized for the periods presented based
on our knowledge of our members heath care utilization
patterns and CMS practices. To the extent that the premium
revenue ultimately received from CMS differs from recorded
amounts, we will adjust reported Medicare revenue.
Historically, membership growth has been the primary reason for
our increasing revenues, although more recently our revenues
have also grown due to the more care intensive benefits
associated with our ABD and Medicare members. We have increased
our membership through both internal growth and acquisitions.
The following table sets forth the approximate total number of
members by state health plan as of the dates indicated:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
As of December 31,
|
|
|
|
2008
|
|
|
2007
|
|
|
2006
|
|
|
Total Ending Membership by Health Plan:
|
|
|
|
|
|
|
|
|
|
|
|
|
California
|
|
|
322,000
|
|
|
|
296,000
|
|
|
|
300,000
|
|
Michigan
|
|
|
206,000
|
|
|
|
209,000
|
|
|
|
228,000
|
|
Missouri(1)
|
|
|
77,000
|
|
|
|
68,000
|
|
|
|
|
|
Nevada(2)
|
|
|
|
|
|
|
|
|
|
|
|
|
New Mexico
|
|
|
84,000
|
|
|
|
73,000
|
|
|
|
65,000
|
|
Ohio
|
|
|
176,000
|
|
|
|
136,000
|
|
|
|
76,000
|
|
Texas(3)
|
|
|
31,000
|
|
|
|
29,000
|
|
|
|
19,000
|
|
Utah
|
|
|
61,000
|
|
|
|
55,000
|
|
|
|
52,000
|
|
Washington
|
|
|
299,000
|
|
|
|
283,000
|
|
|
|
281,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Subtotal
|
|
|
1,256,000
|
|
|
|
1,149,000
|
|
|
|
1,021,000
|
|
Indiana(4)
|
|
|
|
|
|
|
|
|
|
|
56,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
|
1,256,000
|
|
|
|
1,149,000
|
|
|
|
1,077,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Ending Membership by State for our Medicare
Advantage Special Needs Plans:
|
|
|
|
|
|
|
|
|
|
|
|
|
California
|
|
|
1,500
|
|
|
|
1,100
|
|
|
|
500
|
|
Michigan
|
|
|
1,700
|
|
|
|
1,100
|
|
|
|
200
|
|
Nevada
|
|
|
700
|
|
|
|
500
|
|
|
|
|
|
New Mexico
|
|
|
300
|
|
|
|
|
|
|
|
|
|
Texas(3)
|
|
|
400
|
|
|
|
|
|
|
|
|
|
Utah
|
|
|
2,400
|
|
|
|
1,900
|
|
|
|
1,500
|
|
Washington
|
|
|
1,000
|
|
|
|
500
|
|
|
|
200
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
|
8,000
|
|
|
|
5,100
|
|
|
|
2,400
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Ending Membership by State for our Aged, Blind and
Disabled (ABD) Population:
|
|
|
|
|
|
|
|
|
|
|
|
|
California
|
|
|
12,700
|
|
|
|
11,800
|
|
|
|
10,700
|
|
Michigan
|
|
|
30,300
|
|
|
|
31,400
|
|
|
|
33,200
|
|
New Mexico
|
|
|
6,300
|
|
|
|
6,800
|
|
|
|
6,700
|
|
Ohio
|
|
|
19,000
|
|
|
|
14,900
|
|
|
|
|
|
Texas(3)
|
|
|
16,200
|
|
|
|
16,000
|
|
|
|
|
|
Utah
|
|
|
7,300
|
|
|
|
6,800
|
|
|
|
6,900
|
|
Washington
|
|
|
3,000
|
|
|
|
2,800
|
|
|
|
2,700
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
|
94,800
|
|
|
|
90,500
|
|
|
|
60,200
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
38
|
|
|
(1) |
|
Our Missouri health plan was acquired effective November 1,
2007. |
|
(2) |
|
Less than one thousand members. Our Nevada plan serves only
Medicare members and commenced operations in June 2007. |
|
(3) |
|
Our Texas health plan commenced operations in September 2006. |
|
(4) |
|
Our Indiana health plan ceased serving members effective
January 1, 2007. |
The following table provides details of member months (defined
as the aggregation of each months membership for the
period) by state for the years ended December 31, 2008,
2007, and 2006:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2008
|
|
|
2007
|
|
|
2006
|
|
|
Total Member Months by Health Plan:
|
|
|
|
|
|
|
|
|
|
|
|
|
California
|
|
|
3,721,000
|
|
|
|
3,500,000
|
|
|
|
3,694,000
|
|
Michigan
|
|
|
2,526,000
|
|
|
|
2,597,000
|
|
|
|
2,365,000
|
|
Missouri(1)
|
|
|
910,000
|
|
|
|
136,000
|
|
|
|
|
|
Nevada(2)
|
|
|
7,000
|
|
|
|
1,000
|
|
|
|
|
|
New Mexico
|
|
|
970,000
|
|
|
|
803,000
|
|
|
|
726,000
|
|
Ohio
|
|
|
1,998,000
|
|
|
|
1,567,000
|
|
|
|
442,000
|
|
Texas(3)
|
|
|
348,000
|
|
|
|
335,000
|
|
|
|
34,000
|
|
Utah
|
|
|
659,000
|
|
|
|
593,000
|
|
|
|
689,000
|
|
Washington
|
|
|
3,514,000
|
|
|
|
3,419,000
|
|
|
|
3,410,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Subtotal
|
|
|
14,653,000
|
|
|
|
12,951,000
|
|
|
|
11,360,000
|
|
Indiana(4)
|
|
|
|
|
|
|
|
|
|
|
499,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
|
14,653,000
|
|
|
|
12,951,000
|
|
|
|
11,859,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1) |
|
Our Missouri health plan was acquired effective November 1,
2007. |
|
(2) |
|
Our Nevada plan serves only Medicare members and commenced
operations in June 2007. |
|
(3) |
|
Our Texas health plan commenced operations in September 2006. |
|
(4) |
|
Our Indiana health plan ceased serving members effective
January 1, 2007. |
Expenses
Our operating expenses include expenses related to the provision
of medical care services and general and administrative, or
G&A, expenses. Our results of operations are impacted by
our ability to effectively manage expenses related to health
care services and to accurately estimate costs incurred.
Expenses related to medical care services are captured in the
following four categories:
|
|
|
|
|
Fee-for-service: Physician
providers paid on a
fee-for-service
basis are paid according to a fee schedule set by the state or
by our contracts with these providers. We pay hospitals on a
fee-for-service basis in a variety of ways, including per diem
amounts, diagnostic-related groups, or DRGs, percent of billed
charges, and case rates. We also pay a small portion of
hospitals on a capitated basis. We also have stop-loss
agreements with the hospitals with which we contract; under
certain circumstances, we pay escalated charges in connection
with these stop-loss agreements. Under all
fee-for-service
arrangements, we retain the financial responsibility for medical
care provided. Expenses related to
fee-for-service
contracts are recorded in the period in which the related
services are dispensed. The costs of drugs administered in a
physician or hospital setting that are not billed through our
pharmacy benefit managers are included in
fee-for-service
costs.
|
|
|
|
Capitation: Many of our primary care
physicians and a small portion of our specialists and hospitals
are paid on a capitated basis. Under capitation contracts, we
typically pay a fixed PMPM payment to the provider without
regard to the frequency, extent, or nature of the medical
services actually furnished. Under capitated contracts, we
remain liable for the provision of certain health care services.
Certain of our capitated
|
39
|
|
|
|
|
contracts also contain incentive programs based on service
delivery, quality of care, utilization management, and other
criteria. Capitation payments are fixed in advance of the
periods covered and are not subject to significant accounting
estimates. These payments are expensed in the period the
providers are obligated to provide services. The financial risk
for pharmacy services for a small portion of our membership is
delegated to capitated providers.
|
|
|
|
|
|
Pharmacy: Pharmacy costs include all drug,
injectibles, and immunization costs paid through our pharmacy
benefit managers. As noted above, drugs and injectibles not paid
through our pharmacy benefit managers are included in
fee-for-service
costs, except in those limited instances where we capitate drug
and injectible costs.
|
|
|
|
Other: Other medical care costs include
medically related administrative costs, certain provider
incentive costs, reinsurance cost, and other health care
expense. Medically related administrative costs include, for
example, expenses relating to health education, quality
assurance, case management, disease management,
24-hour
on-call nurses, and a portion of our information technology
costs. Salary and benefit costs are a substantial portion of
these expenses. For the years ended December 31, 2008, 2007
and 2006, medically related administrative costs were
approximately $75.9 million, $65.4 million and
$52.6 million, respectively.
|
The following table provides the details of our consolidated
medical care costs for the periods indicated (dollars in
thousands except PMPM amounts):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended December 31,
|
|
|
|
2008
|
|
|
2007
|
|
|
2006
|
|
|
|
|
|
|
|
|
|
% of
|
|
|
|
|
|
|
|
|
% of
|
|
|
|
|
|
|
|
|
% of
|
|
|
|
Amount
|
|
|
PMPM
|
|
|
Total
|
|
|
Amount
|
|
|
PMPM
|
|
|
Total
|
|
|
Amount
|
|
|
PMPM
|
|
|
Total
|
|
|
Fee-for-service
|
|
$
|
1,709,806
|
|
|
$
|
116.69
|
|
|
|
65.2
|
%
|
|
$
|
1,343,911
|
|
|
$
|
103.77
|
|
|
|
64.6
|
%
|
|
$
|
1,125,031
|
|
|
$
|
94.86
|
|
|
|
67.0
|
%
|
Capitation
|
|
|
450,440
|
|
|
|
30.74
|
|
|
|
17.2
|
|
|
|
375,206
|
|
|
|
28.97
|
|
|
|
18.0
|
|
|
|
261,476
|
|
|
|
22.05
|
|
|
|
15.6
|
|
Pharmacy
|
|
|
356,184
|
|
|
|
24.31
|
|
|
|
13.6
|
|
|
|
270,363
|
|
|
|
20.88
|
|
|
|
13.0
|
|
|
|
209,366
|
|
|
|
17.65
|
|
|
|
12.5
|
|
Other
|
|
|
104,882
|
|
|
|
7.16
|
|
|
|
4.0
|
|
|
|
90,603
|
|
|
|
7.00
|
|
|
|
4.4
|
|
|
|
82,779
|
|
|
|
6.98
|
|
|
|
4.9
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
$
|
2,621,312
|
|
|
$
|
178.90
|
|
|
|
100.0
|
%
|
|
$
|
2,080,083
|
|
|
$
|
160.62
|
|
|
|
100.0
|
%
|
|
$
|
1,678,652
|
|
|
$
|
141.54
|
|
|
|
100.0
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Our medical care costs include amounts that have been paid by us
through the reporting date as well as estimated liabilities for
medical care costs incurred but not paid by us as of the
reporting date. See Critical Accounting Policies
below for a comprehensive discussion of how we estimate such
liabilities. The following table provides the details of our
medical claims and benefits payable as of the dates indicated
(in thousands):
|
|
|
|
|
|
|
|
|
|
|
December 31,
|
|
|
|
2008
|
|
|
2007
|
|
|
Fee-for-service
claims incurred but not paid (IBNP)
|
|
$
|
236,492
|
|
|
$
|
264,385
|
|
Capitation payable
|
|
|
28,111
|
|
|
|
27,840
|
|
Pharmacy
|
|
|
18,837
|
|
|
|
14,676
|
|
Other
|
|
|
9,002
|
|
|
|
4,705
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
$
|
292,442
|
|
|
$
|
311,606
|
|
|
|
|
|
|
|
|
|
|
G&A expenses largely consist of wage and benefit costs for
our employees, premium taxes, and other administrative expenses.
Some G&A services are provided locally, while others are
delivered to our health plans from a centralized location. The
primary centralized functions are claims processing, information
systems, finance and accounting services, and legal and
regulatory services. Locally provided functions include member
services, plan administration, and provider relations. G&A
expenses include premium taxes for each of our health plans in
California, Michigan, New Mexico, Ohio, Texas, and Washington.
40
Results
of Operations
The following table sets forth selected consolidated operating
ratios. All ratios, with the exception of the medical care
ratio, are shown as a percentage of total revenue. The medical
care ratio is shown as a percentage of premium revenue because
there is a direct relationship between the premium revenue
earned and the cost of health care.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended December 31,
|
|
|
|
2008
|
|
|
2007
|
|
|
2006
|
|
|
Premium revenue
|
|
|
99.3
|
%
|
|
|
98.8
|
%
|
|
|
99.0
|
%
|
Investment income
|
|
|
0.7
|
|
|
|
1.2
|
|
|
|
1.0
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total revenue
|
|
|
100.0
|
%
|
|
|
100.0
|
%
|
|
|
100.0
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Medical care ratio
|
|
|
84.8
|
%
|
|
|
84.5
|
%
|
|
|
84.6
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
General and administrative expense ratio, excluding premium taxes
|
|
|
8.0
|
%
|
|
|
8.2
|
%
|
|
|
8.4
|
%
|
Premium taxes included in general and administrative expenses
|
|
|
3.1
|
|
|
|
3.3
|
|
|
|
3.0
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total general and administrative expense ratio
|
|
|
11.1
|
%
|
|
|
11.5
|
%
|
|
|
11.4
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Depreciation and amortization expense ratio
|
|
|
1.1
|
%
|
|
|
1.1
|
%
|
|
|
1.1
|
%
|
Effective tax rate
|
|
|
39.9
|
%
|
|
|
37.8
|
%
|
|
|
37.8
|
%
|
Operating income
|
|
|
3.6
|
%
|
|
|
3.9
|
%
|
|
|
3.8
|
%
|
Net income
|
|
|
2.0
|
%
|
|
|
2.3
|
%
|
|
|
2.3
|
%
|
Year
Ended December 31, 2008 Compared with the Year Ended
December 31, 2007
The following table summarizes premium revenue, medical care
costs, medical care ratio, and premium taxes by health plan for
the periods indicated (PMPM amounts are in whole dollars; other
dollar amounts are in thousands):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended December 31, 2008
|
|
|
|
Premium Revenue
|
|
|
Medical Care Costs
|
|
|
Medical
|
|
|
Premium Tax
|
|
|
|
Total
|
|
|
PMPM
|
|
|
Total
|
|
|
PMPM
|
|
|
Care Ratio
|
|
|
Expense
|
|
|
California
|
|
$
|
417,027
|
|
|
$
|
112.06
|
|
|
$
|
363,776
|
|
|
$
|
97.75
|
|
|
|
87.2
|
%
|
|
$
|
12,503
|
|
Michigan
|
|
|
509,782
|
|
|
|
201.86
|
|
|
|
405,683
|
|
|
|
160.64
|
|
|
|
79.6
|
|
|
|
26,710
|
|
Missouri
|
|
|
225,280
|
|
|
|
247.62
|
|
|
|
184,298
|
|
|
|
202.58
|
|
|
|
81.8
|
|
|
|
|
|
Nevada
|
|
|
8,037
|
|
|
|
1,106.45
|
|
|
|
9,099
|
|
|
|
1,252.61
|
|
|
|
113.2
|
|
|
|
|
|
New Mexico
|
|
|
348,576
|
|
|
|
359.45
|
|
|
|
286,004
|
|
|
|
294.92
|
|
|
|
82.1
|
|
|
|
11,713
|
|
Ohio
|
|
|
602,826
|
|
|
|
301.76
|
|
|
|
549,182
|
|
|
|
274.91
|
|
|
|
91.1
|
|
|
|
30,505
|
|
Texas
|
|
|
110,178
|
|
|
|
316.32
|
|
|
|
84,324
|
|
|
|
242.09
|
|
|
|
76.5
|
|
|
|
1,995
|
|
Utah
|
|
|
155,991
|
|
|
|
236.75
|
|
|
|
139,011
|
|
|
|
210.98
|
|
|
|
89.1
|
|
|
|
|
|
Washington
|
|
|
709,943
|
|
|
|
202.02
|
|
|
|
575,085
|
|
|
|
163.64
|
|
|
|
81.0
|
|
|
|
11,668
|
|
Other
|
|
|
3,600
|
|
|
|
|
|
|
|
24,850
|
|
|
|
|
|
|
|
|
|
|
|
21
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
3,091,240
|
|
|
$
|
210.97
|
|
|
$
|
2,621,312
|
|
|
$
|
178.90
|
|
|
|
84.8
|
%
|
|
$
|
95,115
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
41
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended December 31, 2007
|
|
|
|
Premium Revenue
|
|
|
Medical Care Costs
|
|
|
Medical
|
|
|
Premium Tax
|
|
|
|
Total
|
|
|
PMPM
|
|
|
Total
|
|
|
PMPM
|
|
|
Care Ratio
|
|
|
Expense
|
|
|
California
|
|
$
|
378,934
|
|
|
$
|
108.29
|
|
|
$
|
310,226
|
|
|
$
|
88.66
|
|
|
|
81.9
|
%
|
|
$
|
11,338
|
|
Michigan
|
|
|
487,032
|
|
|
|
187.55
|
|
|
|
409,230
|
|
|
|
157.59
|
|
|
|
84.0
|
|
|
|
28,493
|
|
Missouri
|
|
|
30,730
|
|
|
|
226.65
|
|
|
|
26,396
|
|
|
|
194.69
|
|
|
|
85.9
|
|
|
|
|
|
Nevada
|
|
|
2,438
|
|
|
|
1,440.73
|
|
|
|
2,069
|
|
|
|
1,222.76
|
|
|
|
84.9
|
|
|
|
|
|
New Mexico
|
|
|
268,115
|
|
|
|
333.94
|
|
|
|
221,567
|
|
|
|
275.97
|
|
|
|
82.6
|
|
|
|
9,088
|
|
Ohio
|
|
|
436,238
|
|
|
|
278.39
|
|
|
|
394,451
|
|
|
|
251.72
|
|
|
|
90.4
|
|
|
|
19,631
|
|
Texas
|
|
|
88,453
|
|
|
|
263.90
|
|
|
|
68,173
|
|
|
|
203.40
|
|
|
|
77.1
|
|
|
|
1,598
|
|
Utah
|
|
|
116,907
|
|
|
|
197.19
|
|
|
|
109,895
|
|
|
|
185.36
|
|
|
|
94.0
|
|
|
|
|
|
Washington
|
|
|
652,970
|
|
|
|
190.96
|
|
|
|
519,763
|
|
|
|
152.00
|
|
|
|
79.6
|
|
|
|
10,844
|
|
Other
|
|
|
552
|
|
|
|
|
|
|
|
18,313
|
|
|
|
|
|
|
|
|
|
|
|
28
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
2,462,369
|
|
|
$
|
190.13
|
|
|
$
|
2,080,083
|
|
|
$
|
160.62
|
|
|
|
84.5
|
%
|
|
$
|
81,020
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net
Income
For the year ended December 31, 2008, net income increased
to $62.4 million, or $2.25 per diluted share, from
$58.3 million, or $2.05 per diluted share, for the year
ended December 31, 2007.
Premium
Revenue
Premium revenue for the year ended December 31, 2008 was
$3,091.2 million, an increase of $628.8 million, or
26%, over the $2,462.4 million of premium revenue for the
year ended December 31, 2007. Medicare premium revenue for
2008 was $95.1 million, compared with $49.3 million
for 2007.
Significant contributors to the $628.8 million increase in
annual premium revenue included the following:
|
|
|
|
|
A $194.6 million increase in Medicaid premium revenue at
the Missouri health plan, primarily a result of our acquisition
of this plan on November 1, 2007.
|
|
|
|
A $166.6 million increase in Medicaid premium revenue at
the Ohio health plan due to higher enrollment, particularly in
the Covered Families and Children (CFC) population.
|
|
|
|
A $78.7 million increase in Medicaid premium revenue at the
New Mexico health plan, primarily due to higher enrollment.
|
|
|
|
A $51.4 million increase in Medicaid premium revenue at the
Washington health plan, primarily due to higher rates.
|
|
|
|
A $45.8 million increase in Medicare premium revenue across
all health plans that serve Medicare enrollees, primarily due to
increased enrollment.
|
|
|
|
A $34.3 million increase in Medicaid premium revenue at the
California health plan, primarily due to increased enrollment.
|
Investment
income
Investment income for 2008 decreased $9.0 million to
$21.1 million, from $30.1 million earned in 2007. This
30% decline was due to declining interest rates in 2008.
Medical
care costs
Medical care costs as a percentage of premium revenue (the
medical care ratio) increased to 84.8% in 2008 from 84.5% in
2007. Excluding Medicare, our medical care ratio was 84.8% in
2008, compared with 84.7% in 2007.
42
|
|
|
|
|
The medical care ratio of the California health plan was 87.2%
for 2008, up from 81.9% in 2007. The increase in the plans
medical care ratio was caused primarily by increased
fee-for-service
and pharmacy costs that proportionally exceeded the increased
revenue from premium rate increases.
|
|
|
|
The medical care ratio of the Michigan health plan was 79.6% for
2008, down from 84.0% in 2007. This decrease was caused
primarily by premium rate increases that proportionally exceeded
the plans increased medical costs.
|
|
|
|
The medical care ratio of the Missouri health plan was 81.8% for
2008, down from 85.9% in 2007. Premium increases were
proportionally greater than PMPM medical costs due to revised
provider contracts and a fee schedule increase effective
July 1, 2008.
|
|
|
|
The medical care ratio of the New Mexico health plan was 82.1%
in 2008, down from 82.6% in 2007. Between July 1, 2008 and
December 31, 2008, the New Mexico health plan received a
blended rate decrease of approximately 3% under the plans
Medicaid Salud! contract and two separate contracts serving
membership under the states coverage initiative for the
uninsured. The impact of this blended rate decrease was exceeded
by the reversal of a $12.9 million accrual established as
of December 31, 2007, pursuant to a minimum medical care
ratio contract provision. In 2007, the New Mexico health plan
had recorded a charge of $6.0 million related to this
contract provision. Absent the impact of the minimum medical
care ratio contract provision, the New Mexico health plans
MCR would have been 85.2% in 2008, compared with 80.8% in 2007,
due to higher
fee-for-service
and capitation costs and lower PMPM premium revenue.
|
|
|
|
The medical care ratio of the Ohio health plan increased to
91.1% in the 2008 from 90.4% in the 2007, primarily due to
higher pharmacy cost as a parentage of premium revenue. The
medical care ratio of the Ohio health plan, by line of business,
was as follows:
|
|
|
|
|
|
|
|
|
|
|
|
Dec. 31,
|
|
|
Dec. 31,
|
|
|
|
2008
|
|
|
2007
|
|
|
Covered Families and Children (CFC)
|
|
|
89.7
|
%
|
|
|
88.6
|
%
|
Aged, Blind or Disabled (ABD)
|
|
|
93.7
|
|
|
|
94.7
|
|
|
|
|
|
|
|
|
|
|
Aggregate
|
|
|
91.1
|
%
|
|
|
90.4
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
The medical care ratio of the Texas health plan was 76.5% in
2008, down from 77.1% in 2007. Increased premiums more than
offset higher medical costs.
|
|
|
|
The medical care ratio of the Utah health plan was 89.1% in
2008, down from 94.0% in 2007. In 2007, the Utah health plan had
recorded a $4.2 million reduction of revenue as a result of
a reconciliation of amounts due the state of Utah under a
savings sharing arrangement. Absent the savings sharing
adjustment, the medical care ratio in 2007 would have been 90.7%.
|
|
|
|
The medical care ratio of the Washington health plan was 81.0%
in 2008, up from 79.6% in 2007, primarily due to higher
fee-for-service
specialist and hospital costs.
|
General
and administrative expenses
General and administrative expenses were $344.8 million, or
11.1% of total revenue, for 2008, compared with
$285.3 million, or 11.5% of total revenue, for 2007.
Included in G&A expenses were premium taxes totaling
$95.1 million in 2008 and $81.0 million in 2007.
Premium taxes increased in 2008 due to increased revenues in the
states where premium taxes are assessed.
43
Core G&A expenses (defined as G&A expenses less
premium taxes) were 8.0% of revenue in 2008, compared with 8.2%
in 2007. The decrease in core G&A compared with 2007 was
primarily due to lower administrative payroll as a percentage of
revenue, as indicated in the table below.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended December 31,
|
|
|
|
2008
|
|
|
2007
|
|
|
|
|
|
|
% of Total
|
|
|
|
|
|
% of Total
|
|
|
|
Amount
|
|
|
Revenue
|
|
|
Amount
|
|
|
Revenue
|
|
|
|
(In thousands)
|
|
|
Medicare-related administrative costs
|
|
$
|
18,451
|
|
|
|
0.6
|
%
|
|
$
|
9,778
|
|
|
|
0.4
|
%
|
Non Medicare-related administrative costs:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Administrative payroll, including employee incentive compensation
|
|
|
190,932
|
|
|
|
6.1
|
|
|
|
163,420
|
|
|
|
6.6
|
|
Florida health plan start up expenses
|
|
|
2,495
|
|
|
|
0.1
|
|
|
|
|
|
|
|
|
|
All other administrative expense
|
|
|
37,768
|
|
|
|
1.2
|
|
|
|
31,077
|
|
|
|
1.2
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Core G&A expenses
|
|
$
|
249,646
|
|
|
|
8.0
|
%
|
|
$
|
204,275
|
|
|
|
8.2
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Depreciation
and Amortization
Depreciation and amortization expense increased
$5.7 million for the year ended December 31, 2008
compared to 2007, primarily due to depreciation expense
associated with investments in infrastructure. Of the total
increase, amortization expense contributed $2.1 million,
primarily due to the Mercy CarePlus acquisition in Missouri in
2007. The following table presents the components of
depreciation and amortization expense (in thousands):
|
|
|
|
|
|
|
|
|
|
|
Year Ended December 31,
|
|
|
|
2008
|
|
|
2007
|
|
|
Depreciation expense
|
|
$
|
20,718
|
|
|
$
|
17,118
|
|
Amortization expense on intangible assets
|
|
|
12,970
|
|
|
|
10,849
|
|
|
|
|
|
|
|
|
|
|
Total depreciation and amortization expense
|
|
$
|
33,688
|
|
|
$
|
27,967
|
|
|
|
|
|
|
|
|
|
|
Impairment
Charge on Purchased Software
During the second quarter of 2007, we recorded an impairment
charge of $782,000, related to purchased software no longer used
for operations. No such charge was recorded in 2008.
Interest
Expense
Interest expense increased to $8.7 million in 2008 from
$4.6 million in 2007 primarily due to the issuance of our
$200.0 million convertible senior notes in the fourth
quarter of 2007.
Income
Taxes
Income taxes were recorded at an effective rate of 39.9% for the
year ended December 31, 2008, compared with 37.8% in the
prior year. The increase in our effective tax rate was primarily
the result of an increase in Michigan state taxes attributable
to tax law changes that took effect on January 1, 2008. The
increase in Michigan taxes was partially offset by prior
years tax benefits recorded during 2008 relating to
California enterprise zone credits. Absent the enterprise zone
credit tax benefits, our effective tax rate for the year ended
December 31, 2008 would have been approximately 41%.
44
Year
Ended December 31, 2007 Compared with the Year Ended
December 31, 2006
The following table summarizes premium revenue, medical care
costs, medical care ratio, and premium taxes by health plan for
the periods indicated (PMPM amounts are in whole dollars; other
dollar amounts are in thousands):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended December 31, 2007
|
|
|
|
Premium Revenue
|
|
|
Medical Care Costs
|
|
|
Medical
|
|
|
Premium Tax
|
|
|
|
Total
|
|
|
PMPM
|
|
|
Total
|
|
|
PMPM
|
|
|
Care Ratio
|
|
|
Expense
|
|
|
California
|
|
$
|
378,934
|
|
|
$
|
108.29
|
|
|
$
|
310,226
|
|
|
$
|
88.66
|
|
|
|
81.9
|
%
|
|
$
|
11,338
|
|
Michigan
|
|
|
487,032
|
|
|
|
187.55
|
|
|
|
409,230
|
|
|
|
157.59
|
|
|
|
84.0
|
|
|
|
28,493
|
|
Missouri
|
|
|
30,730
|
|
|
|
226.65
|
|
|
|
26,396
|
|
|
|
194.69
|
|
|
|
85.9
|
|
|
|
|
|
Nevada
|
|
|
2,438
|
|
|
|
1,440.73
|
|
|
|
2,069
|
|
|
|
1,222.76
|
|
|
|
84.9
|
|
|
|
|
|
New Mexico
|
|
|
268,115
|
|
|
|
333.94
|
|
|
|
221,567
|
|
|
|
275.97
|
|
|
|
82.6
|
|
|
|
9,088
|
|
Ohio
|
|
|
436,238
|
|
|
|
278.39
|
|
|
|
394,451
|
|
|
|
251.72
|
|
|
|
90.4
|
|
|
|
19,631
|
|
Texas
|
|
|
88,453
|
|
|
|
263.90
|
|
|
|
68,173
|
|
|
|
203.40
|
|
|
|
77.1
|
|
|
|
1,598
|
|
Utah
|
|
|
116,907
|
|
|
|
197.19
|
|
|
|
109,895
|
|
|
|
185.36
|
|
|
|
94.0
|
|
|
|
|
|
Washington
|
|
|
652,970
|
|
|
|
190.96
|
|
|
|
519,763
|
|
|
|
152.00
|
|
|
|
79.6
|
|
|
|
10,844
|
|
Other
|
|
|
552
|
|
|
|
|
|
|
|
18,313
|
|
|
|
|
|
|
|
|
|
|
|
28
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
2,462,369
|
|
|
$
|
190.13
|
|
|
$
|
2,080,083
|
|
|
$
|
160.62
|
|
|
|
84.5
|
%
|
|
$
|
81,020
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended December 31, 2006
|
|
|
|
Premium Revenue
|
|
|
Medical Care Costs
|
|
|
Medical
|
|
|
Premium Tax
|
|
|
|
Total
|
|
|
PMPM
|
|
|
Total
|
|
|
PMPM
|
|
|
Care Ratio
|
|
|
Expense
|
|
|
California
|
|
$
|
372,071
|
|
|
$
|
100.74
|
|
|
$
|
328,532
|
|
|
$
|
88.95
|
|
|
|
88.3
|
%
|
|
$
|
11,738
|
|
Indiana
|
|
|
82,946
|
|
|
|
166.29
|
|
|
|
79,411
|
|
|
|
159.20
|
|
|
|
95.7
|
%
|
|
|
|
|
Michigan
|
|
|
429,835
|
|
|
|
181.73
|
|
|
|
335,696
|
|
|
|
141.93
|
|
|
|
78.1
|
%
|
|
|
25,982
|
|
New Mexico
|
|
|
221,597
|
|
|
|
305.07
|
|
|
|
187,460
|
|
|
|
258.08
|
|
|
|
84.6
|
%
|
|
|
8,203
|
|
Ohio
|
|
|
94,751
|
|
|
|
214.25
|
|
|
|
86,249
|
|
|
|
195.03
|
|
|
|
91.0
|
%
|
|
|
4,265
|
|
Texas
|
|
|
4,508
|
|
|
|
133.37
|
|
|
|
4,688
|
|
|
|
138.70
|
|
|
|
104.0
|
%
|
|
|
79
|
|
Utah
|
|
|
165,507
|
|
|
|
240.10
|
|
|
|
151,417
|
|
|
|
219.66
|
|
|
|
91.5
|
%
|
|
|
|
|
Washington
|
|
|
613,750
|
|
|
|
179.98
|
|
|
|
484,435
|
|
|
|
142.06
|
|
|
|
78.9
|
%
|
|
|
10,506
|
|
Other
|
|
|
144
|
|
|
|
|
|
|
|
20,764
|
|
|
|
|
|
|
|
|
|
|
|
4
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
1,985,109
|
|
|
$
|
167.39
|
|
|
$
|
1,678,652
|
|
|
$
|
141.55
|
|
|
|
84.6
|
%
|
|
$
|
60,777
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net
Income
For the year ended December 31, 2007, net income increased
to $58.3 million, or $2.05 per diluted share, from
$45.7 million, or $1.62 per diluted share, for the year
ended December 31, 2006.
Premium
Revenue
For the year ended December 31, 2007, premium revenue was
$2,462.4 million, an increase of $477.3 million, or
24.0%, over $1,985.1 million for the year ended
December 31, 2006. Medicare premium revenue for 2007 was
$49.3 million compared with $27.2 million in 2006.
Contributing to the $477.3 million increase in annual
premium revenues were the following:
|
|
|
|
|
A $341.5 million increase at the Ohio health plan
principally due to higher enrollment;
|
|
|
|
An $83.9 million increase at the Texas health plan due to
higher enrollment. During 2007, the Texas health plan reduced
revenue by $3.1 million to record amounts due back to the
state under a profit sharing agreement;
|
45
|
|
|
|
|
A $57.2 million increase at our Michigan health plan
principally due to a full year of operations which had included
the revenue of the Cape Health Plan, compared to only eight
months of operations including Cape Health Plan revenues in 2006
(the acquisition of Cape Health Plan was effective May 1,
2006);
|
|
|
|
A $46.5 million increase at our New Mexico health plan due
to higher enrollment and higher premium rates. The New Mexico
health plan reduced revenue by $6.0 million and
$6.9 million in 2007 and 2006, respectively, to meet a
contractually required minimum medical care ratio;
|
|
|
|
A $39.2 million increase at our Washington health plan due
to higher premium rates and slightly higher membership;
|
|
|
|
A $30.7 million increase as a result of our acquisition of
Mercy CarePlus in Missouri effective November 1,
2007; and
|
|
|
|
A $6.9 million increase at our California health plan as
increased premium rates offset lower enrollment.
|
These increases in premium revenues during 2007 were partially
offset by:
|
|
|
|
|
An $82.9 million decrease due to the termination of
operations of our Indiana health plan effective January 1,
2007; and
|
|
|
|
A $48.6 million decrease at our Utah health plan due to
reduced membership (on a member-month basis), and the write-off
of $4.7 million in savings share receivables.
|
Investment
Income
Investment income for 2007 increased $10.2 million to
$30.1 million, from $19.9 million for 2006, as a
result of higher invested balances, due in part to the
investment of proceeds from our offering of convertible senior
notes in the fourth quarter of 2007, and higher investment
yields.
Medical
Care Costs
Medical care costs as a percentage of premium revenue (the
medical care ratio), decreased to 84.5% in the year ended
December 31, 2007, from 84.6% in 2006. Contributing to this
change were the following:
|
|
|
|
|
The medical care ratio of the California health plan decreased
to 81.9% in 2007 from 88.3% in 2006 as a result of the premium
increases received during 2007 in San Bernardino/Riverside,
San Diego, and Sacramento counties, while PMPM medical
costs were essentially flat;
|
|
|
|
The medical care ratio of the Michigan health plan increased to
84.0% in 2007 from 78.1% in 2006 due to higher capitation and
pharmacy and specialty
fee-for-service
costs partially offset by lower hospital
fee-for-service
costs;
|
|
|
|
The medical care ratio of the New Mexico health plan decreased
to 82.6% in 2007 from 84.6% in 2006. The decrease was the result
of higher premium rates and a reduction in the minimum medical
care ratio premium adjustment, partially offset by the impact of
Medicaid fee schedule increases. Absent the adjustments made to
premium revenue in 2007 and 2006, the medical care ratio in New
Mexico would have been 80.8% in 2007 and 82.0% in 2006;
|
|
|
|
The medical care ratio of the Ohio health plan decreased to
90.4% for 2007 from 91.0% in 2006. During 2007, the Ohio health
plan began serving the ABD population for the first time. The
medical care ratio of the Ohio health plan, by line of business,
was as follows:
|
|
|
|
|
|
|
|
|
|
|
|
Dec. 31,
|
|
|
Dec. 31,
|
|
|
|
2007
|
|
|
2006
|
|
|
Covered Families and Children (CFC)
|
|
|
88.6
|
%
|
|
|
91.0
|
%
|
Aged, Blind or Disabled (ABD)
|
|
|
94.7
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Aggregate
|
|
|
90.4
|
%
|
|
|
91.0
|
%
|
|
|
|
|
|
|
|
|
|
46
|
|
|
|
|
The medical care ratio of the Texas health plan decreased in
2007 primarily due to very low medical costs for the Star Plus
membership. As noted above, we recorded a $3.1 million
reduction to revenue in Texas during 2007 to reflect estimated
amounts due back to the state under a profit sharing arrangement;
|
|
|
|
The medical care ratio of the Utah health plan increased due to
the write-off of $4.2 million in savings share receivables
in the second half of 2007. Medical care costs in Utah decreased
on a PMPM basis in 2007 when compared to 2006. Absent the
write-off of $4.2 million in savings share receivable in
the second half of 2007 ($4.0 million of which was accrued
as of December 31, 2006), the Utah health plans
medical care ratio would have been 90.7%, a decrease compared
with the 91.5% reported for 2006. During 2007 our Utah health
plan served the majority of its membership under a cost-plus
contract with the state of Utah;
|
|
|
|
The medical care ratio reported at the Washington health plan
increased to 79.6% in 2007 from 78.9% in 2006, principally due
to higher
fee-for-service
costs; and
|
|
|
|
The termination of our operations in Indiana resulted in a 10
basis-point decrease in our medical care ratio, to 84.5%, in
2007. Absent the impact of the Indiana plan in both years, the
medical care ratio in 2007 would have increased 50 basis
points to 84.6% from 84.1% in 2006.
|
General
and Administrative Expenses
G&A expenses were $285.3 million, or 11.5% of total
revenue, for the year ended December 31, 2007, compared to
$229.1 million, or 11.4% of total revenue, for 2006.
Included in G&A expenses were premium taxes totaling
$81.0 million in 2007 and $60.8 million in 2006.
Premium taxes increased in 2007 due to increased revenues in the
states where premium taxes are assessed.
Core G&A expenses decreased to 8.2% of total revenue for
the year ended December 31, 2007, compared with 8.4% for
2006. Although Core G&A expenses declined slightly in 2007
as a percentage of total revenue, certain categories of expenses
increased. These increases included employee incentive
compensation, recruitment costs, and our continued investment in
the administrative infrastructure necessary to support the
Medicare product line. The following table provides details
regarding the impact of these increases (dollars in thousands):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended December 31,
|
|
|
|
2007
|
|
|
2006
|
|
|
|
|
|
|
% of Total
|
|
|
|
|
|
% of Total
|
|
|
|
Amount
|
|
|
Revenue
|
|
|
Amount
|
|
|
Revenue
|
|
|
Medicare-related administrative costs
|
|
$
|
9,778
|
|
|
|
0.4
|
%
|
|
$
|
3,237
|
|
|
|
0.2
|
%
|
Non Medicare-related administrative costs:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Employee recruitment expense
|
|
|
2,568
|
|
|
|
0.1
|
|
|
|
1,769
|
|
|
|
0.1
|
|
Employee incentive compensation
|
|
|
9,976
|
|
|
|
0.4
|
|
|
|
5,102
|
|
|
|
0.2
|
|
All other administrative expense
|
|
|
182,735
|
|
|
|
7.3
|
|
|
|
158,172
|
|
|
|
7.9
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Core G&A expenses
|
|
$
|
205,057
|
|
|
|
8.2
|
%
|
|
$
|
168,280
|
|
|
|
8.4
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Depreciation
and Amortization
Depreciation and amortization expense increased
$6.5 million for the year ended December 31, 2007
compared to 2006, primarily due to depreciation expense
associated with investments in infrastructure. Of the total
increase, amortization expense contributed $1.3 million,
primarily due to the Cape Health Plan acquisition in Michigan in
2006. The following table presents the components of
depreciation and amortization expense (in thousands):
|
|
|
|
|
|
|
|
|
|
|
Year Ended December 31,
|
|
|
|
2007
|
|
|
2006
|
|
|
Depreciation expense
|
|
$
|
17,118
|
|
|
$
|
11,936
|
|
Amortization expense on intangible assets
|
|
|
10,849
|
|
|
|
9,539
|
|
|
|
|
|
|
|
|
|
|
Total depreciation and amortization expense
|
|
$
|
27,967
|
|
|
$
|
21,475
|
|
|
|
|
|
|
|
|
|
|
47
Impairment
Charge on Purchased Software
During the second quarter of 2007, we recorded an impairment
charge of $782,000 related to purchased software no longer used
for operations. No such charge occurred during the year ended
December 31, 2006.
Interest
Expense
Interest expense increased to $4.6 million in 2007 from
$2.4 million in 2006 primarily due to increased borrowings,
including the issuance of our convertible senior notes in the
fourth quarter of 2007.
Income
Taxes
We recognized income tax expense for the year ended
December 31, 2007 using an effective tax rate of 37.8%,
consistent with the rate used for the year ended
December 31, 2006.
Acquisitions
In August 2008, we announced our intention to acquire Florida
NetPASS, LLC (NetPASS), a provider of care
management and administrative services to approximately 55,000
Florida MediPass members in South and Central Florida. We expect
the closing of the transaction to occur by the third quarter of
2009, at a purchase price of approximately $42 million,
subject to adjustments. On October 1, 2008, we completed
the initial closing of the transaction, under which we acquired
one percent of the ownership interests of NetPASS for
$9.0 million. Additionally, we deposited $9.0 million
to an escrow account that will be used for the purpose of
reimbursing the state of Florida for any sums due under a final
settlement agreement with the state.
On October 7, 2008, we announced that our wholly owned
subsidiary, Molina Healthcare of Florida, Inc., was awarded a
Medicaid managed care contract by the state of Florida. The term
of the contract commenced on December 1, 2008, at which
time Molina Healthcare of Florida began its initial enrollment
of NetPASS Medicaid members, with the full transition of NetPASS
members expected to be completed by the third quarter of 2009.
On June 30, 2008, we paid $1 million and issued a
total of 48,186 shares of our common stock in connection
with our acquisition of the assets of The Game of Work, LLC. The
purchase price consideration totaled $2.3 million. The Game
of Work, LLC is a company specializing in productivity
measurement and improvement and will be used internally to
increase operational efficiency.
Effective November 1, 2007, we acquired Mercy CarePlus, a
licensed Medicaid managed care plan based in St. Louis,
Missouri, to expand our market share within our core Medicaid
managed care business. The results of operations for Mercy
CarePlus are included in the consolidated financial statements
from periods following November 1, 2007. The purchase price
for the acquisition was $80.0 million, and was funded with
available cash and proceeds from our issuance of convertible
senior notes in October 2007. The purchase price was subject to
the following post-closing adjustments: (1) a
reconciliation with respect to incurred but not reported medical
costs; (2) a settlement of income taxes; and (3) the
payment of an additional $5.0 million to the sellers if the
earnings of the health plan (as defined in the purchase
agreement) exceeded $22.0 million for the twelve months
ended June 30, 2008. Upon evaluation, we have preliminarily
determined that: (1) the sellers owe us approximately
$650,000 in connection with the reconciliation of incurred but
not reported medical costs; (2) we owe the sellers
approximately $400,000 in connection with the settlement of
income taxes; and (3) the earnings condition was not met,
so we believe that we do not owe the sellers the additional
$5.0 million payment. However, the sellers have objected to
our first and third determinations as listed above, and the
dispute resolution process provided for under the parties
stock purchase agreement has commenced. During the
post-acquisition period in 2008, we reduced goodwill relating to
the Mercy CarePlus acquisition by approximately
$6.2 million, primarily due to the establishment of a
deferred tax asset relating to the carryover tax basis in
certain identifiable intangibles.
In May 2006, we acquired HCLB, Inc. (HCLB). HCLB is
the parent company of Cape Health Plan, Inc. (Cape),
a Michigan corporation based in Southfield, Michigan. The Cape
acquisition expanded our geographic presence within Michigan.
The purchase price was $44.0 million in cash and the
acquisition was deemed effective May 15, 2006 for
accounting purposes. Accordingly, the results of operations for
Cape have been included in the
48
consolidated financial statements for the periods following
May 15, 2006. Effective December 31, 2006, we merged
Cape into Molina Healthcare of Michigan, Inc., our Michigan
health plan.
Liquidity
and Capital Resources
We manage our cash, investments, and capital structure to meet
the short- and long-term obligations of our business while
maintaining liquidity and financial flexibility. We forecast,
analyze, and monitor our cash flows to enable prudent investment
management and financing within the confines of our financial
strategy.
Our regulated subsidiaries generate significant cash flows from
premium revenue and investment income. Such cash flows are our
primary source of liquidity. Thus, any future decline in our
profitability may have a negative impact on our liquidity. We
generally receive premium revenue in advance of the payment of
claims for the related health care services. A majority of the
assets held by our regulated subsidiaries are in the form of
cash, cash equivalents and investments. After considering
expected cash flows from operating activities, we generally
invest cash of regulated subsidiaries that exceeds our expected
short-term obligations in longer term, investment-grade,
marketable debt securities to improve our overall investment
return. These investments are made pursuant to board approved
investment policies which conform to applicable state laws and
regulations. Our investment policies are designed to provide
liquidity, preserve capital, and maximize total return on
invested assets, all in a manner consistent with state
requirements that prescribe the types of instruments in which
our subsidiaries may invest. These investment policies require
that our investments have final maturities of ten years or less
(excluding auction rate securities and variable rate securities,
for which interest rates are periodically reset) and that the
average maturity be four years or less. Professional portfolio
managers operating under documented guidelines manage our
investments. As of December 31, 2008, a substantial portion
of our cash was invested in a portfolio of highly liquid money
market securities, and our investments consisted solely of
investment-grade debt securities. For a comprehensive discussion
of our auction rate securities, see Fair Value
Measurements, below. Our restricted investments are
invested principally in certificates of deposit and
U.S. treasury securities.
All of our investments are classified as current assets, except
for our investments in auction rate securities, which are
classified as non-current assets. The average annualized
portfolio yields for the years ended December 31, 2008,
2007, and 2006 were approximately 3.0%, 5.2%, and 4.8%,
respectively.
Investments and restricted investments are subject to interest
rate risk and will decrease in value if market rates increase.
We have the ability to hold our restricted investments until
maturity and, as a result, we would not expect the value of
these investments to decline significantly due to a sudden
change in market interest rates. Declines in interest rates over
time will reduce our investment income.
Cash in excess of the capital needs of our regulated health
plans is generally paid to our non-regulated parent company in
the form of dividends, when and as permitted by applicable
regulations, for general corporate use.
Cash provided by operating activities for the year ended
December 31, 2008 was $40.4 million, compared with
$158.6 million for 2007, a decrease of $118.2 million.
The significant components of the 2008 decrease in cash provided
by operating activities included the following:
|
|
|
|
|
Receivables: year-over-year increase in 2008
due primarily to higher birth income receivables as a result of
increased enrollment in Ohio and Missouri, combined with the
addition of receivables from the acquisition of our Missouri
health plan in the fourth quarter of 2007;
|
|
|
|
Medical claims and benefits
payable: year-over-year
decrease due primarily to the ramp up of membership and medical
claims at the Texas and Ohio health plans in 2007 compared with
less significant changes for those plans in 2008;
|
|
|
|
Deferred
revenue: year-over-year
decrease due primarily to the timing of the Ohio health
plans receipts of premium payments from the state of Ohio;
|
|
|
|
Income taxes: the 2008 increase in income
taxes receivable, combined with the 2007 decrease in income
taxes payable, due to timing of receipts and payments.
|
49
Cash used in investing activities was $64.5 million for the
year ended December 31, 2008, compared with
$256.3 million for 2007. The much greater amount invested
in 2007 relates to the $193.4 million in proceeds from our
issuance of $200 million senior convertible notes and our
$70.2 million purchase of our Missouri health plan, Mercy
CarePlus, both of which occurred in the fourth quarter of 2007,
with no comparable activity in 2008.
Cash used in financing activities totaled $47.8 million for
the year ended December 31, 2008, compared with
$153.1 million provided by financing activities for 2007.
The primary use of cash in 2008 was $49.9 million in
repurchases of our common stock, compared with cash provided by,
in 2007, the $193.4 million net proceeds from the issuance
of convertible senior notes, offset by the reduction in
borrowings and the repayment of amounts owed under our credit
facility.
The securities and credit markets have been experiencing extreme
volatility and disruption over the past year, and as a result
the availability of credit has been severely restricted. Such
conditions may persist throughout 2009. In the event we need
access to additional capital to pay our operating expenses, make
payments on our indebtedness, pay capital expenditures, or fund
acquisitions, our ability to obtain such capital may be limited
and the cost of any such capital may be significant,
particularly if we are unable to access our existing credit
facility. While we have not attempted to access the credit
markets recently, we believe that if credit could be obtained,
the terms and costs of such credit would be significantly less
favorable to us than what was obtained in our most recent
financings.
Repurchase Programs. Under our board of
directors authorization, we undertook two common stock
share repurchase programs in 2008. During 2008, we repurchased
approximately 1.9 million shares at an aggregate cost of
approximately $50 million. In January 2009, our board of
directors authorized the repurchase of up to $25 million in
aggregate of either our common stock or our convertible senior
notes. In February 2009, we paid approximately
$10 million to repurchase $13 million face amount of
our convertible senior notes. In February and March 2009, we
repurchased approximately 724,000 shares of our common
stock for an aggregate purchase price of approximately
$13.3 million.
Shelf Registration Statement. In December
2008, we filed a shelf registration statement on
Form S-3
with the Securities and Exchange Commission covering the
issuance of up to $300 million of our securities, including
common stock, warrants, or debt securities, and up to
250,000 shares of outstanding common stock that may be sold
from time to time by the Molina Siblings Trust. We may publicly
offer securities from time to time at prices and terms to be
determined at the time of the offering.
Capital
Resources
At December 31, 2008, we had working capital of
$340.8 million compared with $407.7 million at
December 31, 2007. At December 31, 2008 and
December 31, 2007, cash and cash equivalents were
$387.2 million and $459.1 million, respectively. At
December 31, 2008 and December 31, 2007, investments
were $248.0 million and $242.9 million, respectively.
In 2008, this total included $58.2 million in auction rate
securities classified as non-current assets. In 2007, all
investments were classified as current assets. At
December 31, 2008, the parent company (Molina Healthcare,
Inc.) had cash and investments of approximately
$68.9 million. We believe that our cash resources and
internally generated funds will be sufficient to support our
operations, regulatory requirements, and capital expenditures
for at least the next 12 months.
EBITDA(1)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended
|
|
|
Year Ended
|
|
|
|
December 31,
|
|
|
December 31,
|
|
|
|
2008
|
|
|
2007
|
|
|
2008
|
|
|
2007
|
|
|
|
(In thousands)
|
|
|
Operating income
|
|
$
|
27,467
|
|
|
$
|
30,633
|
|
|
$
|
112,605
|
|
|
$
|
98,327
|
|
Add back:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Depreciation and amortization expense
|
|
|
8,691
|
|
|
|
7,693
|
|
|
|
33,688
|
|
|
|
27,967
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
EBITDA
|
|
$
|
36,158
|
|
|
$
|
38,326
|
|
|
$
|
146,293
|
|
|
$
|
126,294
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1) |
|
We calculate EBITDA by adding back depreciation and amortization
expense to operating income. Operating income included interest
income of $21.1 million and $29.2 million for the
years ended December 31, 2008, |
50
|
|
|
|
|
and 2007, respectively. EBITDA is not prepared in conformity
with GAAP since it excludes depreciation and amortization
expense, as well as interest expense, and the provision for
income taxes. This non-GAAP financial measure should not be
considered as an alternative to net income, operating income,
operating margin, or cash provided by operating activities.
Management uses EBITDA as a supplemental metric in evaluating
our financial performance, in evaluating financing and business
development decisions, and in forecasting and analyzing future
periods. For these reasons, management believes that EBITDA is a
useful supplemental measure to investors in evaluating our
performance and the performance of other companies in our
industry. |
Fair
Value Measurements
Effective January 1, 2008, we adopted SFAS 157,
Fair Value Measurements, for financial assets and
liabilities. The statement defines fair value, provides guidance
for measuring fair value and requires certain disclosures.
SFAS 157 discusses valuation techniques, such as the market
approach (comparable market prices), the income approach
(present value of future income or cash flow) and the cost
approach (cost to replace the service capacity of an asset or
replacement cost). The statement establishes a fair value
hierarchy that prioritizes the inputs to valuation techniques
used to measure fair value into three broad levels. The
following is a brief description of those three levels:
|
|
|
|
|
Level 1: Observable inputs such as quoted
prices (unadjusted) in active markets that are accessible at the
measurement date for identical, unrestricted assets or
liabilities.
|
|
|
|
Level 2: Inputs other than quoted prices
that are observable for the asset or liability, either directly
or indirectly. These include quoted prices for similar assets or
liabilities in active markets and quoted prices for identical or
similar assets or liabilities in markets that are not active.
|
|
|
|
Level 3: Unobservable inputs that reflect
the reporting entitys own assumptions.
|
As of December 31, 2008, we held certain assets that are
required to be measured at fair value on a recurring basis.
These included cash and cash equivalents, investments and
restricted investments as follows:
|
|
|
Balance Sheet Classification
|
|
Description
|
|
Current assets:
|
|
|
Cash and cash
equivalents
|
|
Cash and highly liquid securities with original or purchase date
remaining maturities of up to three months that are readily
convertible into known amounts of cash; reported at fair value
based on market prices that are readily available (Level 1).
|
Investments
|
|
Investment grade debt securities; designated as
available-for-sale; reported at fair value based on market
prices that are readily available (Level 1).
|
Non-current assets:
|
|
|
Investments
|
|
Auction rate securities; designated as available-for-sale;
reported at fair value based on discounted cash flow analysis or
other type of valuation model (Level 3).
|
|
|
Auction rate securities; designated as trading; reported at fair
value based on discounted cash flow analysis or other type of
valuation model (Level 3).
|
Other assets
|
|
Auction rate securities rights (the Rights);
reported at fair value based on discounted cash flow analysis or
other type of valuation model (Level 3).
|
Restricted investments
|
|
Interest-bearing deposits and U.S. treasury securities required
by the respective states in which we operate, or required by
contractual arrangement with a third party such as a provider
group; designated as held-to-maturity; reported at amortized
cost which approximates market value and based on market prices
that are readily available (Level 1).
|
As of December 31, 2008, $70.5 million par value (fair
value of $58.2 million) of our investments consisted of
auction rate securities, of which all were securities
collateralized by student loan portfolios, guaranteed by the
U.S. government. We continued to earn interest on
substantially all of these auction rate securities as of
December 31, 2008. Due to events in the credit markets, the
auction rate securities held by us experienced failed auctions
beginning in the first quarter of 2008. As such, quoted prices
in active markets were not readily available during the majority
of 2008. We used pricing models to estimate the fair value of
these securities. These pricing
51
models included factors such as the collateral underlying the
securities, the creditworthiness of the counterparty, the timing
of expected future cash flows, and the expectation of the next
time the security would be expected to have a successful
auction. The estimated values of these securities were also
compared, when possible, to valuation data with respect to
similar securities held by other parties. We concluded that
these estimates, given the lack of market available pricing,
provided a reasonable basis for determining fair value of the
auction rate securities as of December 31, 2008.
As of December 31, 2008, we held $42.5 million par value
(fair value of $34.9 million) auction rate securities with
a certain investment securities firm. In November 2008, we
entered into a rights agreement with this firm that (1) allows
us to exercise rights (the Rights) to sell the
eligible auction rate securities at par value to this firm
between June 30, 2010 and July 2, 2012, and
(2) gives the investment securities firm the right to
purchase the auction rate securities from us any time after the
agreement date as long as we receive the par value.
We have accounted for the Rights as a freestanding financial
instrument and have elected to record the value of the Rights
under the fair value option of SFAS 159, The Fair Value
Option for Financial Assets and Financial Liabilities. In
the fourth quarter of 2008, this resulted in the recognition of
a $6.9 million non-current asset, with a corresponding
increase to pretax income for the value of the Rights. To
determine the fair value estimate of the Rights, we used a
discounted cash-flow model that was based on the expectation
that the auction rate securities will be put back to the
investment securities firm at par on June 30, 2010, as
permitted by the Rights Agreement.
Simultaneous to the recognition of the $6.9 million rights
agreement, we recorded an
other-than-temporary
impairment of the underlying auction rate securities, and prior
unrealized losses on the auction rate securities that had been
recorded to other comprehensive loss through November 2008 were
charged to income, totaling $7.2 million. Also, at the time
of the execution of the Rights agreement and pursuant to
SFAS 115, we elected to transfer the underlying auction
rate securities from
available-for-sale
to trading securities. For the month of December 2008, we
recorded additional losses of $399,000 on these auction rate
securities. We expect that the future changes in the fair value
of the Rights will be substantially offset by the fair value
movements in the underlying auction rate securities.
As of December 31, 2008, the remainder of our auction rate
securities, which are still designated as
available-for-sale,
amounted to $28.0 million par value (fair value of
$23.3 million). As a result of the decline in fair value of
these auction rate securities, we recorded unrealized losses of
$4.7 million to accumulated other comprehensive (loss)
income for the year ended December 31, 2008. We have deemed
these unrealized losses to be temporary and attribute the
decline in value to liquidity issues, as a result of the failed
auction market, rather than to credit issues. Any future
fluctuation in fair value related to these instruments that we
deem to be temporary, including any recoveries of previous
write-downs, would be recorded to accumulated other
comprehensive (loss) income. If we determine that any future
valuation adjustment was
other-than-temporary,
we would record a charge to earnings as appropriate.
Long-Term
Debt
Convertible
Senior Notes
In October 2008, we completed our offering of
$200.0 million aggregate principal amount of
3.75% Convertible Senior Notes due 2014 (the
Notes). The sale of the Notes resulted in net
proceeds totaling $193.4 million. The Notes rank equally in
right of payment with our existing and future senior
indebtedness.
The Notes are convertible into cash and, under certain
circumstances, shares of our common stock. The initial
conversion rate is 21.3067 shares of our common stock per
$1,000 principal amount of the Notes. This represents an initial
conversion price of approximately $46.93 per share of our common
stock. In addition, if certain corporate transactions that
constitute a change of control occur prior to maturity, we will
increase the conversion rate in certain circumstances. Prior to
July 2014, holders may convert their Notes only under the
following circumstances:
|
|
|
|
|
During any fiscal quarter after our fiscal quarter ending
December 31, 2008, if the closing sale price per share of
our common stock, for each of at least 20 trading days during
the period of 30 consecutive trading days ending on the last
trading day of the previous fiscal quarter, is greater than or
equal to 120% of the conversion price per share of our common
stock;
|
52
|
|
|
|
|
During the five business day period immediately following any
five consecutive trading day period in which the trading price
per $1,000 principal amount of the Notes for each trading day of
such period was less than 98% of the product of the closing
price per share of our common stock on such day and the
conversion rate in effect on such day; or
|
|
|
|
Upon the occurrence of specified corporate transactions or other
specified events.
|
On or after July 1, 2014, holders may convert their Notes
at any time prior to the close of business on the scheduled
trading day immediately preceding the stated maturity date
regardless of whether any of the foregoing conditions is
satisfied.
We will deliver cash and shares of our common stock, if any,
upon conversion of each $1,000 principal amount of Notes, as
follows:
|
|
|
|
|
An amount in cash (the principal return) equal to
the sum of, for each of the 20 Volume-Weighted Average Price
(VWAP) trading days during the conversion period, the lesser of
the daily conversion value for such VWAP trading day and $50
(representing 1/20th of $1,000); and
|
|
|
|
A number of shares based upon, for each of the 20 VWAP trading
days during the conversion period, any excess of the daily
conversion value above $50.
|
On February 18, 2009, we settled the repurchase of
$13.0 million face amount of our convertible senior notes
(see Note 11 of the notes to consolidated financial
statements). We repurchased the notes at an average price of
$74.25 per $100 principal amount, for a total of
$9.6 million. Including accrued interest of approximately
$186,000, our total payment was $9.8 million.
Credit
Facility
In 2005, we entered into an Amended and Restated Credit
Agreement, dated as of March 9, 2005, among Molina
Healthcare Inc., certain lenders, and Bank of America N.A., as
Administrative Agent (the Credit Facility).
Effective May 2008, we entered into a third amendment of the
Credit Facility that increased the size of the revolving line of
credit from $180.0 million to $200.0 million, maturing
in May 2012. The Credit Facility is intended to be used for
working capital and general corporate purposes, and subject to
obtaining commitments from existing or new lenders and
satisfaction of other specified conditions, we may increase the
amount available under the Credit Facility to up to
$250.0 million.
Interest rates on borrowings under the Credit Facility are
based, at our election, on the London Interbank Offered Rate, or
LIBOR, or the base rate plus an applicable margin. The base rate
equals the higher of Bank of Americas prime rate or 0.500%
above the federal funds rate. We also pay a commitment fee on
the total unused commitments of the lenders under the Credit
Facility. The applicable margins and commitment fee are based on
our ratio of consolidated funded debt to consolidated earnings
before interest expense, taxes, depreciation and amortization,
or EBITDA. The applicable margins range between 0.750% and
1.750% for LIBOR loans and between 0.000% and 0.750% for base
rate loans. The commitment fee ranges between 0.150% and 0.275%.
In addition, we are required to pay a fee for each letter of
credit issued under the Credit Facility equal to the applicable
margin for LIBOR loans and a customary fronting fee. As of
December 31, 2008, there were no borrowings outstanding
under the Credit Facility.
Our obligations under the Credit Facility are secured by a lien
on substantially all of our assets and by a pledge of the
capital stock of our health plan subsidiaries (with the
exception of the California health plan). The Credit Facility
includes usual and customary covenants for credit facilities of
this type, including covenants limiting liens, mergers, asset
sales, other fundamental changes, debt, acquisitions, dividends
and other distributions, capital expenditures, investments, and
a fixed charge coverage ratio. The Credit Facility also requires
us to maintain a ratio of total consolidated debt to total
consolidated EBITDA of not more than 2.75 to 1.00 at any time.
At December 31, 2008, we were in compliance with all
financial covenants in the Credit Facility.
53
Regulatory
Capital and Dividend Restrictions
Our principal operations are conducted through our ten health
plan subsidiaries operating in California, Florida, Michigan,
Missouri, Nevada, New Mexico, Ohio, Texas, Utah, and Washington.
The health plans are subject to state laws that, among other
things, require the maintenance of minimum levels of statutory
capital, as defined by each state, and may restrict the timing,
payment, and amount of dividends and other distributions that
may be paid to Molina Healthcare, Inc. as the sole stockholder
of each of our health plans. To the extent the subsidiaries must
comply with these regulations, they may not have the financial
flexibility to transfer funds to us. The net assets in these
subsidiaries, after intercompany eliminations, which may not be
transferable to us in the form of loans, advances, or cash
dividends totaled $355.0 million at December 31, 2008,
and $332.2 million at December 31, 2007.
The National Association of Insurance Commissioners, or NAIC,
has established model rules which, if adopted by a particular
state, set minimum capitalization requirements for health plans
and other insurance entities bearing risk for health care
coverage. The requirements take the form of risk-based capital,
or RBC, rules. These rules, which vary slightly from state to
state, have been adopted in Florida, Michigan, Nevada, New
Mexico, Ohio, Texas, Utah, and Washington. California has not
adopted RBC rules and has not given notice of any intention to
do so. The RBC rules, if adopted by California, may increase the
minimum capital required by that state.
At December 31, 2008, our health plans had aggregate
statutory capital and surplus of approximately
$362.5 million, compared to the required minimum aggregate
statutory capital and surplus of approximately
$211.1 million. All of our health plans were in compliance
with the minimum capital requirements at December 31, 2008.
We have the ability and commitment to provide additional working
capital to each of our health plans when necessary to ensure
that capital and surplus continue to meet regulatory
requirements. Barring any change in regulatory requirements, we
believe that we will continue to be in compliance with these
requirements through 2009.
Critical
Accounting Policies
When we prepare our consolidated financial statements, we use
estimates and assumptions that may affect reported amounts and
disclosures. The determination of our liability for claims and
medical benefits payable is particularly important to the
determination of our financial position and results of
operations in any given period. Such determination of our
liability requires the application of a significant degree of
judgment by our management. As a result, the determination of
our liability for claims and medical benefits is subject to an
inherent degree of uncertainty. Our medical care costs include
amounts that have been paid by us through the reporting date, as
well as estimated liabilities for medical care costs incurred
but not paid by us as of the reporting date. Such medical care
cost liabilities include, among other items, unpaid
fee-for-service claims, capitation payments owed providers,
unpaid pharmacy invoices, and various medically related
administrative costs that have been incurred but not paid. We
use judgment to determine the appropriate assumptions for
determining the required estimates.
The most important element in estimating our medical care costs
is our estimate for
fee-for-service
claims which have been incurred but not paid by us. These
fee-for-service
costs that have been incurred but have not been paid at the
reporting date are collectively referred to as medical costs
that are Incurred But Not Paid, or IBNP. Our IBNP
claims reserve, as reported in our balance sheet, represents our
best estimate of the total amount of claims we will ultimately
pay with respect to claims that we have incurred as of the
balance sheet date. We estimate our IBNP monthly using actuarial
methods based on a number of factors. Our estimated IBNP
liability represented $236.5 million of our total medical
claims and benefits payable of $292.4 million as of
December 31, 2008. Excluding amounts related to our
cost-plus Medicaid contract in Utah and amounts that we
anticipate paying on behalf of a capitated provider in Ohio
(which we will subsequently withhold from that providers
monthly capitation payment), our IBNP liability at
December 31, 2008 was $216.7 million.
The factors we consider when estimating our IBNP include,
without limitation, claims receipt and payment experience (and
variations in that experience), changes in membership, provider
billing practices, health care service utilization trends, cost
trends, product mix, seasonality, prior authorization of medical
services, benefit changes, known outbreaks of disease or
increased incidence of illness such as influenza, provider
contract changes, changes to Medicaid fee schedules, and the
incidence of high dollar or catastrophic claims. Our assessment
of these
54
factors is then translated into an estimate of our IBNP
liability at the relevant measuring point through the
calculation of a base estimate of IBNP, a further reserve for
adverse claims development, and an estimate of the
administrative costs of settling all claims incurred through the
reporting date. The base estimate of IBNP is derived through
application of claims payment completion factors and trended per
member per month (PMPM) cost estimates.
For the fifth month of service prior to the reporting date and
earlier, we estimate our outstanding claims liability based on
actual claims paid, adjusted for estimated completion factors.
Completion factors seek to measure the cumulative percentage of
claims expense that will have been paid for a given month of
service as of the reporting date, based on historical payment
patterns.
The following table reflects the change in our estimate of
claims liability as of December 31, 2008 that would have
resulted had we changed our completion factors for the fifth
through the twelfth months preceding December 31, 2008, by
the percentages indicated. A reduction in the completion factor
results in an increase in medical claims liabilities. Our Utah
health plan is excluded from these calculations, because the
majority of the Utah business is conducted under a cost-plus
reimbursement contract. Dollar amounts are in thousands.
|
|
|
|
|
(Decrease) Increase in
|
|
Increase (Decrease) in
|
|
Estimated
|
|
Medical Claims and
|
|
Completion Factors
|
|
Benefits Payable
|
|
|
(6)%
|
|
$
|
53,199
|
|
(4)%
|
|
|
35,466
|
|
(2)%
|
|
|
17,733
|
|
2%
|
|
|
(17,733
|
)
|
4%
|
|
|
(35,466
|
)
|
6%
|
|
|
(53,199
|
)
|
For the four months of service immediately prior to the
reporting date, actual claims paid are not a reliable measure of
our ultimate liability, given the inherent delay between the
patient/physician encounter and the actual submission of a claim
for payment. For these months of service, we estimate our claims
liability based on trended PMPM cost estimates. These estimates
are designed to reflect recent trends in payments and expense,
utilization patterns, authorized services, and other relevant
factors. The following table reflects the change in our estimate
of claims liability as of December 31, 2008, that would
have resulted had we altered our trend factors by the
percentages indicated. An increase in the PMPM costs results in
an increase in medical claims liabilities. Our Utah health plan
is excluded from these calculations, because the majority of the
Utah business is conducted under a cost-plus reimbursement
contract. Dollar amounts are in thousands.
|
|
|
|
|
(Decrease) Increase in
|
|
(Decrease) Increase in
|
|
Trended Per member Per Month
|
|
Medical Claims and
|
|
Cost Estimates
|
|
Benefits Payable
|
|
|
(6)%
|
|
$
|
(27,129
|
)
|
(4)%
|
|
|
(18,086
|
)
|
(2)%
|
|
|
(9,043
|
)
|
2%
|
|
|
9,043
|
|
4%
|
|
|
18,086
|
|
6%
|
|
|
27,129
|
|
The following per-share amounts are based on a combined federal
and state statutory tax rate of 38%, and 27.8 million
diluted shares outstanding for the year ended December 31,
2008. Assuming a hypothetical 1% change in completion factors
from those used in our calculation of IBNP at December 31,
2008, net income for the year ended December 31, 2008 would
increase or decrease by approximately $5.5 million, or
$0.20 per diluted share, net of tax. Assuming a hypothetical 1%
change in PMPM cost estimates from those used in our calculation
of IBNP at December 31, 2008, net income for the year ended
December 31, 2008 would increase or decrease by
approximately $2.8 million, or $0.10 per diluted share, net
of tax. The corresponding figures for a 5% change in completion
55
factors and PMPM cost estimates would be $27.5 million, or
$0.99 per diluted share, net of tax, and $14.0 million, or
$0.50 per diluted share, net of tax, respectively.
It is important to note that any change in the estimate of
either completion factors or trended PMPM costs would usually be
accompanied by an change in the estimate of the other component,
and that an change in one component would almost always compound
rather than offset the resulting distortion to net income. When
completion factors are overestimated, trended PMPM costs
tend to be underestimated. Both circumstances will create
an overstatement of net income. Likewise, when completion
factors are underestimated, trended PMPM costs tend to be
overestimated, creating an understatement of net income.
In other words, errors in estimates involving both completion
factors and trended PMPM costs will usually act to drive
estimates of claims liabilities and medical care costs in the
same direction. For example, if completion factors were
overestimated by 1%, resulting in an overstatement of net income
by approximately $5.5 million, it is likely that trended
PMPM costs would be underestimated, resulting in an additional
overstatement of net income.
After we have established our base IBNP reserve through the
application of completion factors and trended PMPM cost
estimates, we then compute an additional liability, which also
uses actuarial techniques, to account for adverse developments
in our claims payments which the base actuarial model is not
intended to and does not account for. We refer to this
additional liability as the provision for adverse claims
development. The provision for adverse claims development is a
component of our overall determination of the adequacy of our
IBNP. It is intended to capture the potential inadequacy of our
IBNP estimate as a result of our inability to adequately assess
the impact of factors such as changes in the speed of claims
receipt and payment, the relative magnitude or severity of
claims, known outbreaks of disease such as influenza, our entry
into new geographical markets, our provision of services to new
populations such as the aged, blind or disabled (ABD), changes
to state-controlled fee schedules upon which much of our
provider payments are based, modifications and upgrades to our
claims processing systems and practices, and increasing medical
costs. Because of the complexity of our business, the number of
states in which we operate, and the need to account for
different health care benefit packages among those states, we
make an overall assessment of IBNP after considering the base
actuarial model reserves and the provision for adverse claims
development. We also include in our IBNP liability an estimate
of the administrative costs of settling all claims incurred
through the reporting date. The development of IBNP is a
continuous process that we monitor and refine on a monthly basis
as additional claims payment information becomes available. As
additional information becomes known to us, we adjust our
actuarial model accordingly to establish IBNP.
On a monthly basis, we review and update our estimated IBNP
liability and the methods used to determine that liability. Any
adjustments, if appropriate, are reflected in the period known.
While we believe our current estimates are adequate, we have in
the past been required to increase significantly our claims
reserves for periods previously reported and may be required to
do so again in the future. Any significant increases to prior
period claims reserves would materially decrease reported
earnings for the period in which the adjustment is made.
In our judgment, the estimates for completion factors will
likely prove to be more accurate than trended PMPM cost
estimates because estimated completion factors are subject to
fewer variables in their determination. Specifically, completion
factors are developed over long periods of time, and are most
likely to be affected by changes in claims receipt and payment
experience and by provider billing practices. Trended PMPM cost
estimates, while affected by the same factors, will also be
influenced by health care service utilization trends, cost
trends, product mix, seasonality, prior authorization of medical
services, benefit changes, outbreaks of disease or increased
incidence of illness, provider contract changes, changes to
Medicaid fee schedules, and the incidence of high dollar or
catastrophic claims. As discussed above, however, errors in
estimates involving trended PMPM costs will almost always be
accompanied by errors in estimates involving completion factors,
and vice versa. In such circumstances, errors in estimation
involving both completion factors and trended PMPM costs will
act to drive estimates of claims liabilities (and therefore
medical care costs) in the same direction.
Assuming that base reserves have been adequately set, we believe
that amounts ultimately paid out should generally be between 8%
and 10% less than the liability recorded at the end of the
period as a result of the inclusion in that liability of the
allowance for adverse claims development and the accrued cost of
settling those claims. However, there can be no assurance that
amounts ultimately paid out will not be higher or lower than
this 8% to 10%
56
range, as shown by our results in 2008 and 2007 when the amounts
ultimately paid out were less than the amount of the reserves we
had established as of the beginning of those years by
approximately 20% and 19%, respectively.
As shown in greater detail in the table below, the amounts
ultimately paid out on our liabilities recorded at both
December 31, 2007 and 2006 were less than what we had
expected when we established our reserves. While the specific
reasons for the overestimation of our liabilities were different
at each of the two reporting dates, in general the
overestimations were tied to our assessment of specific
circumstances at our various individual health plans which were
unique to those reporting periods.
In 2008, overestimation of our claims liability, particularly at
our Michigan and Washington health plans, at December 31,
2007 led to the recognition of a benefit from prior period
claims development.
|
|
|
|
|
In Michigan, we overestimated the extent to which both
catastrophic claims and state-mandated changes to the
methodology used to pay outpatient claims had increased our
liability at December 31, 2007.
|
|
|
|
In Washington, we overestimated the extent to which
state-mandated changes to hospital fee schedules implemented in
August 2007 had increased our liability at December 31,
2007.
|
In 2007, overestimation of the claims liability at our
California, New Mexico, and Washington health plans at
December 31, 2006, led to the recognition of a benefit from
prior period claims development, which benefit was partially
offset by the underestimation of our claims liability at
December 31, 2006 at our Michigan health plan.
|
|
|
|
|
In California, we underestimated the impact of changes to
certain provider contracts implemented during the second half of
2006 which lowered medical costs further than we had
anticipated, leading us to overestimate our claims liability at
December 31, 2006.
|
|
|
|
In Washington, we overestimated the impact of the upward trend
in medical costs during the latter half of 2006. Additionally,
we lowered claims inventory in December 2006 in anticipation of
a claims system upgrade in early 2007. While we attempted to
adjust our claims liability estimation procedures for the
increased speed of claims payment, we were only partially
successful in doing so. Both of these circumstances led us to
overestimate our claims liability at December 31, 2006.
|
|
|
|
In Michigan, we underestimated the upward trend in medical costs
during the latter half of 2006. Additionally, we underestimated
the costs associated with the membership we had added as a
result of our acquisition of Cape Health Plan in May 2006.
|
We do not believe that the recognition of a benefit (or
detriment) from prior period claims development had a material
impact on our consolidated results of operations in either 2008
or 2007.
In estimating our claims liability at December 31, 2008, we
adjusted our base calculation to take account of the impact of
the following factors which we believe are reasonably likely to
change our final claims liability amount:
|
|
|
|
|
Uncertainties regarding utilization trends in December at our
California health plan.
|
|
|
|
Delays in the receipt and processing of paper-formatted claims
at our California health plan during the second half of 2008.
Our California health plan receives a far higher percentage of
its
fee-for-service
claims in paper format than do our other health plans.
|
|
|
|
The impact of accruals for potential high dollar provider
settlements at our New Mexico health plan that we expect to be
resolved in 2009.
|
|
|
|
The impact of major revisions to financially significant
provider contracts at the Ohio health plan in the latter half of
2008.
|
|
|
|
The impact of a significant increase to the Ohio health
plans aged, blind or disabled (ABD) membership in the
latter half of 2008.
|
|
|
|
The impact of the Ohio health plans decision to transition
responsibility for the management of behavioral health services
from an independent provider to Company employees in the latter
half of 2008.
|
|
|
|
Decreases in claims inventory across all of our health plans
throughout 2008.
|
57
Any absence of adverse claims development (as well as the
expensing through general and administrative expense of the
costs to settle claims held at the start of the period) will
lead to the recognition of a benefit from prior period claims
development in the period subsequent to the date of the original
estimate. However, that benefit will affect current period
earnings only to the extent that the replenishment of the
reserve for adverse claims development (and the re-accrual of
administrative costs for the settlement of those claims) is less
than the benefit recognized from the prior period liability.
We seek to maintain a consistent claims reserving methodology
across all periods. Accordingly, any prior period benefit from
an un-utilized reserve for adverse claims development may be
offset by the establishment of a new reserve in an approximately
equal amount (relative to premium revenue, medical care costs,
and medical claims and benefits payable) in the current period,
and thus the impact on earnings for the current period may be
minimal.
The following table presents the components of the change in our
medical claims and benefits payable for the years ended
December 31, 2008 and 2007. The negative amounts displayed
for components of medical care costs related to prior
years represent the amount by which our original
estimate of claims and benefits payable at the beginning of the
period exceeded the actual amount of the liability based on
information (principally the payment of claims) developed since
that liability was first reported. The benefit of this prior
period development may be offset by the addition of a reserve
for adverse claims development when estimating the liability at
the end of the period (captured as a component of
medical care costs related to current year).
|
|
|
|
|
|
|
|
|
|
|
Year Ended December 31,
|
|
|
|
2008
|
|
|
2007
|
|
|
|
(Dollars in thousands, except per-member amounts)
|
|
|
Balances at beginning of period
|
|
$
|
311,606
|
|
|
$
|
290,048
|
|
Medical claims and benefits payable from business acquired
|
|
|
|
|
|
|
14,876
|
|
Components of medical care costs related to:
|
|
|
|
|
|
|
|
|
Current year
|
|
|
2,683,399
|
|
|
|
2,136,381
|
|
Prior years
|
|
|
(62,087
|
)
|
|
|
(56,298
|
)
|
|
|
|
|
|
|
|
|
|
Total medical care costs
|
|
|
2,621,312
|
|
|
|
2,080,083
|
|
|
|
|
|
|
|
|
|
|
Payments for medical care costs related to:
|
|
|
|
|
|
|
|
|
Current year
|
|
|
2,413,128
|
|
|
|
1,851,035
|
|
Prior years
|
|
|
227,348
|
|
|
|
222,366
|
|
|
|
|
|
|
|
|
|
|
Total paid
|
|
|
2,640,476
|
|
|
|
2,073,401
|
|
|
|
|
|
|
|
|
|
|
Balances at end of period
|
|
$
|
292,442
|
|
|
$
|
311,606
|
|
|
|
|
|
|
|
|
|
|
Benefit from prior period as a percentage of:
|
|
|
|
|
|
|
|
|
Balance at beginning of period
|
|
|
19.9
|
%
|
|
|
19.4
|
%
|
Premium revenue
|
|
|
2.0
|
%
|
|
|
2.3
|
%
|
Total medical care costs
|
|
|
2.4
|
%
|
|
|
2.7
|
%
|
Days in claims payable
|
|
|
41
|
|
|
|
52
|
|
Number of members at end of period
|
|
|
1,256,000
|
|
|
|
1,149,000
|
|
Fee-for-service
claims processing and inventory information:
|
|
|
|
|
|
|
|
|
Number of claims in inventory at end of period
|
|
|
87,300
|
|
|
|
161,400
|
|
Billed charges of claims in inventory at end of period
|
|
$
|
115,400
|
|
|
$
|
212,000
|
|
Claims in inventory per member at end of period
|
|
|
0.07
|
|
|
|
0.14
|
|
Billed charges of claims in inventory per member at end of period
|
|
$
|
91.88
|
|
|
$
|
184.51
|
|
Number of claims received during the period
|
|
|
11,095,100
|
|
|
|
9,578,900
|
|
Billed charges of claims received during the period
|
|
$
|
7,794,900
|
|
|
$
|
6,190,900
|
|
Commitments
and Contingencies
We lease office space and equipment under various operating
leases. As of December 31, 2008, our lease obligations for
the next five years and thereafter were as follows:
$15.5 million in 2009, $15.3 million in 2010,
$14.9 million in 2011, $13.8 million in 2012,
$12.0 million in 2013, and an aggregate of
$40.9 million thereafter.
We are not an obligor to or guarantor of any indebtedness of any
other party. We are not a party to off-balance sheet financing
arrangements except for operating leases which are disclosed in
Note 15 to the accompanying
58
audited consolidated financial statements for the year ended
December 31, 2008. We have certain advances to related
parties, which are discussed in Note 14 to the accompanying
audited consolidated financial statements for the year ended
December 31, 2008.
Contractual
Obligations
In the table below, we present our contractual obligations as of
December 31, 2008. Some of the amounts we have included in
this table are based on managements estimates and
assumptions about these obligations, including their duration,
the possibility of renewal, anticipated actions by third
parties, and other factors. Because these estimates and
assumptions are necessarily subjective, the contractual
obligations we will actually pay in future periods may vary from
those reflected in the table. Amounts are in thousands.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
|
2009
|
|
|
2010-2011
|
|
|
2012-2013
|
|
|
2014 and Beyond
|
|
|
Medical claims and benefits payable
|
|
$
|
292,442
|
|
|
$
|
292,442
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
Long-term debt(1)
|
|
|
200,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
200,000
|
|
Operating leases
|
|
|
112,310
|
|
|
|
15,514
|
|
|
|
30,204
|
|
|
|
25,725
|
|
|
|
40,867
|
|
Interest on long-term debt(1)
|
|
|
43,125
|
|
|
|
7,500
|
|
|
|
15,000
|
|
|
|
15,000
|
|
|
|
5,625
|
|
Purchase commitments
|
|
|
28,086
|
|
|
|
15,528
|
|
|
|
9,028
|
|
|
|
3,515
|
|
|
|
15
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total contractual obligations
|
|
$
|
675,963
|
|
|
$
|
330,984
|
|
|
$
|
54,232
|
|
|
$
|
44,240
|
|
|
$
|
246,507
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1) |
|
Amounts relate to our October 2007 offering of
$200.0 million aggregate principal amount of
3.75% Convertible Senior Notes due 2014. |
In accordance with Financial Accounting Standards Board
Interpretation No. 48, Accounting for Uncertainty in
Income Taxes, we have recorded approximately
$11.7 million of unrecognized tax benefits as liabilities.
The above table does not contain this amount because we cannot
reasonably estimate when or if such amount may be settled. See
Note 12 to the accompanying audited consolidated financial
statements for the year ended December 31, 2008 for further
information.
|
|
Item 7A.
|
Quantitative
and Qualitative Disclosures About Market Risk
|
Quantitative
and Qualitative Disclosures About Market Risk
Financial instruments that potentially subject us to
concentrations of credit risk consist primarily of cash and cash
equivalents, investments, receivables, and restricted
investments. We invest a substantial portion of our cash in the
PFM Fund Prime Series Cash Management Class,
PFM Fund Prime Series Institutional Class, and
the PFM Fund Government Series. These funds represent a
portfolio of highly liquid money market securities that are
managed by PFM Asset Management LLC (PFM), a Virginia business
trust registered as an open-end management investment fund. Our
investments and a portion of our cash equivalents are managed by
professional portfolio managers operating under documented
investment guidelines. No investment that is in a loss position
can be sold by our managers without our prior approval. Our
investments consist solely of investment grade debt securities
with a maximum maturity of ten years and an average duration of
four years. Restricted investments are invested principally in
certificates of deposit and U.S. treasury securities.
Concentration of credit risk with respect to accounts receivable
is limited due to payors consisting principally of the
governments of each state in which our HMO subsidiaries operate.
Inflation
Although the general rate of inflation has remained relatively
stable and health care cost inflation has stabilized in recent
years, the national health care cost inflation rate still
exceeds the general inflation rate. We use various strategies to
mitigate the negative effects of health care cost inflation.
Specifically, our health plans try to control medical and
hospital costs through contracts with independent providers of
health care services. Through these contracted providers, our
health plans emphasize preventive health care and appropriate
use of specialty and hospital services. While we currently
believe our strategies will mitigate health care cost inflation,
competitive pressures, new health care and pharmaceutical
product introductions, demands from health care providers and
customers, applicable regulations, or other factors may affect
our ability to control health care costs.
59
MOLINA
HEALTHCARE, INC.
|
|
Item 8.
|
Financial
Statements and Supplementary Data
|
INDEX TO
FINANCIAL STATEMENTS
|
|
|
|
|
|
|
Page
|
|
MOLINA HEALTHCARE INC.
|
|
|
|
|
|
|
|
61
|
|
|
|
|
62
|
|
|
|
|
63
|
|
|
|
|
64
|
|
|
|
|
65
|
|
|
|
|
67
|
|
60
REPORT OF
INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
The Board of Directors and Stockholders
of Molina Healthcare, Inc.
We have audited the accompanying consolidated balance sheets of
Molina Healthcare, Inc. (the Company) as of December 31,
2008 and 2007, and the related consolidated statements of
income, stockholders equity and cash flows for each of the
three years in the period ended December 31, 2008. These
financial statements are the responsibility of the
Companys management. Our responsibility is to express an
opinion on these financial statements based on our audits.
We conducted our audits in accordance with the standards of the
Public Company Accounting Oversight Board (United States). Those
standards require that we plan and perform the audit to obtain
reasonable assurance about whether the financial statements are
free of material misstatement. An audit includes examining, on a
test basis, evidence supporting the amounts and disclosures in
the financial statements. An audit also includes assessing the
accounting principles used and significant estimates made by
management, as well as evaluating the overall financial
statement presentation. We believe that our audits provide a
reasonable basis for our opinion.
In our opinion, the consolidated financial statements referred
to above present fairly, in all material respects, the
consolidated financial position of Molina Healthcare, Inc. at
December 31, 2008 and 2007, and the consolidated results of
its operations and its cash flows for each of the three years in
the period ended December 31, 2008, in conformity with
U.S. generally accepted accounting principles.
As discussed in Note 4, the Company adopted the provisions
of Statement of Financial Accounting Standards No. 159,
The Fair Value Option for Financial Assets and
Liabilities, effective January 1, 2008, and elected
to apply this Standard to a transaction completed in the fourth
quarter of 2008.
We also have audited, in accordance with the standards of the
Public Company Accounting Oversight Board (United States),
Molina Healthcare, Inc.s internal control over financial
reporting as of December 31, 2008, based on criteria
established in Internal Control Integrated
Framework issued by the Committee of Sponsoring
Organizations of the Treadway Commission and our report dated
March 16, 2009 expressed an unqualified opinion thereon.
Los Angeles, California
March 16, 2009
61
MOLINA
HEALTHCARE, INC.
CONSOLIDATED
BALANCE SHEETS
|
|
|
|
|
|
|
|
|
|
|
December 31,
|
|
|
|
2008
|
|
|
2007
|
|
|
|
(In thousands,
|
|
|
|
except per share data)
|
|
|
ASSETS
|
Current assets:
|
|
|
|
|
|
|
|
|
Cash and cash equivalents
|
|
$
|
387,162
|
|
|
$
|
459,064
|
|
Investments
|
|
|
189,870
|
|
|
|
242,855
|
|
Receivables
|
|
|
128,562
|
|
|
|
111,537
|
|
Income tax refundable
|
|
|
4,019
|
|
|
|
|
|
Deferred income taxes
|
|
|
4,603
|
|
|
|
8,616
|
|
Prepaid expenses and other current assets
|
|
|
14,766
|
|
|
|
12,521
|
|
|
|
|
|
|
|
|
|
|
Total current assets
|
|
|
728,982
|
|
|
|
834,593
|
|
Property and equipment, net
|
|
|
65,058
|
|
|
|
49,555
|
|
Intangible assets, net
|
|
|
79,133
|
|
|
|
89,776
|
|
Goodwill and indefinite-lived intangible assets
|
|
|
113,466
|
|
|
|
117,447
|
|
Investments
|
|
|
58,169
|
|
|
|
|
|
Deferred income taxes
|
|
|
4,488
|
|
|
|
|
|
Restricted investments
|
|
|
38,202
|
|
|
|
29,019
|
|
Receivable for ceded life and annuity contracts
|
|
|
27,367
|
|
|
|
29,240
|
|
Other assets
|
|
|
34,321
|
|
|
|
21,675
|
|
|
|
|
|
|
|
|
|
|
Total assets
|
|
$
|
1,149,186
|
|
|
$
|
1,171,305
|
|
|
|
|
|
|
|
|
|
|
|
LIABILITIES AND STOCKHOLDERS EQUITY
|
Current liabilities:
|
|
|
|
|
|
|
|
|
Medical claims and benefits payable
|
|
$
|
292,442
|
|
|
$
|
311,606
|
|
Accounts payable and accrued liabilities
|
|
|
66,247
|
|
|
|
69,266
|
|
Deferred revenue
|
|
|
29,538
|
|
|
|
40,104
|
|
Income tax payable
|
|
|
|
|
|
|
5,946
|
|
|
|
|
|
|
|
|
|
|
Total current liabilities
|
|
|
388,227
|
|
|
|
426,922
|
|
Long-term debt
|
|
|
200,000
|
|
|
|
200,000
|
|
Liability for ceded life and annuity contracts
|
|
|
27,367
|
|
|
|
29,240
|
|
Deferred income taxes
|
|
|
|
|
|
|
10,136
|
|
Other long-term liabilities
|
|
|
22,928
|
|
|
|
14,529
|
|
|
|
|
|
|
|
|
|
|
Total liabilities
|
|
|
638,522
|
|
|
|
680,827
|
|
|
|
|
|
|
|
|
|
|
Stockholders equity:
|
|
|
|
|
|
|
|
|
Common stock, $0.001 par value; 80,000 shares
authorized; outstanding: 26,725 shares at December 31,
2008 and 28,444 shares at December 31, 2007
|
|
|
27
|
|
|
|
28
|
|
Preferred stock, $0.001 par value; 20,000 shares
authorized, no shares issued and outstanding
|
|
|
|
|
|
|
|
|
Additional paid-in capital
|
|
|
146,179
|
|
|
|
185,808
|
|
Accumulated other comprehensive (loss) income
|
|
|
(2,310
|
)
|
|
|
272
|
|
Retained earnings
|
|
|
387,158
|
|
|
|
324,760
|
|
Treasury stock (1,201 shares, at cost)
|
|
|
(20,390
|
)
|
|
|
(20,390
|
)
|
|
|
|
|
|
|
|
|
|
Total stockholders equity
|
|
|
510,664
|
|
|
|
490,478
|
|
|
|
|
|
|
|
|
|
|
Total liabilities and stockholders equity
|
|
$
|
1,149,186
|
|
|
$
|
1,171,305
|
|
|
|
|
|
|
|
|
|
|
See accompanying notes.
62
MOLINA
HEALTHCARE, INC.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended December 31,
|
|
|
|
2008
|
|
|
2007
|
|
|
2006
|
|
|
|
(In thousands, except per share data)
|
|
|
Revenue:
|
|
|
|
|
|
|
|
|
|
|
|
|
Premium revenue
|
|
$
|
3,091,240
|
|
|
$
|
2,462,369
|
|
|
$
|
1,985,109
|
|
Investment income
|
|
|
21,126
|
|
|
|
30,085
|
|
|
|
19,886
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total revenue
|
|
|
3,112,366
|
|
|
|
2,492,454
|
|
|
|
2,004,995
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Expenses:
|
|
|
|
|
|
|
|
|
|
|
|
|
Medical care costs
|
|
|
2,621,312
|
|
|
|
2,080,083
|
|
|
|
1,678,652
|
|
General and administrative expenses
|
|
|
344,761
|
|
|
|
285,295
|
|
|
|
229,057
|
|
Depreciation and amortization
|
|
|
33,688
|
|
|
|
27,967
|
|
|
|
21,475
|
|
Impairment charge on purchased software
|
|
|
|
|
|
|
782
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total expenses
|
|
|
2,999,761
|
|
|
|
2,394,127
|
|
|
|
1,929,184
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating income
|
|
|
112,605
|
|
|
|
98,327
|
|
|
|
75,811
|
|
Interest expense
|
|
|
(8,714
|
)
|
|
|
(4,631
|
)
|
|
|
(2,353
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income before income taxes
|
|
|
103,891
|
|
|
|
93,696
|
|
|
|
73,458
|
|
Provision for income taxes
|
|
|
41,493
|
|
|
|
35,366
|
|
|
|
27,731
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income
|
|
$
|
62,398
|
|
|
$
|
58,330
|
|
|
$
|
45,727
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income per share(1):
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic
|
|
$
|
2.25
|
|
|
$
|
2.06
|
|
|
$
|
1.64
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Diluted
|
|
$
|
2.25
|
|
|
$
|
2.05
|
|
|
$
|
1.62
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted average shares outstanding:
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic
|
|
|
27,676
|
|
|
|
28,275
|
|
|
|
27,966
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Diluted
|
|
|
27,772
|
|
|
|
28,419
|
|
|
|
28,164
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1) |
|
Potentially dilutive shares issuable pursuant to the
Companys 2007 offering of convertible senior notes were
not included in the computation of diluted net income per share
because to do so would have been anti-dilutive for the years
ended December 31, 2008 and 2007. |
See accompanying notes.
63
MOLINA
HEALTHCARE, INC.
CONSOLIDATED
STATEMENTS OF STOCKHOLDERS EQUITY
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Accumulated
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Additional
|
|
|
Other
|
|
|
|
|
|
|
|
|
|
|
|
|
Common Stock
|
|
|
Paid-in
|
|
|
Comprehensive
|
|
|
Retained
|
|
|
Treasury
|
|
|
|
|
|
|
Outstanding
|
|
|
Amount
|
|
|
Capital
|
|
|
Income (Loss)
|
|
|
Earnings
|
|
|
Stock
|
|
|
Total
|
|
|
|
(In thousands)
|
|
|
|
|
|
Balance at January 1, 2006
|
|
|
27,792
|
|
|
$
|
28
|
|
|
$
|
162,693
|
|
|
$
|
(629
|
)
|
|
$
|
221,148
|
|
|
$
|
(20,390
|
)
|
|
$
|
362,850
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Comprehensive income:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
45,727
|
|
|
|
|
|
|
|
45,727
|
|
Other comprehensive loss, net of tax:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Unrealized gain on Investments
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
292
|
|
|
|
|
|
|
|
|
|
|
|
292
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total comprehensive income
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
292
|
|
|
|
45,727
|
|
|
|
|
|
|
|
46,019
|
|
Stock options exercised, employee stock grants and employee
stock purchases
|
|
|
327
|
|
|
|
|
|
|
|
10,070
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
10,070
|
|
Tax benefit from employee stock compensation
|
|
|
|
|
|
|
|
|
|
|
1,227
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1,227
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance at December 31, 2006
|
|
|
28,119
|
|
|
$
|
28
|
|
|
$
|
173,990
|
|
|
$
|
(337
|
)
|
|
$
|
266,875
|
|
|
$
|
(20,390
|
)
|
|
$
|
420,166
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Comprehensive income:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
58,330
|
|
|
|
|
|
|
|
58,330
|
|
Other comprehensive income, net of tax:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Unrealized gain on investments
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
609
|
|
|
|
|
|
|
|
|
|
|
|
609
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total comprehensive income
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
609
|
|
|
|
58,330
|
|
|
|
|
|
|
|
58,939
|
|
Adjustment to initially apply FIN 48
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(445
|
)
|
|
|
|
|
|
|
(445
|
)
|
Stock options exercised, employee stock grants and employee
stock purchases
|
|
|
325
|
|
|
|
|
|
|
|
10,965
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
10,965
|
|
Tax benefit from employee stock compensation
|
|
|
|
|
|
|
|
|
|
|
853
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
853
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance at December 31, 2007
|
|
|
28,444
|
|
|
$
|
28
|
|
|
$
|
185,808
|
|
|
$
|
272
|
|
|
$
|
324,760
|
|
|
$
|
(20,390
|
)
|
|
$
|
490,478
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Comprehensive income:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
62,398
|
|
|
|
|
|
|
|
62,398
|
|
Other comprehensive loss, net of tax:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Unrealized loss on investments
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(7,025
|
)
|
|
|
|
|
|
|
|
|
|
|
(7,025
|
)
|
Other-than-temporary impairment of available-for-sale securities
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
4,443
|
|
|
|
|
|
|
|
|
|
|
|
4,443
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total comprehensive income
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(2,582
|
)
|
|
|
62,398
|
|
|
|
|
|
|
|
59,816
|
|
Purchase of treasury stock
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(49,940
|
)
|
|
|
(49,940
|
)
|
Retirement of treasury stock
|
|
|
(1,943
|
)
|
|
|
(1
|
)
|
|
|
(49,939
|
)
|
|
|
|
|
|
|
|
|
|
|
49,940
|
|
|
|
|
|
Stock issued in business purchase transaction
|
|
|
48
|
|
|
|
|
|
|
|
1,262
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1,262
|
|
Stock options exercised, employee stock grants and employee
stock purchases
|
|
|
176
|
|
|
|
|
|
|
|
9,340
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
9,340
|
|
Tax deficiency from employee stock compensation
|
|
|
|
|
|
|
|
|
|
|
(292
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(292
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance at December 31, 2008
|
|
|
26,725
|
|
|
$
|
27
|
|
|
$
|
146,179
|
|
|
$
|
(2,310
|
)
|
|
$
|
387,158
|
|
|
$
|
(20,390
|
)
|
|
$
|
510,664
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
See accompanying notes.
64
MOLINA
HEALTHCARE, INC.
CONSOLIDATED
STATEMENTS OF CASH FLOWS
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended December 31,
|
|
|
|
2008
|
|
|
2007
|
|
|
2006
|
|
|
|
(In thousands)
|
|
|
Operating activities:
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income
|
|
$
|
62,398
|
|
|
$
|
58,330
|
|
|
$
|
45,727
|
|
Adjustments to reconcile net income to net cash provided by
operating activities:
|
|
|
|
|
|
|
|
|
|
|
|
|
Depreciation and amortization
|
|
|
33,688
|
|
|
|
27,967
|
|
|
|
21,475
|
|
Other-than-temporary impairment on available-for-sale securities
|
|
|
7,166
|
|
|
|
|
|
|
|
|
|
Unrealized loss on trading securities
|
|
|
399
|
|
|
|
|
|
|
|
|
|
Gain on rights agreement
|
|
|
(6,907
|
)
|
|
|
|
|
|
|
|
|
Deferred income taxes
|
|
|
(1,688
|
)
|
|
|
(9,057
|
)
|
|
|
(399
|
)
|
Stock-based compensation
|
|
|
7,811
|
|
|
|
7,188
|
|
|
|
5,505
|
|
Amortization of deferred financing costs
|
|
|
1,626
|
|
|
|
1,042
|
|
|
|
885
|
|
Tax deficiency from employee stock compensation recorded as
additional paid-in capital
|
|
|
(335
|
)
|
|
|
|
|
|
|
|
|
Loss on disposal of property and equipment
|
|
|
142
|
|
|
|
|
|
|
|
|
|
Changes in operating assets and liabilities, net of effects of
acquisitions:
|
|
|
|
|
|
|
|
|
|
|
|
|
Receivables
|
|
|
(17,025
|
)
|
|
|
15,007
|
|
|
|
(38,847
|
)
|
Prepaid expenses and other current assets
|
|
|
(2,245
|
)
|
|
|
(2,911
|
)
|
|
|
1,369
|
|
Medical claims and benefits payable
|
|
|
(19,164
|
)
|
|
|
6,683
|
|
|
|
51,550
|
|
Accounts payable and accrued liabilities
|
|
|
(4,904
|
)
|
|
|
18,700
|
|
|
|
5,188
|
|
Deferred revenue
|
|
|
(10,566
|
)
|
|
|
21,984
|
|
|
|
10,443
|
|
Income taxes
|
|
|
(9,965
|
)
|
|
|
13,693
|
|
|
|
(579
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net cash provided by operating activities
|
|
|
40,431
|
|
|
|
158,626
|
|
|
|
102,317
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Investing activities:
|
|
|
|
|
|
|
|
|
|
|
|
|
Purchases of equipment
|
|
|
(34,690
|
)
|
|
|
(22,299
|
)
|
|
|
(20,297
|
)
|
Purchases of investments
|
|
|
(263,229
|
)
|
|
|
(264,115
|
)
|
|
|
(148,795
|
)
|
Sales and maturities of investments
|
|
|
246,524
|
|
|
|
103,718
|
|
|
|
171,225
|
|
Net cash (paid) acquired in business purchase transactions
|
|
|
(1,000
|
)
|
|
|
(70,172
|
)
|
|
|
5,820
|
|
Increase in restricted investments
|
|
|
(9,183
|
)
|
|
|
(8,365
|
)
|
|
|
(912
|
)
|
Increase in other assets
|
|
|
(8,973
|
)
|
|
|
(4,330
|
)
|
|
|
(3,334
|
)
|
Increase in other long-term liabilities
|
|
|
6,031
|
|
|
|
9,290
|
|
|
|
239
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net cash (used in) provided by investing activities
|
|
|
(64,520
|
)
|
|
|
(256,273
|
)
|
|
|
3,946
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Financing activities:
|
|
|
|
|
|
|
|
|
|
|
|
|
Treasury stock purchases
|
|
|
(49,940
|
)
|
|
|
|
|
|
|
|
|
Borrowings under credit facility
|
|
|
|
|
|
|
|
|
|
|
50,000
|
|
Proceeds from issuance of convertible senior notes
|
|
|
|
|
|
|
200,000
|
|
|
|
|
|
Repayment of amounts borrowed under credit facility
|
|
|
|
|
|
|
(45,000
|
)
|
|
|
(5,000
|
)
|
Payment of credit facility fees
|
|
|
|
|
|
|
(551
|
)
|
|
|
(459
|
)
|
Payment of convertible senior notes fees
|
|
|
|
|
|
|
(6,498
|
)
|
|
|
|
|
Tax benefit from employee stock compensation recorded as
additional paid-in capital
|
|
|
43
|
|
|
|
853
|
|
|
|
1,227
|
|
Proceeds from exercise of stock options and employee stock plan
purchases
|
|
|
2,084
|
|
|
|
4,257
|
|
|
|
2,416
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net cash (used in) provided by financing activities
|
|
|
(47,813
|
)
|
|
|
153,061
|
|
|
|
48,184
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net (decrease) increase in cash and cash equivalents
|
|
|
(71,902
|
)
|
|
|
55,414
|
|
|
|
154,447
|
|
Cash and cash equivalents at beginning of year
|
|
|
459,064
|
|
|
|
403,650
|
|
|
|
249,203
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash and cash equivalents at end of year
|
|
$
|
387,162
|
|
|
$
|
459,064
|
|
|
$
|
403,650
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
65
MOLINA
HEALTHCARE, INC.
CONSOLIDATED
STATEMENTS OF CASH FLOWS (Continued)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended December 31,
|
|
|
|
2008
|
|
|
2007
|
|
|
2006
|
|
|
|
(In thousands)
|
|
|
Supplemental cash flow information
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash paid during the year for:
|
|
|
|
|
|
|
|
|
|
|
|
|
Income taxes
|
|
$
|
50,130
|
|
|
$
|
27,734
|
|
|
$
|
27,354
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest
|
|
$
|
7,797
|
|
|
$
|
9,419
|
|
|
$
|
2,260
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Schedule of non-cash investing and financing activities:
|
|
|
|
|
|
|
|
|
|
|
|
|
Unrealized (loss) gain on investments
|
|
$
|
(3,956
|
)
|
|
$
|
977
|
|
|
$
|
474
|
|
Deferred income taxes
|
|
|
1,374
|
|
|
|
(368
|
)
|
|
|
(182
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net unrealized (loss) gain on investments
|
|
$
|
(2,582
|
)
|
|
$
|
609
|
|
|
$
|
292
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Retirement of common stock used for stock-based compensation
|
|
$
|
(555
|
)
|
|
$
|
(480
|
)
|
|
$
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Accrued purchases of equipment
|
|
$
|
65
|
|
|
$
|
672
|
|
|
$
|
945
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Retirement of treasury stock
|
|
$
|
49,940
|
|
|
$
|
|
|
|
$
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Impairment of purchased software
|
|
$
|
|
|
|
$
|
782
|
|
|
$
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cumulative effect of adoption of Financial Interpretation
No. 48, Accounting for Uncertainty in Income Taxes
|
|
$
|
|
|
|
$
|
445
|
|
|
$
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Accrual of software license fees
|
|
$
|
|
|
|
$
|
|
|
|
$
|
2,375
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Value of stock issued for employee compensation earned in the
previous year
|
|
$
|
|
|
|
$
|
|
|
|
$
|
2,149
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Details of business purchase transactions:
|
|
|
|
|
|
|
|
|
|
|
|
|
Fair value of assets acquired
|
|
$
|
(2,262
|
)
|
|
$
|
(106,233
|
)
|
|
$
|
(86,024
|
)
|
Common stock issued to seller
|
|
|
1,262
|
|
|
|
|
|
|
|
|
|
Less cash acquired
|
|
|
|
|
|
|
10,843
|
|
|
|
49,820
|
|
Liabilities assumed
|
|
|
|
|
|
|
25,218
|
|
|
|
42,024
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net cash (paid) acquired in business purchase transactions
|
|
$
|
(1,000
|
)
|
|
$
|
(70,172
|
)
|
|
$
|
5,820
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Business purchase transactions adjustments:
|
|
|
|
|
|
|
|
|
|
|
|
|
Accounts payable and accrued liabilities
|
|
$
|
1,265
|
|
|
$
|
|
|
|
$
|
|
|
Other long-term liabilities
|
|
|
2,368
|
|
|
|
|
|
|
|
|
|
Deferred taxes
|
|
|
(7,549
|
)
|
|
|
2,747
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Goodwill and intangible assets, net
|
|
$
|
(3,916
|
)
|
|
$
|
2,747
|
|
|
$
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
See accompanying notes.
66
MOLINA
HEALTHCARE, INC.
Organization
and Operations
Molina Healthcare, Inc. is a multi-state managed care
organization participating exclusively in government-sponsored
health care programs for low-income persons, such as the
Medicaid program and the Childrens Health Insurance
Program, or CHIP. We also serve a small number of low-income
Medicare members. We conduct our business primarily through 10
licensed health plans in the states of California, Florida,
Michigan, Missouri, Nevada, New Mexico, Ohio, Texas, Utah, and
Washington. The health plans are locally operated by our
respective wholly owned subsidiaries in those ten states, each
of which is licensed as a health maintenance organization, or
HMO.
Our results of operations include the results of recent
acquisitions, including the acquisition of Mercy CarePlus, a
Medicaid managed care organization based in St. Louis,
Missouri, effective as of November 1, 2007, and the
acquisition of Cape Health Plan, Inc. based in Southfield,
Michigan, effective as of May 15, 2006. We acquired the
Cape Health Plan, Inc. by acquiring its parent, HCLB, Inc.
(HCLB). The Cape Health Plan, Inc. was merged into
our Michigan health plan effective December 31, 2006.
Consolidation
The consolidated financial statements include the accounts of
Molina Healthcare, Inc. and all majority owned subsidiaries. All
significant intercompany transactions and balances have been
eliminated in consolidation. Financial information related to
subsidiaries acquired during any year is included only for the
period subsequent to their acquisition.
Use of
Estimates
The preparation of consolidated financial statements in
conformity with accounting principles generally accepted in the
United States requires management to make estimates and
assumptions that affect the reported amounts of assets and
liabilities and the disclosure of contingent assets and
liabilities at the date of the financial statements. Estimates
also affect the reported amounts of revenues and expenses during
the reporting period. Actual results could differ from these
estimates. Principal areas requiring the use of estimates
include medical claims payable and accruals, determination of
allowances for uncollectible accounts, the valuation of certain
investments, settlements under risks/savings sharing programs,
impairment of long-lived and intangible assets, professional and
general liability claims, reserves for potential absorption of
claims unpaid by insolvent providers, reserves for the outcome
of litigation, valuation allowances for deferred tax assets, and
the determination of unrecognized tax benefits.
Reclassification
In the accompanying consolidated balance sheets, we have
reclassified certain amounts to conform to the 2008 presentation.
|
|
2.
|
Significant
Accounting Policies
|
Premium
Revenue
Premium revenue is fixed in advance of the periods covered and,
except as described below, is not generally subject to
significant accounting estimates. For the year ended
December 31, 2008, we received approximately 92% of our
premium revenue as a fixed amount per member per month, or PMPM,
pursuant to our contracts with state Medicaid agencies, Medicare
and other managed care organizations for which we operate as a
subcontractor. These premium revenues are recognized in the
month that members are entitled to receive health care services.
The state Medicaid programs and the federal Medicare program
periodically adjust premium rates.
67
MOLINA
HEALTHCARE, INC.
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
Approximately 3% of our premium revenue for the year ended
December 31, 2008 was realized under a Medicaid cost-plus
reimbursement agreement that our Utah plan has with that state.
For the year ended December 31, 2008, we also received
approximately 5% of our premium revenue in the form of
birth income a one-time payment for the
delivery of a child from the Medicaid programs in
Michigan, Missouri, Ohio, Texas, and Washington. Such payments
are recognized as revenue in the month the birth occurs.
Certain components of premium revenue are subject to accounting
estimates. Chief among these are (1) that portion of
premium revenue paid to our New Mexico health plan by the state
of New Mexico that may be refunded to the state if certain
minimum amounts are not expended on defined medical care costs,
or if administrative costs or profit (as defined) exceed certain
amounts, (2) that portion of the revenue of our Ohio health
plan that is at risk if certain performance measures are not
met, (3) the additional premium revenue our Utah health
plan is entitled to receive from the state of Utah as an
incentive payment for saving the state of Utah money in relation
to fee-for-service Medicaid, (4) the profit-sharing
agreement between our Texas health plan and the state of Texas,
where we pay a rebate to the state of Texas if our Texas health
plan generates pretax income above a certain specified
percentage, according to a tiered rebate schedule, and
(5) that portion of our Medicare revenue that is subject to
retroactive adjustment for member risk adjustment and recoupment
of pharmacy related revenue.
Our contract with the state of New Mexico requires that we spend
a minimum percentage of premium revenue on certain explicitly
defined medical care costs (the medical cost floor). Our
contract is for a three-year period, and the medical cost floor
is based on premiums and medical care costs over the entire
contract period. During the six months ended June 30, 2008,
we recorded adjustments totaling $12.9 million to increase
premium revenue associated with this requirement. The revenue
resulted from a reversal of previously recorded amounts due the
state of New Mexico when we were below the minimum percentage,
because we exceeded the minimum percentage for the six months
ended June 30, 2008.
Effective July 1, 2008, our New Mexico health plan entered
into a new three year contract that, in addition to retaining
the medical cost floor, added certain limits on the amount our
New Mexico health plan can: (1) expend on administrative
costs; and (2) retain as profit. At December 31, 2008,
there was no liability recorded under the terms of these
contract provisions. Any changes to the terms of these
provisions, including revisions to the definitions of premium
revenue, medical care costs, administrative costs or profit, the
period of time over which performance is measured or the manner
of its measurement, or the percentages used in the calculations,
may trigger a change in the amounts owed. If the state of New
Mexico disagrees with our interpretation of the existing
contract terms, an adjustment to the amounts owed may be
required.
Under our contract with the state of Ohio, up to 1% of our Ohio
health plans revenue may be refundable to the state if
certain performance measures are not met. At December 31,
2008, we had recorded a liability of approximately
$1.6 million under the terms of this contract provision.
In prior years, we estimated amounts we believed were
recoverable under our savings sharing agreement with the state
of Utah based on available information and our interpretation of
our contract with the state. The state may not agree with our
interpretation or our application of the contract language, and
it may also not agree with the manner in which we have processed
and analyzed our member claims and encounter records. Thus, the
ultimate amount of savings sharing revenue that we realize from
prior years may be subject to negotiation with the state. During
2007, as a result of an ongoing disagreement with the state of
Utah, we wrote off the entire receivable, totaling
$4.7 million. Our Utah health plan continues to work with
the state to assure an appropriate determination of amounts due
to us under the savings share agreement. When additional
information is known, or agreement is reached with the state
regarding the appropriate savings sharing payment amount for
prior years, we will adjust the amount of savings sharing
revenue recorded in our financial statements as appropriate in
light of such new information or agreement.
As of December 31, 2008, we had a liability of
approximately $619,000 accrued pursuant to our profit-sharing
agreement with the state of Texas for the 2008 contract year
(ending August 31, 2008) and the 2009 contract year
68
MOLINA
HEALTHCARE, INC.
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
(ending August 31, 2009). During 2008, we paid the state of
Texas $10.1 million relating to the 2007 and 2008 contract
years, and the 2007 contract year is now closed. Because the
final settlement calculations include a claims run-out period of
nearly one year, the amounts recorded, based on our estimates,
may be adjusted. We believe that the ultimate settlement will
not differ materially from our estimates.
Medicare revenue paid to us is subject to retroactive adjustment
for both member risk scores and member pharmacy cost experience.
Based on member encounter data that we submit to the Centers for
Medicare and Medicaid Services (CMS), our Medicare revenue is
subject to adjustment for up to two years after the original
year of service. This adjustment takes into account the acuity
of each members medical needs relative to what was
anticipated when premiums were originally set for that member.
In the event that our membership (measured on an individual by
individual basis) requires less acute medical care than was
anticipated by the original premium amount, CMS may recover
premium from us. In the event that our membership requires more
acute medical care than was anticipated by the original premium
amount, CMS may pay us additional retroactive premium. A similar
retroactive reconciliation is undertaken by CMS for our Medicare
members pharmacy utilization. That analysis is similar to
the process for the adjustment of member risk scores, but is
further complicated by member pharmacy cost sharing provisions
attached to the Medicare pharmacy benefit that do not apply to
the services measured by the member risk adjustment process. We
estimate the amount of Medicare revenue that will ultimately be
realized for the periods presented based on our knowledge of our
members heath care utilization patterns and CMS practices.
To the extent that the premium revenue ultimately received from
CMS differs from recorded amounts, we will adjust reported
Medicare revenue.
Medical
Care Costs
Expenses related to medical care services are captured in the
following four categories:
|
|
|
|
|
Fee-for-service: Physician providers paid on a
fee-for-service basis are paid according to a fee schedule set
by the state or by our contracts with these providers. We pay
hospitals on a fee-for-service basis in a variety of ways,
including per diem amounts, diagnostic-related groups or DRGs,
percent of billed charges, and case rates. We also pay a small
portion of hospitals on a capitated basis. We also have
stop-loss agreements with the hospitals with which we contract.
Under all fee-for-service arrangements, we retain the financial
responsibility for medical care provided. Expenses related to
fee-for-service contracts are recorded in the period in which
the related services are dispensed. The costs of drugs
administered in a physician or hospital setting that are not
billed through our pharmacy benefit managers are included in
fee-for-service costs.
|
|
|
|
Capitation: Many of our primary care
physicians and a small portion of our specialists and hospitals
are paid on a capitated basis. Under capitation contracts, we
typically pay a fixed PMPM payment to the provider without
regard to the frequency, extent, or nature of the medical
services actually furnished. Under capitated contracts, we
remain liable for the provision of certain health care services.
Certain of our capitated contracts also contain incentive
programs based on service delivery, quality of care, utilization
management, and other criteria. Capitation payments are fixed in
advance of the periods covered and are not subject to
significant accounting estimates. These payments are expensed in
the period the providers are obligated to provide services. The
financial risk for pharmacy services for a small portion of our
membership is delegated to capitated providers.
|
|
|
|
Pharmacy: Pharmacy costs include all drug,
injectibles, and immunization costs paid through our pharmacy
benefit managers. As noted above, drugs and injectibles not paid
through our pharmacy benefit managers are included in
fee-for-service costs, except in those limited instances where
we capitate drug and injectible costs.
|
|
|
|
Other: Other medical care costs include
medically related administrative costs, certain provider
incentive costs, reinsurance cost, and other health care
expense. Medically related administrative costs include, for
example, expenses relating to health education, quality
assurance, case management, disease management,
|
69
MOLINA
HEALTHCARE, INC.
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
|
|
|
|
|
24-hour
on-call nurses, and a portion of our information technology
costs. Salary and benefit costs are a substantial portion of
these expenses. For the years ended December 31, 2008,
2007, and 2006, medically related administrative costs were
approximately $75.9 million, $65.4 million, and
$52.6 million, respectively.
|
The following table provides the details of our consolidated
medical care costs for the periods indicated (dollars in
thousands, except PMPM amounts):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended December 31,
|
|
|
|
2008
|
|
|
2007
|
|
|
2006
|
|
|
|
|
|
|
|
|
|
% of
|
|
|
|
|
|
|
|
|
% of
|
|
|
|
|
|
|
|
|
% of
|
|
|
|
Amount
|
|
|
PMPM
|
|
|
Total
|
|
|
Amount
|
|
|
PMPM
|
|
|
Total
|
|
|
Amount
|
|
|
PMPM
|
|
|
Total
|
|
|
Fee-for- service
|
|
$
|
1,709,806
|
|
|
$
|
116.69
|
|
|
|
65.2
|
%
|
|
$
|
1,343,911
|
|
|
$
|
103.77
|
|
|
|
64.6
|
%
|
|
$
|
1,125,031
|
|
|
$
|
94.86
|
|
|
|
67.0
|
%
|
Capitation
|
|
|
450,440
|
|
|
|
30.74
|
|
|
|
17.2
|
|
|
|
375,206
|
|
|
|
28.97
|
|
|
|
18.0
|
|
|
|
261,476
|
|
|
|
22.05
|
|
|
|
15.6
|
|
Pharmacy
|
|
|
356,184
|
|
|
|
24.31
|
|
|
|
13.6
|
|
|
|
270,363
|
|
|
|
20.88
|
|
|
|
13.0
|
|
|
|
209,366
|
|
|
|
17.65
|
|
|
|
12.5
|
|
Other
|
|
|
104,882
|
|
|
|
7.16
|
|
|
|
4.0
|
|
|
|
90,603
|
|
|
|
7.00
|
|
|
|
4.4
|
|
|
|
82,779
|
|
|
|
6.98
|
|
|
|
4.9
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
$
|
2,621,312
|
|
|
$
|
178.90
|
|
|
|
100.0
|
%
|
|
$
|
2,080,083
|
|
|
$
|
160.62
|
|
|
|
100.0
|
%
|
|
$
|
1,678,652
|
|
|
$
|
141.54
|
|
|
|
100.0
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Our medical care costs include amounts that have been paid by us
through the reporting date, as well as estimated liabilities for
medical care costs incurred but not paid by us as of the
reporting date. Such medical care cost liabilities include,
among other items, capitation payments owed providers, unpaid
pharmacy invoices, and various medically related administrative
costs that have been incurred but not paid. We use judgment to
determine the appropriate assumptions for determining the
required estimates. See Note 10, Medical Claims and
Benefits Payable.
We report reinsurance premiums as medical care costs, while
related reinsurance recoveries are reported as deductions from
medical care costs. We limit our risk of catastrophic losses by
maintaining high deductible reinsurance coverage. We do not
consider this coverage to be material as the cost is not
significant and the likelihood that coverage will be applicable
is low.
Taxes
Based on Premiums
Our California, Michigan, New Mexico, Ohio, Texas and Washington
health plans are assessed a tax based on premium revenue
collected. We report these taxes on a gross basis, included in
general and administrative expenses. Premium tax expense totaled
$95.1 million, $81.0 million, and $60.8 million
in 2008, 2007, and 2006, respectively.
Delegated
Provider Insolvency
Circumstances may arise where providers to whom we have
delegated risk, due to insolvency or other circumstances, are
unable to pay claims they have incurred with third parties in
connection with referral services provided to our members. The
inability of delegated providers to pay referral claims presents
us with both immediate financial risk and potential disruption
to member care. Depending on states laws, we may be held
liable for such unpaid referral claims even though the delegated
provider has contractually assumed such risk. Additionally,
competitive pressures may force us to pay such claims even when
we have no legal obligation to do so. To reduce the risk that
delegated providers are unable to pay referral claims, we
monitor the operational and financial performance of such
providers. We also maintain contingency plans that include
transferring members to other providers in response to potential
network instability.
In certain instances, we have required providers to place funds
on deposit with us as protection against their potential
insolvency. These reserves are frequently in the form of
segregated funds received from the provider and held by us or
placed in a third-party financial institution. These funds may
be used to pay claims that are the financial responsibility of
the provider in the event the provider is unable to meet these
obligations. Additionally, we
70
MOLINA
HEALTHCARE, INC.
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
have recorded liabilities for estimated losses arising from
provider instability or insolvency in excess of provider funds
on deposit with us. Such liabilities were not material at
December 31, 2008 or 2007.
Premium
Deficiency Reserves on Loss Contracts
We assess the profitability of our contracts for providing
medical care services to our members and identify those
contracts where current operating results or forecasts indicate
probable future losses. Anticipated future premiums are compared
to anticipated medical care costs, including the cost of
processing claims. If the anticipated future costs exceed the
premiums, a loss contract accrual is recognized. No such accrual
was recorded as of December 31, 2008, or 2007.
Cash
and Cash Equivalents
Cash and cash equivalents consist of cash and short-term, highly
liquid investments that are both readily convertible into known
amounts of cash and have a maturity of three months or less on
the date of purchase.
Investments
We account for our investments in marketable securities in
accordance with Statement of Financial Accounting Standards No.
(SFAS) 115, Accounting for Certain Investments in Debt and
Equity Securities. Except for restricted investments and
certain student loan portfolios (the auction rate
securities), marketable securities are designated as
available-for-sale and are carried at fair value. Unrealized
gains or losses on available-for-sale securities, if any, are
recorded in stockholders equity as other comprehensive
income (loss) net of applicable income taxes. Realized gains and
losses and unrealized losses judged to be other than temporary
with respect to available-for-sale and held-to-maturity
securities are included in the determination of net income. The
cost of securities sold is determined using the
specific-identification method, on an amortized cost basis. Fair
values of securities are generally based on quoted prices in
active markets.
Our investment policy requires that all of our investments have
final maturities of ten years or less (excluding auction rate
and variable rate securities where interest rates may be
periodically reset), and that the average maturity be four years
or less. Investments and restricted investments are subject to
interest rate risk and will decrease in value if market rates
increase. Declines in interest rates over time will reduce our
investment income.
In general, our available-for-sale securities are classified as
current assets without regard to the securities
contractual maturity dates because they may be readily
liquidated. During 2008, our auction rate securities were
classified as non-current assets. During the fourth quarter of
2008, certain auction rate securities were designated as trading
securities. For comprehensive discussions of the fair value and
classification of our current and non-current investments,
including auction rate securities, see Note 4, Fair
Value Measurements, and Note 5,
Investments.
Receivables
Receivables consist primarily of amounts due from the various
states in which we operate. All receivables are subject to
potential retroactive adjustment. Because the amounts of all
receivables are readily determinable and our creditors are state
governments, our allowance for doubtful accounts is immaterial.
Any amounts determined to be uncollectible are charged to
expense when such determination is made. See Note 6,
Receivables.
Property
and Equipment
Property and equipment are stated at historical cost.
Replacements and major improvements are capitalized, and repairs
and maintenance are charged to expense as incurred. Software
developed for internal use is capitalized in accordance with the
provision of AICPA Statement of Position
No. 98-1,
Accounting for the Costs of Computer Software Developed or
Obtained for Internal Use. Furniture and equipment are
depreciated using the straight-line method over estimated useful
lives ranging from three to seven years. Software is amortized
over its estimated
71
MOLINA
HEALTHCARE, INC.
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
useful life of three years. Leasehold improvements are amortized
over the term of the lease or five to 10 years, whichever
is shorter. Buildings are depreciated over their estimated
useful lives of 31.5 years. See Note 7, Property
and Equipment.
Goodwill
and Intangible Assets
Goodwill represents the excess of the purchase price over the
fair value of net assets acquired. Identifiable intangible
assets (consisting principally of purchased contract rights and
provider contracts) are amortized on a straight-line basis over
the expected period to be benefited (between one and
15 years). See Note 8, Goodwill and Intangible
Assets.
Under SFAS 142, Goodwill and Other Intangible
Assets, goodwill and indefinite lived assets are not
amortized, but are subject to impairment tests on an annual
basis or more frequently if indicators of impairment exist.
Under the guidance of SFAS 142, we used a discounted cash
flow methodology to assess the fair values of our reporting
units at December 31, 2008 and 2007. If book equity values
of our reporting units exceed the fair values, we perform a
hypothetical purchase price allocation. Impairment is measured
by comparing the goodwill derived from the hypothetical purchase
price allocation to the carrying value of the goodwill and
indefinite lived asset balance. Based on the results of our
impairment testing, no adjustments were required for the years
ended December 31, 2008, 2007, and 2006.
Long-Lived
Asset Impairment
Situations may arise where the carrying value of a long-lived
asset may exceed the undiscounted expected cash flows associated
with that asset. In such circumstances, the asset is deemed to
be impaired. We review material long-lived assets for impairment
on an annual basis, as well as when events or changes in
business conditions suggest potential impairment. Impaired
assets are written down to fair value. In the second quarter of
2007, we recorded an impairment charge totaling $782,000 related
to commercial software no longer used in operations. Other than
this 2007 charge, we have determined that no long-lived assets
were impaired in the years ended December 31, 2008, 2007,
and 2006.
Restricted
Investments
Restricted investments, which consist of certificates of deposit
and treasury securities, are designated as held-to-maturity and
are carried at amortized cost, which approximates market value.
The use of these funds is limited to specific purposes as
required by each state, or as protection against the insolvency
of capitated providers. We have the ability to hold our
restricted investments until maturity and, as a result, we would
not expect the value of these investments to decline
significantly due to a sudden change in market interest rates.
See Note 9, Restricted Investments.
Receivable/Liability
for Ceded Life and Annuity Contracts
We report an acquired 100% ceded reinsurance arrangement related
to the December 2005 purchase of Molina Healthcare Insurance
Company by recording a non-current receivable from the reinsurer
with a corresponding non-current liability for ceded life and
annuity contracts.
Other
Assets
During 2008, other assets increased due to the $9.0 million
payment on the initial closing of the Florida NetPASS
acquisition (see Note 3, Business Purchase
Transactions), and the addition of a $6.9 million
non-current asset in connection with a rights agreement (see
Note 4, Fair Value Measurements). Other
significant items included in other assets include deferred
financing costs associated with long-term debt, certain
investments held in connection with our employee deferred
compensation program, and an investment in a vision services
provider (see
72
MOLINA
HEALTHCARE, INC.
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
Note 14, Related Party Transactions). The
deferred financing costs are being amortized on a straight-line
basis over the seven-year term of the convertible senior notes.
Income
Taxes
We account for income taxes under SFAS 109, Accounting
for Income Taxes. Deferred tax assets and liabilities are
recorded based on temporary differences between the financial
statement basis and the tax basis of assets and liabilities
using presently enacted tax rates. On January 1, 2007, we
adopted the provisions of Financial Accounting Standards Board
(FASB) Interpretation No. (FIN) 48, Accounting for
Uncertainty in Income Taxes, which clarifies the accounting
for uncertainty in income taxes recognized in companies
financial statements in accordance with SFAS 109.
FIN 48 prescribes a recognition threshold and measurement
attribute for the financial statement recognition and
measurement of a tax position taken or expected to be taken in a
tax return. The evaluation of a tax position in accordance with
FIN 48 is a two-step process. The first step is recognition
to determine whether it is more likely than not that a tax
position will be sustained upon examination. In the second step,
a tax position that meets the more-likely-than-not recognition
threshold is measured to determine the amount of benefit to
recognize in the financial statements. FIN 48 also provides
guidance on de-recognition of recognized tax benefits,
classification, interest and penalties, accounting in interim
periods, disclosure and transition. See Note 12,
Income Taxes.
Earnings
Per Share
The denominators for the computation of basic and diluted
earnings per share were calculated as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended December 31,
|
|
|
|
2008
|
|
|
2007
|
|
|
2006
|
|
|
|
(In thousands)
|
|
|
Shares outstanding at the beginning of the year
|
|
|
28,444
|
|
|
|
28,119
|
|
|
|
27,792
|
|
Weighted-average number of shares repurchased
|
|
|
(871
|
)
|
|
|
|
|
|
|
|
|
Weighted-average number of shares issued
|
|
|
103
|
|
|
|
156
|
|
|
|
174
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Denominator for basic earnings per share
|
|
|
27,676
|
|
|
|
28,275
|
|
|
|
27,966
|
|
Dilutive effect of employee stock options and stock grants(1)
|
|
|
96
|
|
|
|
144
|
|
|
|
198
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Denominator for diluted earnings per share(2)
|
|
|
27,772
|
|
|
|
28,419
|
|
|
|
28,164
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1) |
|
Options to purchase common shares are included in the
calculation of diluted earnings per share when their exercise
prices are below the average fair value of the common shares for
each of the periods presented. |
|
(2) |
|
Potentially dilutive shares issuable pursuant to our 2007
offering of convertible senior notes were not included in the
computation of diluted net income per share because to do so
would have been anti-dilutive for the years ended
December 31, 2008 and 2007. |
Concentrations
of Credit Risk
Financial instruments that potentially subject us to
concentrations of credit risk consist primarily of cash and cash
equivalents, investments, receivables, and restricted
investments. We invest a substantial portion of our cash in the
PFM Fund Prime Series Cash Management Class,
PFM Fund Prime Series Institutional Class, and
the PFM Fund Government Series. These funds represent a
portfolio of highly liquid money market securities that are
managed by PFM Asset Management LLC (PFM), a Virginia business
trust registered as an open-end management investment fund. Our
investments and a portion of our cash equivalents are managed by
professional portfolio managers operating under documented
investment guidelines. No investment that is in a loss position
can be sold by our managers without our prior approval. Our
investments consist solely of investment grade debt securities
with a maximum maturity of ten years and an average duration of
four years. Restricted investments are invested principally in
certificates of deposit and treasury securities. Concentration
of credit risk with respect to accounts
73
MOLINA
HEALTHCARE, INC.
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
receivable is limited due to payors consisting principally of
the governments of each state in which our HMO subsidiaries
operate.
Fair
Value of Financial Instruments
Our consolidated balance sheets include the following financial
instruments: cash and cash equivalents, investments,
receivables, trade accounts payable, medical claims and benefits
payable, long-term debt and other liabilities. We consider the
carrying amounts of cash and cash equivalents, receivables,
other current assets and current liabilities to approximate
their fair value because of the relatively short period of time
between the origination of these instruments and their expected
realization or payment. For a comprehensive discussion of fair
value measurements with regard to our current and non-current
investments, see Note 4, Fair Value
Measurements.
Based on quoted market prices, the fair value of our convertible
senior notes issued in October 2007 was $115.5 million as
of December 31, 2008, and $225.6 million as of
December 31, 2007. The carrying amount of the convertible
senior notes was $200.0 million as of December 31,
2008.
Risks
and Uncertainties
Our profitability depends in large part on accurately predicting
and effectively managing medical care costs. We continually
review our medical costs in light of our underlying claims
experience and revised actuarial data. However, several factors
could adversely affect medical care costs. These factors, which
include changes in health care practices, inflation, new
technologies, major epidemics, natural disasters, and
malpractice litigation, are beyond our control and may have an
adverse effect on our ability to accurately predict and
effectively control medical care costs. Costs in excess of those
anticipated could have a material adverse effect on our
financial condition, results of operations, or cash flows.
At December 31, 2008, we operated in 10 states, in
some instances as a direct contractor with the state, and in
others as a subcontractor to another health plan holding a
direct contract with the state. We are therefore dependent upon
a small number of contracts to support our revenue. The loss of
any one of those contracts could have a material adverse effect
on our financial position, results of operations, or cash flows.
Our ability to arrange for the provision of medical services to
our members is dependent upon our ability to develop and
maintain adequate provider networks. Our inability to develop or
maintain such networks might, in certain circumstances, have a
material adverse effect on our financial position, results of
operations, or cash flows.
Segment
Information
We present segment information externally in the same manner
used by management to make operating decisions and assess
performance. Each of our subsidiaries arranges for the provision
of health care services to Medicaid and CHIP members in return
for compensation from state agencies. They share similar
characteristics in the membership they serve, the nature of
services provided and the method by which medical care is
rendered. The subsidiaries are also subject to similar
regulatory environments and long-term economic prospects. As
such, we have one reportable segment.
Recent
Accounting Pronouncements
In May 2008, the Financial Accounting Standards Board
(FASB) issued FASB Staff Position APB
14-1,
Accounting for Convertible Debt Instruments That May Be
Settled in Cash upon Conversion (Including Partial Cash
Settlement) (the FSP). The FSP requires the
proceeds from the issuance of such convertible debt instruments
to be allocated between a liability component and an equity
component. The resulting debt discount is amortized over the
period the convertible debt is expected to be outstanding, as
additional non-cash interest expense. The change in accounting
treatment is effective for fiscal years beginning after
December 15, 2008, and shall be applied
74
MOLINA
HEALTHCARE, INC.
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
retrospectively to prior periods. The FSP changes the accounting
treatment for our $200.0 million 3.75% Convertible
Senior Notes due 2014, which were issued in October 2007 (see
Note 11, Long-Term Debt). The impact of this
new accounting treatment will result in an increase to non-cash
interest expense beginning in fiscal year 2009 for financial
statements covering past and future periods. We have determined
that the applicable interest rate will be 7.5%. This rate is
principally based on the seven-year U.S. treasury note rate
as of the October 2007 issuance date, plus a credit spread.
Using this interest rate, the incremental impact of the FSP to
our results of operations in 2009 will be approximately
$3.1 million, or $0.12 per diluted share, net of tax, but
does not include the impact of our repurchase of
$13 million face amount of the Notes in February 2009. See
Note 20, Subsequent Events. This estimate
assumes a 38% combined federal and state statutory tax rate and
27 million diluted shares outstanding. We estimate the
retroactive adjustment for prior periods will be approximately
$627,000, or $0.02 per diluted share, net of tax, for 2007, and
$2.9 million, or $0.11 per diluted share, net of tax, for
2008. For prior periods, the estimates assume a 38% combined
federal and state statutory tax rate and actual diluted shares
outstanding for those periods.
In December 2007, the FASB issued SFAS 141(R), Business
Combinations and SFAS 160, Noncontrolling Interests
in Consolidated Financial Statements. The standards are
intended to improve, simplify, and converge internationally the
accounting for business combinations and the reporting of
noncontrolling (minority) interests in consolidated financial
statements. SFAS 141(R) requires the acquiring entity in a
business combination to recognize all (and only) the assets
acquired and liabilities assumed in the transaction; establishes
the acquisition-date fair value as the measurement objective for
all assets acquired and liabilities assumed; and requires the
acquirer to disclose to investors and other users all of the
information they need to evaluate and understand the nature and
financial effect of the business combination. SFAS 141(R)
is effective for fiscal years, and interim periods within those
fiscal years, beginning on or after December 15, 2008, and
is applied prospectively to business combinations for which the
acquisition date is on or after the effective date. Earlier
adoption is prohibited. We will apply SFAS 141(R) to the
acquisition of Florida NetPASS, LLC, which we expect to complete
by the third quarter of 2009. For more information on this
acquisition, see Note 3, Business Purchase
Transactions.
SFAS 160 is designed to improve the relevance,
comparability, and transparency of financial information
provided to investors by requiring all entities to report
minority interests in subsidiaries in the same way
as equity in the consolidated financial statements. Moreover,
SFAS 160 eliminates the diversity that currently exists in
accounting for transactions between an entity and minority
interests by requiring they be treated as equity transactions.
In addition, SFAS 160 requires that a parent company
recognize a gain or loss in net income when a subsidiary is
deconsolidated upon a change in control. SFAS 160 is
effective for fiscal years, and interim periods within those
fiscal years, beginning on or after December 15, 2008.
Earlier adoption is prohibited. In addition, SFAS 160 shall
be applied prospectively as of the beginning of the fiscal year
in which it is initially applied, except for the presentation
and disclosure requirements. The presentation and disclosure
requirements shall be applied retrospectively for all periods
presented. As of December 31, 2008, we did not have
material outstanding minority interests.
Other recent accounting pronouncements issued by the FASB
(including its Emerging Issues Task Force), the AICPA, and the
SEC did not, or are not believed by management to, have a
material impact on our present or future consolidated financial
statements.
|
|
3.
|
Business
Purchase Transactions
|
Missouri subsidiary. Effective
November 1, 2007, we acquired Mercy CarePlus, a licensed
Medicaid managed care plan based in St. Louis, Missouri, to
expand our market share within our core Medicaid managed care
business. The results of operations for Mercy CarePlus are
included in the consolidated financial statements from periods
following November 1, 2007. The purchase price for the
acquisition was $80.0 million, and was funded with
available cash and proceeds from our issuance of convertible
senior notes in October 2007. The purchase price was subject to
the following post-closing adjustments: (1) a
reconciliation with respect to incurred but not reported medical
costs; (2) a settlement of income taxes; and (3) the
payment of an additional $5.0 million to
75
MOLINA
HEALTHCARE, INC.
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
the sellers if the earnings of the health plan (as defined in
the purchase agreement ) exceeded $22.0 million for the
twelve months ended June 30, 2008. Upon evaluation, we have
preliminarily determined that: (1) the sellers owe us
approximately $650,000 in connection with the reconciliation of
incurred but not reported medical costs; (2) we owe the
sellers approximately $400,000 in connection with the settlement
of income taxes; and (3) the earnings condition was not
met, so we believe that we do not owe the sellers the additional
$5.0 million payment. However, the sellers have objected to
our first and third determinations as listed above, and the
dispute resolution process provided for under the parties
stock purchase agreement has commenced. During the
post-acquisition period in 2008, we reduced goodwill relating to
the Mercy CarePlus acquisition by approximately
$6.2 million, primarily due to the establishment of a
deferred tax asset relating to the carryover tax basis in
certain identifiable intangibles.
Florida subsidiary. In August 2008, we
announced our intention to acquire Florida NetPASS, LLC
(NetPASS), a provider of care management and
administrative services at that time to approximately 55,000
Florida MediPass members in South and Central Florida. We expect
the closing of the transaction to occur by the third quarter of
2009, at a purchase price of approximately $42 million,
subject to adjustments. On October 1, 2008, we completed
the initial closing of the transaction, under which we acquired
one percent of the ownership interests of NetPASS for
$9.0 million. Additionally, we deposited $9.0 million
to an escrow account that will be used for the purpose of
reimbursing the state of Florida for any sums due under a final
settlement agreement with the state. On October 7, 2008, we
announced that our wholly owned subsidiary, Molina Healthcare of
Florida, Inc., was awarded a Medicaid managed care contract by
the state of Florida. The term of the contract commenced on
December 1, 2008, at which time Molina Healthcare of
Florida began its initial enrollment of NetPASS Medicaid
members, with the full transition of NetPASS members expected to
be completed by the third quarter of 2009.
Other. On June 30, 2008, we paid
$1 million and issued a total of 48,186 shares of our
common stock in connection with our acquisition of the assets of
The Game of Work, LLC. The purchase price consideration totaled
$2.3 million. The Game of Work, LLC is a company
specializing in productivity measurement and improvement and
will be used internally to increase operational efficiency.
|
|
4.
|
Fair
Value Measurements
|
Effective January 1, 2008, we adopted SFAS 157,
Fair Value Measurements, for financial assets and
liabilities. The statement defines fair value, provides guidance
for measuring fair value and requires certain disclosures.
SFAS 157 discusses valuation techniques, such as the market
approach (comparable market prices), the income approach
(present value of future income or cash flow) and the cost
approach (cost to replace the service capacity of an asset or
replacement cost). The statement establishes a fair value
hierarchy that prioritizes the inputs to valuation techniques
used to measure fair value into three broad levels. The
following is a brief description of those three levels:
|
|
|
|
|
Level 1: Observable inputs such as quoted
prices (unadjusted) in active markets that are accessible at the
measurement date for identical, unrestricted assets or
liabilities.
|
|
|
|
Level 2: Inputs other than quoted prices
that are observable for the asset or liability, either directly
or indirectly. These include quoted prices for similar assets or
liabilities in active markets and quoted prices for identical or
similar assets or liabilities in markets that are not active.
|
|
|
|
Level 3: Unobservable inputs that reflect
the reporting entitys own assumptions.
|
76
MOLINA
HEALTHCARE, INC.
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
As of December 31, 2008, we held certain assets that are
required to be measured at fair value on a recurring basis.
These included cash and cash equivalents, investments and
restricted investments as follows:
|
|
|
Balance Sheet Classification
|
|
Description
|
|
Current assets:
|
|
|
Cash and cash equivalents
|
|
Cash and highly liquid securities with original or purchase date
remaining maturities of up to three months that are readily
convertible into known amounts of cash; reported at fair value
based on market prices that are readily available (Level 1).
|
Investments
|
|
Investment grade debt securities; designated as
available-for-sale; reported at fair value based on market
prices that are readily available (Level 1).
|
Non-current assets:
|
|
|
Investments
|
|
Auction rate securities; designated as available-for-sale;
reported at fair value based on discounted cash flow analysis or
other type of valuation model (Level 3).
|
|
|
Auction rate securities; designated as trading; reported at fair
value based on discounted cash flow analysis or other type of
valuation model (Level 3).
|
Other assets
|
|
Other assets include auction rate securities rights (the
Rights); reported at fair value based on discounted
cash flow analysis or other type of valuation model
(Level 3).
|
Restricted investments
|
|
Interest-bearing deposits and U.S. treasury securities required
by the respective states in which we operate, or required by
contractual arrangement with a third party such as a provider
group; designated as held-to-maturity; reported at amortized
cost which approximates market value and based on market prices
that are readily available (Level 1).
|
As of December 31, 2008, $70.5 million par value (fair
value of $58.2 million) of our investments consisted of
auction rate securities, of which all were securities
collateralized by student loan portfolios, guaranteed by the
U.S. government. We continued to earn interest on
substantially all of these auction rate securities as of
December 31, 2008. Due to events in the credit markets, the
auction rate securities held by us experienced failed auctions
beginning in the first quarter of 2008. As such, quoted prices
in active markets were not readily available during the
majority of 2008. We used pricing models to estimate the fair
value of these securities. These pricing models included factors
such as the collateral underlying the securities, the
creditworthiness of the counterparty, the timing of expected
future cash flows, and the expectation of the next time the
security would be expected to have a successful auction. The
estimated values of these securities were also compared, when
possible, to valuation data with respect to similar securities
held by other parties. We concluded that these estimates, given
the lack of market available pricing, provided a reasonable
basis for determining fair value of the auction rate securities
as of December 31, 2008.
As of December 31, 2008, we held $42.5 million par value
(fair value of $34.9 million) auction rate securities with
a certain investment securities firm. In November 2008, we
entered into a rights agreement with this firm that (1) allows
us to exercise rights (the Rights) to sell the
eligible auction rate securities at par value to this firm
between June 30, 2010 and July 2, 2012, and
(2) gives the investment securities firm the right to
purchase the auction rate securities from us any time after the
agreement date as long as we receive the par value.
We have accounted for the Rights as a freestanding financial
instrument and have elected to record the value of the Rights
under the fair value option of SFAS 159, The Fair Value
Option for Financial Assets and Financial Liabilities. In
the fourth quarter of 2008, this resulted in the recognition of
a $6.9 million non-current asset, with a corresponding
increase to pretax income for the value of the Rights. To
determine the fair value estimate of the Rights, we used a
discounted cash-flow model that was based on the expectation
that the auction rate securities will be put back to the
investment securities firm at par on June 30, 2010, as permitted
by the Rights Agreement.
Simultaneous to the recognition of the $6.9 million rights
agreement, we recorded an other-than-temporary impairment of the
underlying auction rate securities, and prior unrealized losses
on the auction rate securities that
77
MOLINA
HEALTHCARE, INC.
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
had been recorded to other comprehensive loss through November
2008 were charged to income, totaling $7.2 million. Also,
at the time of the execution of the Rights agreement and
pursuant to SFAS 115, we elected to transfer the underlying
auction rate securities from available-for-sale to trading
securities. For the month of December 2008, we recorded
additional losses of $399,000 on these auction rate securities.
We expect that the future changes in the fair value of the
Rights will be substantially offset by the fair value movements
in the underlying auction rate securities.
As of December 31, 2008, the remainder of our auction rate
securities, which are still designated as available-for-sale,
amounted to $28.0 million par value (fair value of
$23.3 million). As a result of the decline in fair value of
these auction rate securities, we recorded unrealized losses of
$4.7 million ($2.9 million net of tax) to accumulated
other comprehensive (loss) income for the year ended
December 31, 2008. We have deemed these unrealized losses
to be temporary and attribute the decline in value to liquidity
issues, as a result of the failed auction market, rather than to
credit issues. Any future fluctuation in fair value related to
these instruments that we deem to be temporary, including any
recoveries of previous write-downs, would be recorded to
accumulated other comprehensive (loss) income. If we determine
that any future valuation adjustment was other-than-temporary,
we would record a charge to earnings as appropriate.
Our assets measured at fair value on a recurring basis subject
to the disclosure requirements of SFAS 157 at
December 31, 2008, were as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fair Value Measurements at Reporting Date Using
|
|
|
|
Total
|
|
|
Level 1
|
|
|
Level 2
|
|
|
Level 3
|
|
|
|
(In thousands)
|
|
|
Cash and cash equivalents
|
|
$
|
387,162
|
|
|
$
|
387,162
|
|
|
$
|
|
|
|
$
|
|
|
Investments
|
|
|
189,870
|
|
|
|
189,870
|
|
|
|
|
|
|
|
|
|
Auction rate securities (available-for-sale)
|
|
|
23,284
|
|
|
|
|
|
|
|
|
|
|
|
23,284
|
|
Auction rate securities (trading)
|
|
|
34,885
|
|
|
|
|
|
|
|
|
|
|
|
34,885
|
|
Auction rate securities rights
|
|
|
6,907
|
|
|
|
|
|
|
|
|
|
|
|
6,907
|
|
Restricted investments
|
|
|
38,202
|
|
|
|
38,202
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total assets measured at fair value
|
|
$
|
680,310
|
|
|
$
|
615,234
|
|
|
$
|
|
|
|
$
|
65,076
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Based on market conditions that resulted in the absence of
quoted prices in active markets for our auction rate securities,
we changed our valuation methodology for auction rate securities
to a discounted cash flow analysis during the first quarter of
2008. Accordingly, since our initial adoption of SFAS 157
on January 1, 2008, these securities changed from
Level 1 to Level 3 within SFAS 157s
hierarchy. The following table presents our assets measured at
fair value on a recurring basis using significant unobservable
inputs (Level 3) as defined in SFAS 157:
|
|
|
|
|
|
|
(Level 3)
|
|
|
|
(In thousands)
|
|
|
Balance at December 31, 2007
|
|
$
|
|
|
Transfers to Level 3
|
|
|
82,150
|
|
Auction rate securities rights
|
|
|
6,907
|
|
Total losses (realized or unrealized):
|
|
|
|
|
Included in earnings
|
|
|
(7,565
|
)
|
Included in other comprehensive loss
|
|
|
(4,716
|
)
|
Settlements
|
|
|
(11,700
|
)
|
|
|
|
|
|
Balance at December 31, 2008
|
|
$
|
65,076
|
|
|
|
|
|
|
The amount of total losses for the period included in other
comprehensive income attributable to the change in unrealized
losses relating to assets still held at December 31, 2008
|
|
$
|
(4,716
|
)
|
|
|
|
|
|
78
MOLINA
HEALTHCARE, INC.
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
The following tables summarize our investments as of the dates
indicated:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
December 31, 2008
|
|
|
|
Cost or
|
|
|
Gross
|
|
|
Estimated
|
|
|
|
Amortized
|
|
|
Unrealized
|
|
|
Fair
|
|
|
|
Cost
|
|
|
Gains
|
|
|
Losses
|
|
|
Value
|
|
|
|
(In thousands)
|
|
|
Municipal securities (including auction rate securities)
|
|
$
|
85,973
|
|
|
$
|
23
|
|
|
$
|
5,313
|
|
|
$
|
80,683
|
|
U.S. government agency securities
|
|
|
93,994
|
|
|
|
1,309
|
|
|
|
79
|
|
|
|
95,224
|
|
U.S. treasury notes
|
|
|
8,604
|
|
|
|
295
|
|
|
|
|
|
|
|
8,899
|
|
Certificates of deposit
|
|
|
13,494
|
|
|
|
|
|
|
|
|
|
|
|
13,494
|
|
Corporate bonds
|
|
|
50,315
|
|
|
|
155
|
|
|
|
731
|
|
|
|
49,739
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
252,380
|
|
|
$
|
1,782
|
|
|
$
|
6,123
|
|
|
$
|
248,039
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
December 31, 2007
|
|
|
|
Cost or
|
|
|
Gross
|
|
|
Estimated
|
|
|
|
Amortized
|
|
|
Unrealized
|
|
|
Fair
|
|
|
|
Cost
|
|
|
Gains
|
|
|
Losses
|
|
|
Value
|
|
|
|
(In thousands)
|
|
|
Municipal securities (including auction rate securities)
|
|
$
|
114,123
|
|
|
$
|
10
|
|
|
$
|
36
|
|
|
$
|
114,097
|
|
U.S. government agency securities
|
|
|
42,727
|
|
|
|
162
|
|
|
|
18
|
|
|
|
42,871
|
|
U.S. treasury notes
|
|
|
31,563
|
|
|
|
510
|
|
|
|
|
|
|
|
32,073
|
|
Certificates of deposit
|
|
|
29,136
|
|
|
|
|
|
|
|
|
|
|
|
29,136
|
|
Corporate bonds
|
|
|
24,556
|
|
|
|
155
|
|
|
|
33
|
|
|
|
24,678
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
242,105
|
|
|
$
|
837
|
|
|
$
|
87
|
|
|
$
|
242,855
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
The contractual maturities of our investments as of
December 31, 2008 are summarized below.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Estimated
|
|
|
|
Amortized
|
|
|
Fair
|
|
|
|
Cost
|
|
|
Value
|
|
|
|
(In thousands)
|
|
|
Due in one year or less
|
|
$
|
102,327
|
|
|
$
|
102,293
|
|
Due one year through five years
|
|
|
87,071
|
|
|
|
87,672
|
|
Due after five years through ten years
|
|
|
1,230
|
|
|
|
1,146
|
|
Due after ten years
|
|
|
61,752
|
|
|
|
56,928
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
252,380
|
|
|
$
|
248,039
|
|
|
|
|
|
|
|
|
|
|
Gross realized gains and gross realized losses from sales of
available-for-sale securities are calculated under the specific
identification method and are included in investment income.
Total proceeds from sales of available-for-sale securities were
$55.3 million, $13.1 million, and $12.6 million
for the years ended December 31, 2008, 2007 and 2006,
respectively. Net realized investment gains (losses) for the
years ended December 31, 2008, 2007 and 2006 were $342,000,
$(78,000) and $(151,000) respectively.
We monitor our investments for other-than-temporary impairment.
For investments other than our municipal securities, we have
determined that unrealized gains and losses at December 31,
2008 and 2007 are temporary in nature, because the change in
market value for these securities has resulted from fluctuating
interest rates, rather than a deterioration of the credit
worthiness of the issuers. So long as we hold these securities
to maturity, we are unlikely to experience gains or losses. In
the event that we dispose of these securities before maturity,
we expect that realized gains or losses, if any, will be
immaterial.
79
MOLINA
HEALTHCARE, INC.
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
Our investment in municipal securities consists primarily of
auction rate securities. As described in Note 4, Fair
Value Measurements, the unrealized losses on these
investments were caused primarily by the illiquidity in the
auction markets. Because the decline in market value is not due
to the credit quality of the issuers, and because we have the
ability and intent to hold these investments until a recovery of
fair value, which may be maturity, we do not consider the
auction rate securities that are designated as
available-for-sale to be other-than-temporarily impaired at
December 31, 2008.
For investments presented in the table above, the disclosures
required by FASB Staff Position Nos.
FAS 115-1
and
FAS 124-1,
The Meaning of Other-Than-Temporary Impairment and Its
Application to Certain Investments, have not been included
because our unrealized losses were immaterial at
December 31, 2007. The following table segregates those
available-for-sale investments that have been in a continuous
loss position for less than 12 months and those that have
been in a loss position for 12 months or more as of
December 31, 2008.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
In a Continuous Loss
|
|
|
|
|
|
|
|
|
|
In a Continuous Loss Position
|
|
|
Position
|
|
|
|
|
|
|
|
|
|
for Less than 12 Months
|
|
|
for 12 Months or More
|
|
|
Total
|
|
|
|
Estimated
|
|
|
|
|
|
Estimated
|
|
|
|
|
|
Estimated
|
|
|
|
|
|
|
Fair
|
|
|
Unrealized
|
|
|
Fair
|
|
|
Unrealized
|
|
|
Fair
|
|
|
Unrealized
|
|
|
|
Value
|
|
|
Losses
|
|
|
Value
|
|
|
Losses
|
|
|
Value
|
|
|
Losses
|
|
|
|
(In thousands)
|
|
|
Municipal securities
|
|
$
|
41,901
|
|
|
$
|
4,914
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
41,901
|
|
|
$
|
4,914
|
|
U.S. government agency securities
|
|
|
7,237
|
|
|
|
79
|
|
|
|
|
|
|
|
|
|
|
|
7,237
|
|
|
|
79
|
|
Corporate bonds
|
|
|
30,276
|
|
|
|
731
|
|
|
|
|
|
|
|
|
|
|
|
30,276
|
|
|
|
731
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
79,414
|
|
|
$
|
5,724
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
79,414
|
|
|
$
|
5,724
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Accounts receivable by health plan operating subsidiary were as
follows:
|
|
|
|
|
|
|
|
|
|
|
December 31,
|
|
|
|
2008
|
|
|
2007
|
|
|
|
(In thousands)
|
|
|
California
|
|
$
|
20,740
|
|
|
$
|
23,046
|
|
Michigan
|
|
|
6,637
|
|
|
|
6,419
|
|
Missouri
|
|
|
24,024
|
|
|
|
15,986
|
|
New Mexico
|
|
|
5,712
|
|
|
|
3,887
|
|
Ohio
|
|
|
34,562
|
|
|
|
28,522
|
|
Utah
|
|
|
20,614
|
|
|
|
23,987
|
|
Washington
|
|
|
14,184
|
|
|
|
8,308
|
|
Other
|
|
|
2,089
|
|
|
|
1,382
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
$
|
128,562
|
|
|
$
|
111,537
|
|
|
|
|
|
|
|
|
|
|
Substantially all receivables due our California and Missouri
health plans at December 31, 2008 were collected in January
2009.
Ohio. As of December 31, 2008, the
receivable due our Ohio health plan included two significant
components. The first is approximately $11.8 million of
accrued birth income, net, due from the state of Ohio. Birth
income is a one-time payment for the delivery of a child from
the Medicaid program in Ohio.
The second significant component of the Ohio receivable is
approximately $20.6 million due from a capitated provider
group. Although we have a capitation arrangement with this
provider group, our agreement with them calls for us to pay for
certain medical services incurred by the provider groups
members, and then to deduct the amount
80
MOLINA
HEALTHCARE, INC.
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
of such payments from future monthly capitation amounts owed to
the provider group. Of the $20.6 million receivable,
approximately $14.0 million represents medical services we
have paid on behalf of the provider group, which we will deduct
from capitation payments in the months of January and February
2009. The other component of the Ohio receivable includes an
estimate of our liability for claims incurred by members of this
provider group, not covered by capitation, for which we have not
yet made payment. This amount totaled $6.6 million as of
December 31, 2008. The offsetting liability for the amount
of this receivable established for claims incurred but not paid
is included in Medical claims and benefits payable
in our consolidated balance sheets. As part of the agreement
with this provider group, our Ohio health plan has withheld
approximately $7.7 million from capitation payments due the
group, and placed the funds in an escrow account. The Ohio
health plan is entitled to the escrow amount if the provider
group is unable to repay amounts owed to us for these incurred
but not reported claims. The escrow account is included in
Restricted investments in our consolidated balance
sheets. During the quarter ended December 31, 2008, our
average monthly capitation payment to this provider group was
approximately $12 million.
Utah. Our Utah health plans agreement
with the state of Utah calls for the reimbursement of medical
costs incurred in serving our members plus an administrative fee
of 9% of that medical cost amount, plus a portion of any cost
savings realized as defined in the agreement. Our Utah health
plan bills the state of Utah monthly for actual paid health care
claims plus administrative fees. Our receivable balance from the
state of Utah includes: (1) amounts billed to the state for
actual paid health care claims plus administrative fees; and
(2) amounts estimated for incurred but not reported claims,
which, along with the related administrative fees, are not
billable to the state of Utah until such claims are actually
paid. For amounts reimbursed by the state subsequent to
December 31, 2008, the administrative fee will be reduced
to 8% of the medical cost amount.
|
|
7.
|
Property
and Equipment
|
A summary of property and equipment is as follows:
|
|
|
|
|
|
|
|
|
|
|
December 31,
|
|
|
|
2008
|
|
|
2007
|
|
|
|
(In thousands)
|
|
|
Land
|
|
$
|
3,461
|
|
|
$
|
3,000
|
|
Building and improvements
|
|
|
25,047
|
|
|
|
21,928
|
|
Furniture, equipment and automobiles
|
|
|
47,074
|
|
|
|
38,439
|
|
Capitalized computer software costs
|
|
|
56,211
|
|
|
|
34,895
|
|
|
|
|
|
|
|
|
|
|
|
|
|
131,793
|
|
|
|
98,262
|
|
|
|
|
|
|
|
|
|
|
Less: accumulated depreciation and amortization on building and
improvements, furniture, equipment and automobiles
|
|
|
(42,056
|
)
|
|
|
(34,071
|
)
|
Less: accumulated amortization on capitalized computer software
costs
|
|
|
(24,679
|
)
|
|
|
(14,636
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
(66,735
|
)
|
|
|
(48,707
|
)
|
|
|
|
|
|
|
|
|
|
Property and equipment, net
|
|
$
|
65,058
|
|
|
$
|
49,555
|
|
|
|
|
|
|
|
|
|
|
Depreciation expense recognized for building and improvements,
furniture, equipment and automobiles was $9.0 million,
$8.5 million, and $7.7 million for the years ended
December 31, 2008, 2007, and 2006, respectively.
Amortization expense recognized for capitalized computer
software costs was $11.7 million, $8.6 million, and
$4.3 million for the years ended December 31, 2008,
2007, and 2006, respectively.
|
|
8.
|
Goodwill
and Intangible Assets
|
Other intangible assets are amortized over their useful lives
ranging from one to 15 years. The weighted average
amortization period for contract rights and licenses is
approximately 11.5 years, and for provider network is
approximately 9.9 years. Amortization expense on intangible
assets recognized for the years ended December 31,
81
MOLINA
HEALTHCARE, INC.
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
2008, 2007, and 2006 was $13.0 million, $10.8 million,
and $9.5 million, respectively. We estimate that our
intangible asset amortization expense will be $11.6 million
in 2009, $11.6 million in 2010, $10.4 million in 2011,
$8.3 million in 2012, and $5.9 million in 2013. The
following table provides the details of identified intangible
assets, by major class, for the periods indicated:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Accumulated
|
|
|
Net
|
|
|
|
Cost
|
|
|
Amortization
|
|
|
Balance
|
|
|
|
(In thousands)
|
|
|
Intangible assets:
|
|
|
|
|
|
|
|
|
|
|
|
|
Contract rights and licenses
|
|
$
|
114,219
|
|
|
$
|
46,160
|
|
|
$
|
68,059
|
|
Provider network
|
|
|
14,548
|
|
|
|
3,474
|
|
|
|
11,074
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance at December 31, 2008
|
|
$
|
128,767
|
|
|
$
|
49,634
|
|
|
$
|
79,133
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Intangible assets:
|
|
|
|
|
|
|
|
|
|
|
|
|
Contract rights and licenses
|
|
$
|
111,892
|
|
|
$
|
34,775
|
|
|
$
|
77,117
|
|
Provider network
|
|
|
14,548
|
|
|
|
1,889
|
|
|
|
12,659
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance at December 31, 2007
|
|
$
|
126,440
|
|
|
$
|
36,664
|
|
|
$
|
89,776
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
The changes in the carrying amount of goodwill and
indefinite - lived intangible assets were as follows (in
thousands):
|
|
|
|
|
Balance as of December 31, 2007
|
|
$
|
117,447
|
|
Goodwill adjustment related to acquisition of Mercy CarePlus
|
|
|
(6,150
|
)
|
Goodwill adjustment related to acquisition of Cape Health Plans
|
|
|
2,169
|
|
|
|
|
|
|
Balance at December 31, 2008
|
|
$
|
113,466
|
|
|
|
|
|
|
|
|
9.
|
Restricted
Investments
|
Pursuant to the regulations governing our subsidiaries, we
maintain statutory deposits and deposits required by state
Medicaid authorities. Additionally, we maintain restricted
investments as protection against the insolvency of capitated
providers. The following table presents the balances of
restricted investments by health plan, and by our insurance
company:
|
|
|
|
|
|
|
|
|
|
|
December 31,
|
|
|
|
2008
|
|
|
2007
|
|
|
|
(In thousands)
|
|
|
California
|
|
$
|
367
|
|
|
$
|
524
|
|
Florida
|
|
|
9,828
|
|
|
|
307
|
|
Insurance Company
|
|
|
4,718
|
|
|
|
4,722
|
|
Michigan
|
|
|
1,000
|
|
|
|
1,000
|
|
Missouri
|
|
|
506
|
|
|
|
500
|
|
Nevada
|
|
|
787
|
|
|
|
885
|
|
New Mexico
|
|
|
9,670
|
|
|
|
8,991
|
|
Ohio
|
|
|
8,459
|
|
|
|
9,370
|
|
Texas
|
|
|
1,521
|
|
|
|
1,491
|
|
Utah
|
|
|
577
|
|
|
|
575
|
|
Washington
|
|
|
151
|
|
|
|
154
|
|
Other
|
|
|
618
|
|
|
|
500
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
$
|
38,202
|
|
|
$
|
29,019
|
|
|
|
|
|
|
|
|
|
|
82
MOLINA
HEALTHCARE, INC.
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
The increase in restricted investments at our Florida health
plan relates primarily to an escrow deposit that will be used
for the purpose of reimbursing the state of Florida for any sums
due under a final settlement agreement with the state, under our
purchase agreement with NetPASS, as discussed in Note 3,
Business Purchase Transactions.
The contractual maturities of our held-to-maturity restricted
investments as of December 31, 2008 are summarized below.
|
|
|
|
|
|
|
|
|
|
|
Amortized
|
|
|
Estimated
|
|
|
|
Cost
|
|
|
Fair Value
|
|
|
|
(In thousands)
|
|
|
Due in one year or less
|
|
$
|
33,485
|
|
|
$
|
33,485
|
|
Due one year through five years
|
|
|
4,572
|
|
|
|
4,572
|
|
Due after five years through ten years
|
|
|
145
|
|
|
|
145
|
|
Due after ten years
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
38,202
|
|
|
$
|
38,202
|
|
|
|
|
|
|
|
|
|
|
|
|
10.
|
Medical
Claims and Benefits Payable
|
The following table presents the components of the change in our
medical claims and benefits payable for the years ended
December 31, 2008 and 2007. The negative amounts displayed
for components of medical care costs related to prior
years represent the amount by which our original
estimate of claims and benefits payable at the beginning of the
period exceeded the actual amount of the liability based on
information (principally the payment of claims) developed since
that liability was first reported. The benefit of this prior
period development may be offset by the addition of a reserve
for adverse claims development when estimating the liability at
the end of the period (captured as components of
medical care costs related to current year).
|
|
|
|
|
|
|
|
|
|
|
Year Ended December 31,
|
|
|
|
2008
|
|
|
2007
|
|
|
|
(Dollars in thousands)
|
|
|
Balances at beginning of period
|
|
$
|
311,606
|
|
|
$
|
290,048
|
|
Medical claims and benefits payable from business acquired
|
|
|
|
|
|
|
14,876
|
|
Components of medical care costs related to:
|
|
|
|
|
|
|
|
|
Current year
|
|
|
2,683,399
|
|
|
|
2,136,381
|
|
Prior years
|
|
|
(62,087
|
)
|
|
|
(56,298
|
)
|
|
|
|
|
|
|
|
|
|
Total medical care costs
|
|
|
2,621,312
|
|
|
|
2,080,083
|
|
|
|
|
|
|
|
|
|
|
Payments for medical care costs related to:
|
|
|
|
|
|
|
|
|
Current year
|
|
|
2,413,128
|
|
|
|
1,851,035
|
|
Prior years
|
|
|
227,348
|
|
|
|
222,366
|
|
|
|
|
|
|
|
|
|
|
Total paid
|
|
|
2,640,476
|
|
|
|
2,073,401
|
|
|
|
|
|
|
|
|
|
|
Balances at end of period
|
|
$
|
292,442
|
|
|
$
|
311,606
|
|
|
|
|
|
|
|
|
|
|
Benefit from prior period as a percentage of:
|
|
|
|
|
|
|
|
|
Balance at beginning of period
|
|
|
19.9
|
%
|
|
|
19.4
|
%
|
Premium revenue
|
|
|
2.0
|
%
|
|
|
2.3
|
%
|
Total medical care costs
|
|
|
2.4
|
%
|
|
|
2.7
|
%
|
Days in claims payable
|
|
|
41
|
|
|
|
52
|
|
Number of members at end of period
|
|
|
1,256,000
|
|
|
|
1,149,000
|
|
83
MOLINA
HEALTHCARE, INC.
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
Convertible
Senior Notes
In October 2007, we completed our offering of
$200.0 million aggregate principal amount of
3.75% Convertible Senior Notes due 2014 (the
Notes). The sale of the Notes resulted in net
proceeds totaling $193.4 million. The Notes rank equally in
right of payment with our existing and future senior
indebtedness.
The Notes are convertible into cash and, under certain
circumstances, shares of our common stock. The initial
conversion rate is 21.3067 shares of our common stock per
one thousand dollar principal amount of the Notes. This
represents an initial conversion price of approximately $46.93
per share of our common stock. In addition, if certain corporate
transactions that constitute a change of control occur prior to
maturity, we will increase the conversion rate in certain
circumstances. Prior to July 2014, holders may convert their
Notes only under the following circumstances:
|
|
|
|
|
During any fiscal quarter after our fiscal quarter ending
December 31, 2008, if the closing sale price per share of
our common stock, for each of at least 20 trading days during
the period of 30 consecutive trading days ending on the last
trading day of the previous fiscal quarter, is greater than or
equal to 120% of the conversion price per share of our common
stock;
|
|
|
|
During the five business day period immediately following any
five consecutive trading day period in which the trading price
per one thousand dollar principal amount of the Notes for each
trading day of such period was less than 98% of the product of
the closing price per share of our common stock on such day and
the conversion rate in effect on such day; or
|
|
|
|
Upon the occurrence of specified corporate transactions or other
specified events.
|
On or after July 1, 2014, holders may convert their Notes
at any time prior to the close of business on the scheduled
trading day immediately preceding the stated maturity date
regardless of whether any of the foregoing conditions is
satisfied.
We will deliver cash and shares of our common stock, if any,
upon conversion of each $1,000 principal amount of Notes, as
follows:
|
|
|
|
|
An amount in cash (the principal return) equal to
the sum of, for each of the 20 Volume-Weighted Average Price
(VWAP) trading days during the conversion period, the lesser of
the daily conversion value for such VWAP trading day and fifty
dollars (representing 1/20th of one thousand
dollars); and
|
|
|
|
A number of shares based upon, for each of the 20 VWAP trading
days during the conversion period, any excess of the daily
conversion value above fifty dollars.
|
See Note 20, Subsequent Events, for a
discussion of our repurchase of a portion of the Notes.
As discussed in Note 2, Significant Account
Policies, the FASB issued FSP APB
14-1 in
2008. The impact of this new accounting guidance will result in
an increase to non-cash interest expense related to the Notes
beginning in fiscal year 2009 for financial statements covering
past and future periods.
Credit
Facility
In 2005, we entered into the Amended and Restated Credit
Agreement, dated as of March 9, 2005, among Molina
Healthcare Inc., certain lenders, and Bank of America N.A., as
Administrative Agent (the Credit Facility).
Effective May 2007, we entered into a third amendment of the
Credit Facility that increased the size of the revolving line of
credit from $180.0 million to $200.0 million, maturing
in May 2012. The Credit Facility is intended to be used for
working capital and general corporate purposes, and subject to
obtaining commitments from existing or new lenders and
satisfaction of other specified conditions, we may increase the
amount available under the Credit Facility to up to
$250.0 million.
84
MOLINA
HEALTHCARE, INC.
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
Interest rates on borrowings under the Credit Facility are
based, at our election, on the London Interbank Offered Rate, or
LIBOR, or the base rate plus an applicable margin. The base rate
equals the higher of Bank of Americas prime rate or 0.500%
above the federal funds rate. We also pay a commitment fee on
the total unused commitments of the lenders under the Credit
Facility. The applicable margins and commitment fee are based on
our ratio of consolidated funded debt to consolidated earnings
before interest expense, taxes, depreciation and amortization,
or EBITDA. The applicable margins range between 0.750% and
1.750% for LIBOR loans and between 0.000% and 0.750% for base
rate loans. The commitment fee ranges between 0.150% and 0.275%.
In addition, we are required to pay a fee for each letter of
credit issued under the Credit Facility equal to the applicable
margin for LIBOR loans and a customary fronting fee. As of
December 31, 2008 and 2007, there were no amounts
outstanding under the Credit Facility.
Our obligations under the Credit Facility are secured by a lien
on substantially all of our assets and by a pledge of the
capital stock of our health plan subsidiaries (with the
exception of our California health plan). The Credit Facility
includes usual and customary covenants for credit facilities of
this type, including covenants limiting liens, mergers, asset
sales, other fundamental changes, debt, acquisitions, dividends
and other distributions, capital expenditures, investments, and
a fixed charge coverage ratio. The Credit Facility also requires
us to maintain a ratio of total consolidated debt to total
consolidated EBITDA of not more than 2.75 to 1.00 at any time.
At December 31, 2008, we were in compliance with all
financial covenants in the Credit Facility.
The provision for income taxes consisted of the following:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended December 31,
|
|
|
|
2008
|
|
|
2007
|
|
|
2006
|
|
|
|
(In thousands)
|
|
|
Current:
|
|
|
|
|
|
|
|
|
|
|
|
|
Federal
|
|
$
|
32,972
|
|
|
$
|
36,171
|
|
|
$
|
24,987
|
|
State
|
|
|
6,916
|
|
|
|
3,073
|
|
|
|
3,143
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total current
|
|
|
39,888
|
|
|
|
39,244
|
|
|
|
28,130
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Deferred:
|
|
|
|
|
|
|
|
|
|
|
|
|
Federal
|
|
|
1,886
|
|
|
|
(3,630
|
)
|
|
|
(471
|
)
|
State
|
|
|
(281
|
)
|
|
|
(293
|
)
|
|
|
(578
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total deferred
|
|
|
1,605
|
|
|
|
(3,923
|
)
|
|
|
(1,049
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Change in valuation allowance
|
|
|
|
|
|
|
45
|
|
|
|
650
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total provision for income taxes
|
|
$
|
41,493
|
|
|
$
|
35,366
|
|
|
$
|
27,731
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
A reconciliation of the effective income tax rate to the
statutory federal income tax rate is as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended December 31,
|
|
|
|
2008
|
|
|
2007
|
|
|
2006
|
|
|
|
(In thousands)
|
|
|
Taxes on income at statutory federal tax rate (35%)
|
|
$
|
36,362
|
|
|
$
|
32,794
|
|
|
$
|
25,710
|
|
State income taxes, net of federal benefit
|
|
|
4,313
|
|
|
|
1,954
|
|
|
|
2,097
|
|
Other
|
|
|
818
|
|
|
|
618
|
|
|
|
(76
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Reported income tax expense
|
|
$
|
41,493
|
|
|
$
|
35,366
|
|
|
$
|
27,731
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Our effective tax rate is based on expected income, statutory
tax rates, and tax planning opportunities available to us in the
various jurisdictions in which we operate. Significant
management estimates and judgments are required
85
MOLINA
HEALTHCARE, INC.
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
in determining our effective tax rate. We are routinely under
audit by federal, state, or local authorities regarding the
timing and amount of deductions, nexus of income among various
tax jurisdictions, and compliance with federal, state, and local
tax laws. We have pursued various strategies to reduce our
federal, state and local taxes. As a result, we have reduced our
state income tax expense due to California enterprise zone
credits.
During 2008, 2007, and 2006, tax-related benefits (deficiencies)
on share-based compensation were $(292,000), $853,000 and
$1.2 million, respectively. Such amounts were recorded as
adjustments to income taxes payable with a corresponding
increase (decrease) to additional paid-in capital.
Deferred tax assets and liabilities are classified as current or
non-current according to the classification of the related asset
or liability. Significant components of our deferred tax assets
and liabilities as of December 31, 2008 and 2007 were as
follows:
|
|
|
|
|
|
|
|
|
|
|
December 31,
|
|
|
|
2008
|
|
|
2007
|
|
|
|
(In thousands)
|
|
|
Accrued expenses
|
|
$
|
6,785
|
|
|
$
|
6,335
|
|
Reserve liabilities
|
|
|
1,046
|
|
|
|
624
|
|
State taxes
|
|
|
172
|
|
|
|
911
|
|
Other accrued medical costs
|
|
|
1,724
|
|
|
|
863
|
|
Prepaid expenses
|
|
|
(3,979
|
)
|
|
|
(2,783
|
)
|
Net operating losses
|
|
|
27
|
|
|
|
27
|
|
Unrealized losses
|
|
|
(3,194
|
)
|
|
|
(165
|
)
|
Unearned premiums
|
|
|
2,063
|
|
|
|
2,806
|
|
Other, net
|
|
|
(41
|
)
|
|
|
|
|
Valuation allowance
|
|
|
|
|
|
|
(2
|
)
|
|
|
|
|
|
|
|
|
|
Deferred tax asset, net of valuation allowance
current
|
|
|
4,603
|
|
|
|
8,616
|
|
|
|
|
|
|
|
|
|
|
Net operating losses
|
|
|
971
|
|
|
|
856
|
|
State taxes
|
|
|
1,830
|
|
|
|
840
|
|
Depreciation and amortization
|
|
|
(10,698
|
)
|
|
|
(14,453
|
)
|
Deferred compensation
|
|
|
5,876
|
|
|
|
3,208
|
|
Other accrued medical costs
|
|
|
108
|
|
|
|
103
|
|
Reserve liabilities
|
|
|
1,684
|
|
|
|
885
|
|
Unrealized losses
|
|
|
4,667
|
|
|
|
|
|
Other, net
|
|
|
745
|
|
|
|
(882
|
)
|
Valuation allowance
|
|
|
(695
|
)
|
|
|
(693
|
)
|
|
|
|
|
|
|
|
|
|
Deferred tax asset (liability) net of valuation
allowance long term
|
|
|
4,488
|
|
|
|
(10,136
|
)
|
|
|
|
|
|
|
|
|
|
Net deferred income tax asset (liability)
|
|
$
|
9,091
|
|
|
$
|
(1,520
|
)
|
|
|
|
|
|
|
|
|
|
At December 31, 2008, we had federal and state net
operating loss carryforwards of $422,000 and $10.9 million,
respectively. The federal net operating loss begins expiring in
2011, and state net operating losses begin expiring in 2013. The
utilization of the net operating losses is subject to certain
limitations under federal and state law.
We have determined that as of both December 31, 2008, and
December 31, 2007, $695,000 of deferred tax assets did not
satisfy the recognition criteria set forth in SFAS 109.
Accordingly, a valuation allowance has been recorded for these
amounts. This valuation allowance primarily relates to the
uncertainty of realizing certain state
86
MOLINA
HEALTHCARE, INC.
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
net operating loss carryforwards. In the future, if we determine
that the realization of the net operating losses is more likely
than not, the reversal of the related valuation allowance will
reduce the provision for income taxes.
During 2008, $7.4 million of net deferred tax assets were
established with a corresponding reduction to goodwill for
certain acquired intangible assets in connection with the 2007
purchase of Mercy CarePlus. Additionally during 2008,
$2.2 million of deferred tax assets relating to the 2006
purchase of the Cape Health Plan were derecognized which
resulted in a corresponding increase to goodwill under purchase
accounting.
Accruals for uncertain tax positions are provided for in
accordance with the requirements of FIN 48. Pursuant to
FIN 48, tax benefits are recognized only if the tax
position is more likely than not of being sustained.
We are subject to income taxes in the U.S. and numerous
state jurisdictions. Significant judgment is required in
evaluating our tax positions and determining our provision for
income taxes. During the ordinary course of business, there are
many transactions and calculations for which the ultimate tax
determination is uncertain. We establish reserves for
tax-related uncertainties based on estimates of whether, and the
extent to which, additional taxes will be due. These reserves
are established when we believe that certain positions might be
challenged despite our belief that our tax return positions are
fully supportable. We adjust these reserves in light of changing
facts and circumstances, such as the outcome of tax audit. The
provision for income taxes includes the impact of reserve
provisions and changes to reserves that are considered
appropriate.
The roll forward of our unrecognized tax benefits is as follows
(in thousands):
|
|
|
|
|
Gross unrecognized tax benefits at December 31, 2007
|
|
$
|
(10,278
|
)
|
Increases in tax positions for prior years
|
|
|
(3,310
|
)
|
Decreases in tax positions for prior years
|
|
|
2,682
|
|
Increases in tax positions for current year
|
|
|
(2,061
|
)
|
Decreases in tax positions for current year
|
|
|
892
|
|
Settlements
|
|
|
|
|
Lapse in statute of limitations
|
|
|
399
|
|
|
|
|
|
|
Gross unrecognized tax benefits at December 31, 2008
|
|
$
|
(11,676
|
)
|
|
|
|
|
|
As of December 31, 2008, we had $11.7 million of
unrecognized tax benefits of which $5.8 million, if fully
recognized, would affect our effective tax rate. We anticipate a
decrease of $165,000 to our liability for unrecognized tax
benefits within the next twelve-month period due to normal
expiration of tax statutes.
Our continuing practice is to recognize interest
and/or
penalties related to unrecognized tax benefits in income tax
expense. As of December 31, 2008, and December 31,
2007, we had accrued $1.4 million and $638,000,
respectively, for the payment of interest and penalties.
We are under examination, or may be subject to examination, by
the Internal Revenue Service (IRS) for calendar
years 2005 through 2008. We are under examination, or may be
subject to examination, in certain state and local
jurisdictions, with the major jurisdictions being California,
Missouri, and Michigan, for the years 2004 through 2008. Our
subsidiary, HCLB, is being examined by the IRS for the year
ended May 2006. The IRS has issued a notice of proposed
adjustment to decrease HCLBs compensation deductions and
related tax loss for the year ended May 2006 by approximately
$16 million. If sustained, the reduction in the tax loss
would increase taxes payable by $5.4 million. Management
disagrees with the IRS assessment and believes that adequate
accruals have been provided for the HCLB examination.
We sponsor a defined contribution 401(k) plan that covers
substantially all full-time salaried and hourly employees of our
company and its subsidiaries. Eligible employees are permitted
to contribute up to the maximum amount allowed by law. We match
up to the first 4% of compensation contributed by employees.
Expense
87
MOLINA
HEALTHCARE, INC.
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
recognized in connection with our contributions to the 401(k)
plan totaled $3.9 million, $3.6 million and
$2.5 million in the years ended December 31, 2008,
2007, and 2006, respectively.
We also have a nonqualified deferred compensation plan for
certain key employees. Under this plan, eligible participants
may defer up to 100% of their base salary and 100% of their
bonus to provide tax-deferred growth for retirement. The funds
deferred are invested in corporate-owned life insurance, under a
rabbi trust.
|
|
14.
|
Related
Party Transactions
|
We have an equity investment in a medical service provider that
provides certain vision services to our members. We account for
this investment under the equity method of accounting because we
have an ownership interest in the investee that provides us with
significant influence over operating and financial policies of
the investee. As of December 31, 2008 and 2007, our
carrying amount for this investment totaled $3.6 million
and $3.5 million, respectively. During 2007, we paid this
provider a $0.9 million network access fee that was fully
amortized as of June 30, 2008. During 2008, we advanced
this provider $1.3 million, of which $417,000 remained
outstanding as of December 31, 2008. We expect to collect
this outstanding advance in the first quarter of 2009. For the
years ended December 31, 2008, 2007 and 2006, we paid
$15.4 million, $10.9 million, and $7.9 million,
respectively, for medical service fees to this provider.
We are a party to a fee-for-service agreement with Pacific
Hospital of Long Beach (Pacific Hospital). Pacific
Hospital is owned by Abrazos Healthcare, Inc., the shares of
which are held as community property by the husband of
Dr. Martha Bernadett, our Executive Vice President,
Research and Development. Amounts paid under the terms of this
fee-for-service agreement were $242,000, $157,000 and $357,000
for the years ended December 31, 2008, 2007 and 2006,
respectively. We also have a capitation arrangement with Pacific
Hospital, where we pay a fixed monthly fee based on member type.
We paid Pacific Hospital for capitation services totaling
approximately $3.8 million, $4.8 million and
$1.7 million for the years ended December 31, 2008,
2007 and 2006, respectively. We believe that both arrangements
with Pacific Hospital are based on prevailing market rates for
similar services. Also as of December 31, 2008, we had an
advance outstanding to Pacific Hospital totaling $23,000, which
will offset capitation payments in 2009.
|
|
15.
|
Commitments
and Contingencies
|
Leases
We lease office space, clinics, equipment, and automobiles under
agreements that expire at various dates through 2018. Future
minimum lease payments by year and in the aggregate under all
non-cancelable operating leases, including those payments
described in Note 14, Related Party
Transactions, consist of the following approximate amounts:
|
|
|
|
|
Year ending December 31,
|
|
(In thousands)
|
|
|
2009
|
|
$
|
15,514
|
|
2010
|
|
|
15,321
|
|
2011
|
|
|
14,883
|
|
2012
|
|
|
13,771
|
|
2013
|
|
|
11,954
|
|
Thereafter
|
|
|
40,867
|
|
|
|
|
|
|
Total minimum lease payments
|
|
$
|
112,310
|
|
|
|
|
|
|
Rental expense related to these leases totaled
$17.5 million, $18.1 million and $12.2 million
for the years ended December 31, 2008, 2007, and 2006,
respectively.
88
MOLINA
HEALTHCARE, INC.
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
Employment
Agreements
During 2001 and 2002, we entered into employment agreements with
three current executives with initial terms of one to three
years, subject to automatic one-year extensions thereafter. In
most cases, should the executive be terminated without cause or
resign for good reason before a Change of Control, as defined,
we will pay one years base salary and Target Bonus, as
defined, for the year of termination, in addition to full
vesting of 401(k) employer contributions and stock options, and
continued health and welfare benefits for the earlier of
18 months or the date the executive receives substantially
similar benefits from another employer. If any of the executives
are terminated for cause, no further payments are due under the
contracts.
In most cases, if termination occurs within two years following
a Change of Control, the employee will receive two times their
base salary and Target Bonus for the year of termination in
addition to full vesting of 401(k) employer contributions and
stock options and continued health and welfare benefits for the
earlier of three years or the date the executive receives
substantially similar benefits from another employer.
Executives who receive severance benefits, whether or not in
connection with a Change of Control, will also receive all
accrued benefits for prior service including a pro rata Target
Bonus for the year of termination.
Legal
Proceedings
The health care industry is subject to numerous laws and
regulations of federal, state, and local governments. Compliance
with these laws and regulations can be subject to government
review and interpretation, as well as regulatory actions unknown
and unasserted at this time. Penalties associated with
violations of these laws and regulations include significant
fines and penalties, exclusion from participating in
publicly-funded programs, and the repayment of previously billed
and collected revenues.
We are involved in legal actions in the ordinary course of
business, some of which seek monetary damages, including claims
for punitive damages, which are not covered by insurance. The
outcome of such legal actions is inherently uncertain.
Nevertheless, we believe that these actions, when finally
concluded and determined, are not likely to have a material
adverse effect on our consolidated financial position, results
of operations, or cash flows.
Professional
Liability Insurance
We carry medical malpractice insurance for health care services
rendered through our clinics in California. Claims-made coverage
under this policy is $1.0 million per occurrence with an
annual aggregate limit of $3.0 million for each of the
years ended December 31, 2008, 2007, and 2006. We also
carry claims-made managed care errors and omissions professional
liability insurance for our HMO operations. This insurance is
subject to a coverage limit of $10.0 million per occurrence
and $10.0 million in the aggregate for each policy year.
Provider
Claims
Many of our medical contracts are complex in nature and may be
subject to differing interpretations regarding amounts due for
the provision of various services. Such differing
interpretations may lead medical providers to pursue us for
additional compensation. The claims made by providers in such
circumstances often involve issues of contract compliance,
interpretation, payment methodology, and intent. These claims
often extend to services provided by the providers over a number
of years.
Various providers have contacted us seeking additional
compensation for claims that we believe to have been settled.
These matters, when finally concluded and determined, will not,
in our opinion, have a material adverse effect on our
consolidated financial position, results of operations, or cash
flows.
89
MOLINA
HEALTHCARE, INC.
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
Regulatory
Capital and Dividend Restrictions
Our principal operations are conducted through our health plan
subsidiaries operating in California, Florida, Michigan,
Missouri, Nevada, New Mexico, Ohio, Texas, Washington and Utah.
Our health plans are subject to state regulations that, among
other things, require the maintenance of minimum levels of
statutory capital, as defined by each state, and restrict the
timing, payment and amount of dividends and other distributions
that may be paid to us as the sole stockholder. To the extent
the subsidiaries must comply with these regulations, they may
not have the financial flexibility to transfer funds to us. The
net assets in these subsidiaries (after intercompany
eliminations) which may not be transferable to us in the form of
loans, advances or cash dividends was $355.0 million at
December 31, 2008, and $332.2 million at
December 31, 2007. The National Association of Insurance
Commissioners, or NAIC, adopted rules effective
December 31, 1998, which, if implemented by the states, set
new minimum capitalization requirements for insurance companies,
HMOs and other entities bearing risk for health care coverage.
The requirements take the form of risk-based capital (RBC)
rules. Michigan, Nevada, New Mexico, Ohio, Texas, Washington,
and Utah have adopted these rules, which may vary from state to
state. California has not yet adopted NAIC risk-based capital
requirements for HMOs and has not formally given notice of its
intention to do so. Such requirements, if adopted by California,
may increase the minimum capital required for that state.
As of December 31, 2008, our health plans had aggregate
statutory capital and surplus of approximately
$362.5 million compared with the required minimum aggregate
statutory capital and surplus of approximately
$211.1 million. All of our HMOs were in compliance with the
minimum capital requirements at December 31, 2008. We have
the ability and commitment to provide additional capital to each
of our health plans when necessary to ensure that statutory
capital and surplus continue to meet regulatory requirements.
In 2002, we adopted the 2002 Equity Incentive Plan (the
2002 Plan), which provides for the award of stock
options, restricted stock, performance shares, and stock bonuses
to the companys officers, employees, directors,
consultants, advisors, and other service providers. The 2002
Plan became effective upon our initial public offering
(IPO) of common stock in July 2003, and allowed for
the issuance of 1.6 million shares of common stock.
Beginning January 1, 2004, shares eligible for issuance
automatically increase by the lesser of 400,000 shares or
2% of total outstanding capital stock on a fully diluted basis,
unless the board of directors affirmatively acts to nullify the
automatic increase. There were 3.6 million shares reserved
for issuance under the 2002 Plan as of January 1, 2008.
Restricted stock awards are granted with a fair value equal to
the market price of our common stock on the date of grant, and
generally vest in equal annual installments over periods up to
five years from the date of grant. Stock option awards have an
exercise price equal to the fair market value of our common
stock on the date of grant, generally vest in equal annual
installments over periods up to four years from the date of
grant, and have a maximum term of ten years from the date of
grant.
In July 2002, we adopted the 2002 Employee Stock Purchase Plan
(the ESPP), which also became effective upon our IPO
in July 2003. During each six-month offering period, eligible
employees may purchase common shares at 85% of the lower of the
fair market value of our common stock on either the first or
last trading day of the offering period. Each participant is
limited to a maximum purchase of $25,000 (as measured by the
fair value of the stock acquired) per year through payroll
deductions. Under the ESPP, we issued 86,400 and
48,000 shares of our common stock during the years ended
December 31, 2008 and 2007, respectively. Beginning
January 1, 2004, and each year until the 2.2 million
maximum aggregate number of shares reserved for issuance is
reached, shares available for issuance under the ESPP
automatically increase by 1% of total outstanding capital stock.
The number of unissued common shares available for future grants
under the 2002 Plan and the ESPP was 3.9 million and
3.6 million as of December 31, 2008 and 2007,
respectively.
90
MOLINA
HEALTHCARE, INC.
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
The following table illustrates the components of our
stock-based compensation expense as reported in general and
administrative expenses in the consolidated statements of income:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended December 31,
|
|
|
|
2008
|
|
|
2007
|
|
|
2006
|
|
|
|
Pretax
|
|
|
Net-of-Tax
|
|
|
Pretax
|
|
|
Net-of-Tax
|
|
|
Pretax
|
|
|
Net-of-Tax
|
|
|
|
Charges
|
|
|
Amount
|
|
|
Charges
|
|
|
Amount
|
|
|
Charges
|
|
|
Amount
|
|
|
|
(In thousands)
|
|
|
Restricted stock awards
|
|
$
|
5,171
|
|
|
$
|
3,206
|
|
|
$
|
3,751
|
|
|
$
|
2,335
|
|
|
$
|
2,257
|
|
|
$
|
1,404
|
|
Stock options (including shares issued under our ESPP)
|
|
|
2,640
|
|
|
|
1,637
|
|
|
|
3,437
|
|
|
|
2,139
|
|
|
|
3,248
|
|
|
|
2,020
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
$
|
7,811
|
|
|
$
|
4,843
|
|
|
$
|
7,188
|
|
|
$
|
4,474
|
|
|
$
|
5,505
|
|
|
$
|
3,424
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For both restricted stock and stock option awards, the expense
is recognized over the vesting period, generally straight-line
over four years. As of December 31, 2008, there was
$14.2 million of unrecognized compensation cost related to
unvested restricted stock awards, which we expect to recognize
over a weighted-average period of 2.8 years. Also as of
December 31, 2008, there was $1.8 million of
unrecognized compensation expense related to unvested stock
options, which we expect to recognize over a weighted-average
period of 1.6 years.
The total fair value of restricted shares vested during the
years ended December 31, 2008, 2007, and 2006 was
$2.5 million, $2.6 million, and $2.0 million,
respectively. Unvested restricted stock activity for the year
ended December 31, 2008 was as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted-
|
|
|
|
|
|
|
Average Grant Date
|
|
|
|
Shares
|
|
|
Fair Value
|
|
|
Unvested balance as of December 31, 2007
|
|
|
235,413
|
|
|
$
|
34.14
|
|
Granted
|
|
|
392,000
|
|
|
$
|
30.96
|
|
Vested
|
|
|
(89,446
|
)
|
|
$
|
32.04
|
|
Forfeited
|
|
|
(67,012
|
)
|
|
$
|
33.75
|
|
|
|
|
|
|
|
|
|
|
Unvested balance as of December 31, 2008
|
|
|
470,955
|
|
|
$
|
31.95
|
|
|
|
|
|
|
|
|
|
|
The total intrinsic value of stock options exercised during the
years ended December 31, 2008, 2007, and 2006 amounted to
$69,000, $4.3 million, and $3.8 million, respectively.
Stock option activity for the year ended December 31, 2008
was as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted-
|
|
|
|
|
|
|
|
|
|
Weighted-
|
|
|
Average
|
|
|
Aggregate
|
|
|
|
|
|
|
Average
|
|
|
Remaining
|
|
|
Intrinsic
|
|
|
|
Number
|
|
|
Exercise
|
|
|
Contractual
|
|
|
Value
|
|
|
|
of Options
|
|
|
Price
|
|
|
Term (Years)
|
|
|
(000s)
|
|
|
Outstanding at December 31, 2007
|
|
|
733,713
|
|
|
$
|
30.45
|
|
|
|
|
|
|
|
|
|
Granted
|
|
|
12,000
|
|
|
$
|
33.57
|
|
|
|
|
|
|
|
|
|
Exercised
|
|
|
(18,987
|
)
|
|
$
|
27.85
|
|
|
|
|
|
|
|
|
|
Forfeited
|
|
|
(61,387
|
)
|
|
$
|
33.70
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Outstanding at December 31, 2008
|
|
|
665,339
|
|
|
$
|
30.29
|
|
|
|
6.9
|
|
|
$
|
87
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Exercisable and expected to vest at December 31, 2008(a)
|
|
|
638,532
|
|
|
$
|
30.21
|
|
|
|
6.8
|
|
|
$
|
87
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Exercisable at December 31, 2008
|
|
|
427,450
|
|
|
$
|
29.87
|
|
|
|
6.2
|
|
|
$
|
87
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(a) |
|
Stock options exercisable and expected to vest at
December 31, 2008 information is based on a forfeiture rate
of 12.9%. |
91
MOLINA
HEALTHCARE, INC.
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
The following is a summary of information about stock options
outstanding and exercisable at December 31, 2008:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Options Outstanding
|
|
|
Options Exercisable
|
|
|
|
Number
|
|
|
Weighted-
|
|
|
|
|
|
Number
|
|
|
|
|
|
|
Outstanding
|
|
|
Average
|
|
|
Weighted-
|
|
|
Exercisable
|
|
|
Weighted-
|
|
|
|
at
|
|
|
Remaining
|
|
|
Average
|
|
|
at
|
|
|
Average
|
|
|
|
December 31,
|
|
|
Contractual
|
|
|
Exercise
|
|
|
December 31,
|
|
|
Exercise
|
|
Range of Exercise Prices
|
|
2008
|
|
|
Life (Years)
|
|
|
Price
|
|
|
2008
|
|
|
Price
|
|
|
$4.50 - $27.49
|
|
|
164,170
|
|
|
|
5.0
|
|
|
$
|
23.11
|
|
|
|
161,053
|
|
|
$
|
23.08
|
|
$28.66 - $28.66
|
|
|
174,744
|
|
|
|
7.1
|
|
|
$
|
28.66
|
|
|
|
113,100
|
|
|
$
|
28.66
|
|
$29.17 - $30.85
|
|
|
12,700
|
|
|
|
7.3
|
|
|
$
|
30.12
|
|
|
|
7,682
|
|
|
$
|
29.97
|
|
$31.32 - $44.29
|
|
|
313,725
|
|
|
|
7.7
|
|
|
$
|
34.95
|
|
|
|
145,615
|
|
|
$
|
38.30
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
665,339
|
|
|
|
6.9
|
|
|
$
|
30.29
|
|
|
|
427,450
|
|
|
$
|
29.87
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
In the year ended December 31, 2008, a total of 12,000
stock options were granted. The Black-Scholes valuation model
was used to estimate the fair value of stock options at grant
date based on the assumptions noted in the following table. The
risk-free interest rate is based on the implied yield on
U.S. treasury zero coupon issues for the expected option
term. The expected volatility is based on historical volatility
levels of our common stock. Beginning in the first quarter of
2008, we used an expected term for each option award based on
historical experience of employee post-vesting exercise and
termination behavior. Prior to 2008, the expected option term of
each award granted was calculated using the simplified
method in accordance with Staff Accounting
Bulletin No. 107. This change did not produce
materially different valuation results for the stock options
awarded in 2008. The assumptions disclosed below represent a
weighted-average of the assumptions used for all of our stock
option grants throughout each of the years presented.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended December 31,
|
|
|
|
2008
|
|
|
2007
|
|
|
2006
|
|
|
Risk-free interest rate
|
|
|
2.5
|
%
|
|
|
4.5
|
%
|
|
|
4.5
|
%
|
Expected volatility
|
|
|
45.3
|
%
|
|
|
47.1
|
%
|
|
|
53.1
|
%
|
Expected option life (in years)
|
|
|
4
|
|
|
|
6
|
|
|
|
6
|
|
Expected dividend yield
|
|
|
0
|
%
|
|
|
0
|
%
|
|
|
0
|
%
|
Grant date weighted-average fair value
|
|
$
|
12.80
|
|
|
$
|
16.37
|
|
|
$
|
16.01
|
|
As described in Note 16, Stock Plans, we award
shares of restricted stock to employees and others under our
equity incentive plan. When these shares vest, employees may
choose to settle their associated tax obligation by instructing
us to withhold the number of shares that will settle the tax
obligation based on the current market value of the stock. When
we settle tax obligations associated with the vesting of
restricted stock awards in this manner, we retire the stock
used. During 2008, we retired 18,464 shares of common
stock, totaling $555,000. During 2007, we retired
14,391 shares of common stock, totaling $480,000.
In April 2008, our board of directors authorized the repurchase
of up to $30 million of our common stock on the open market
or through privately negotiated transactions. We used working
capital to fund the repurchases under this program. The timing
and amount of repurchases were primarily made pursuant to a
Rule 10b5-1
trading plan effective as of May 5, 2008, and terminated
when the aggregate cost of the repurchases totaled
$30 million on June 12, 2008. During the quarter ended
June 30, 2008, we repurchased approximately
1.1 million shares. These shares were subsequently retired
in 2008.
In July 2008, our board of directors authorized the repurchase
of up to an additional one million shares of our common stock.
We used working capital to fund the repurchases under this
program. The timing and amount of
92
MOLINA
HEALTHCARE, INC.
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
repurchases were primarily made pursuant to a
Rule 10b5-1
trading plan effective as of August 1, 2008. During the
third and fourth quarters of 2008, we repurchased approximately
812,000 shares for an aggregate purchase price of
$20 million. These shares were subsequently retired in 2008.
In December 2008, we filed a shelf registration statement on
Form S-3
with the Securities and Exchange Commission covering the
issuance of up to $300 million of securities, including
common stock or debt securities, and up to 250,000 shares
of our common stock, offered by selling stockholders. We may
publicly offer securities from time to time at prices and terms
to be determined at the time of the offering.
See Note 20, Subsequent Events, regarding our
share and convertible senior notes repurchase program that began
in 2009.
|
|
18.
|
Quarterly
Results of Operations (Unaudited)
|
The following is a summary of the quarterly results of
operations for the years ended December 31, 2008 and 2007.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For The Quarter Ended
|
|
|
|
March 31,
|
|
|
June 30,
|
|
|
September 30,
|
|
|
December 31,
|
|
|
|
2008
|
|
|
2008
|
|
|
2008
|
|
|
2008
|
|
|
|
(In thousands)
|
|
|
Premium revenue
|
|
$
|
729,638
|
|
|
$
|
761,153
|
|
|
$
|
791,554
|
|
|
$
|
808,895
|
|
Operating income
|
|
|
24,451
|
|
|
|
30,258
|
|
|
|
30,429
|
|
|
|
27,467
|
|
Income before income taxes
|
|
|
22,179
|
|
|
|
27,951
|
|
|
|
28,449
|
|
|
|
25,312
|
|
Net income
|
|
|
13,155
|
|
|
|
16,516
|
|
|
|
17,186
|
|
|
|
15,541
|
|
Net income per share(1):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic
|
|
$
|
0.46
|
|
|
$
|
0.59
|
|
|
$
|
0.63
|
|
|
$
|
0.58
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Diluted
|
|
$
|
0.46
|
|
|
$
|
0.59
|
|
|
$
|
0.62
|
|
|
$
|
0.58
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For The Quarter Ended
|
|
|
|
March 31,
|
|
|
June 30,
|
|
|
September 30,
|
|
|
December 31,
|
|
|
|
2007
|
|
|
2007
|
|
|
2007
|
|
|
2007
|
|
|
|
(In thousands)
|
|
|
Premium revenue
|
|
$
|
556,235
|
|
|
$
|
607,127
|
|
|
$
|
628,402
|
|
|
$
|
670,605
|
|
Operating income
|
|
|
16,595
|
|
|
|
22,284
|
|
|
|
28,815
|
|
|
|
30,633
|
|
Income before income taxes
|
|
|
15,470
|
|
|
|
21,559
|
|
|
|
28,285
|
|
|
|
28,382
|
|
Net income
|
|
|
9,592
|
|
|
|
13,314
|
|
|
|
17,513
|
|
|
|
17,911
|
|
Net income per share(1):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic
|
|
$
|
0.34
|
|
|
$
|
0.47
|
|
|
$
|
0.62
|
|
|
$
|
0.63
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Diluted
|
|
$
|
0.34
|
|
|
$
|
0.47
|
|
|
$
|
0.62
|
|
|
$
|
0.63
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1) |
|
Potentially dilutive shares issuable pursuant to the
Companys 2007 offering of convertible senior notes were
not included in the computation of diluted net income per share
because to do so would have been anti-dilutive for the years
ended December 31, 2008 and 2007. |
93
MOLINA
HEALTHCARE, INC.
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
|
|
19.
|
Condensed
Financial Information of Registrant
|
Following are our parent company only condensed balance sheets
as of December 31, 2008 and 2007, and our condensed
statements of income and condensed statements of cash flows for
each of the three years in the period ended December 31,
2008.
Condensed
Balance Sheets
|
|
|
|
|
|
|
|
|
|
|
December 31,
|
|
|
|
2008
|
|
|
2007
|
|
|
|
(In thousands except per-share data)
|
|
|
ASSETS
|
Current assets:
|
|
|
|
|
|
|
|
|
Cash and cash equivalents
|
|
$
|
42,776
|
|
|
$
|
36,286
|
|
Investments
|
|
|
9,745
|
|
|
|
61,970
|
|
Income tax receivable
|
|
|
3,119
|
|
|
|
|
|
Deferred income taxes
|
|
|
1,762
|
|
|
|
4,072
|
|
Due from affiliates
|
|
|
13,247
|
|
|
|
6,705
|
|
Prepaid and other current assets
|
|
|
10,228
|
|
|
|
9,234
|
|
|
|
|
|
|
|
|
|
|
Total current assets
|
|
|
80,877
|
|
|
|
118,267
|
|
Property and equipment, net
|
|
|
53,471
|
|
|
|
37,448
|
|
Goodwill
|
|
|
3,721
|
|
|
|
1,742
|
|
Investments
|
|
|
16,364
|
|
|
|
|
|
Investment in subsidiaries
|
|
|
568,224
|
|
|
|
548,931
|
|
Deferred income taxes
|
|
|
4,869
|
|
|
|
1,583
|
|
Advances to related parties and other assets
|
|
|
20,477
|
|
|
|
19,933
|
|
|
|
|
|
|
|
|
|
|
Total assets
|
|
$
|
748,003
|
|
|
$
|
727,904
|
|
|
|
|
|
|
|
|
|
|
|
LIABILITIES AND STOCKHOLDERS EQUITY
|
Current liabilities:
|
|
|
|
|
|
|
|
|
Accounts payable and accrued liabilities
|
|
$
|
24,595
|
|
|
$
|
29,222
|
|
Long-term debt
|
|
|
200,000
|
|
|
|
200,000
|
|
Other long-term liabilities
|
|
|
12,744
|
|
|
|
8,204
|
|
|
|
|
|
|
|
|
|
|
Total liabilities
|
|
|
237,339
|
|
|
|
237,426
|
|
|
|
|
|
|
|
|
|
|
Stockholders equity:
|
|
|
|
|
|
|
|
|
Common stock, $0.001 par value; 80,000 shares
authorized, outstanding 26,725 shares at December 31,
2008 and 28,444 shares at December 31, 2007
|
|
|
27
|
|
|
|
28
|
|
Preferred stock, $0.001 par value; 20,000 shares
authorized, no shares issued and outstanding
|
|
|
|
|
|
|
|
|
Paid-in capital
|
|
|
146,179
|
|
|
|
185,808
|
|
Accumulated other comprehensive gain (loss), net of tax
|
|
|
(2,310
|
)
|
|
|
272
|
|
Retained earnings
|
|
|
387,158
|
|
|
|
324,760
|
|
Treasury stock (1,201 shares, at cost)
|
|
|
(20,390
|
)
|
|
|
(20,390
|
)
|
|
|
|
|
|
|
|
|
|
Total stockholders equity
|
|
|
510,664
|
|
|
|
490,478
|
|
|
|
|
|
|
|
|
|
|
Total liabilities and stockholders equity
|
|
$
|
748,003
|
|
|
$
|
727,904
|
|
|
|
|
|
|
|
|
|
|
94
MOLINA
HEALTHCARE, INC.
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
Condensed
Statements of Income
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended December 31,
|
|
|
|
2008
|
|
|
2007
|
|
|
2006
|
|
|
|
(In thousands)
|
|
|
Revenue:
|
|
|
|
|
|
|
|
|
|
|
|
|
Management fees
|
|
$
|
190,361
|
|
|
$
|
154,071
|
|
|
$
|
120,036
|
|
Other operating revenue
|
|
|
177
|
|
|
|
186
|
|
|
|
144
|
|
Investment income
|
|
|
2,733
|
|
|
|
2,915
|
|
|
|
1,361
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total revenue
|
|
|
193,271
|
|
|
|
157,172
|
|
|
|
121,541
|
|
Expenses:
|
|
|
|
|
|
|
|
|
|
|
|
|
Medical care costs
|
|
|
21,759
|
|
|
|
22,042
|
|
|
|
20,764
|
|
General and administrative expenses
|
|
|
143,709
|
|
|
|
114,616
|
|
|
|
91,347
|
|
Depreciation and amortization
|
|
|
18,980
|
|
|
|
15,101
|
|
|
|
10,162
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total expenses
|
|
|
184,448
|
|
|
|
151,759
|
|
|
|
122,273
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating income (loss)
|
|
|
8,823
|
|
|
|
5,413
|
|
|
|
(732
|
)
|
Interest expense
|
|
|
(8,651
|
)
|
|
|
(4,485
|
)
|
|
|
(2,239
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income (loss) before income taxes and equity in net income of
subsidiaries
|
|
|
172
|
|
|
|
928
|
|
|
|
(2,971
|
)
|
Income tax expense (benefit)
|
|
|
1,260
|
|
|
|
2,333
|
|
|
|
(610
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net loss before equity in net income of subsidiaries
|
|
|
(1,088
|
)
|
|
|
(1,405
|
)
|
|
|
(2,361
|
)
|
Equity in net income of subsidiaries
|
|
|
63,486
|
|
|
|
59,735
|
|
|
|
48,088
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income
|
|
$
|
62,398
|
|
|
$
|
58,330
|
|
|
$
|
45,727
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
95
MOLINA
HEALTHCARE, INC.
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
Condensed
Statements of Cash Flows
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended December 31,
|
|
|
|
2008
|
|
|
2007
|
|
|
2006
|
|
|
|
(In thousands)
|
|
|
Operating activities:
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash provided by operating activities
|
|
$
|
17,532
|
|
|
$
|
23,500
|
|
|
$
|
24,205
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Investing activities:
|
|
|
|
|
|
|
|
|
|
|
|
|
Net dividends from and capital contributions to subsidiaries
|
|
|
42,872
|
|
|
|
(16,890
|
)
|
|
|
(51,260
|
)
|
Purchases of investments
|
|
|
(25,515
|
)
|
|
|
(74,604
|
)
|
|
|
(20,613
|
)
|
Sales and maturities of investments
|
|
|
56,833
|
|
|
|
29,946
|
|
|
|
29,181
|
|
Cash paid in business purchase transactions
|
|
|
(1,000
|
)
|
|
|
(80,045
|
)
|
|
|
|
|
Purchases of equipment
|
|
|
(33,047
|
)
|
|
|
(20,159
|
)
|
|
|
(17,723
|
)
|
Changes in amounts due to and due from affiliates
|
|
|
(6,542
|
)
|
|
|
2,887
|
|
|
|
5,684
|
|
Change in other assets and liabilities
|
|
|
3,170
|
|
|
|
1,192
|
|
|
|
(2,996
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net cash provided by (used in) investing activities
|
|
|
36,771
|
|
|
|
(157,673
|
)
|
|
|
(57,727
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Financing activities:
|
|
|
|
|
|
|
|
|
|
|
|
|
Treasury stock purchases
|
|
|
(49,940
|
)
|
|
|
|
|
|
|
|
|
Borrowings under credit facility
|
|
|
|
|
|
|
|
|
|
|
50,000
|
|
Proceeds from issuance of convertible senior notes
|
|
|
|
|
|
|
200,000
|
|
|
|
|
|
Repayments of amounts borrowed under credit facility
|
|
|
|
|
|
|
(45,000
|
)
|
|
|
(5,000
|
)
|
Payment of credit facility fees
|
|
|
|
|
|
|
(551
|
)
|
|
|
(459
|
)
|
Payment of convertible senior notes fees
|
|
|
|
|
|
|
(6,498
|
)
|
|
|
|
|
Excess tax benefits from employee stock compensation
|
|
|
43
|
|
|
|
853
|
|
|
|
1,227
|
|
Proceeds from exercise of stock options and employee stock plan
purchases
|
|
|
2,084
|
|
|
|
4,257
|
|
|
|
2,416
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net cash (used in) provided by financing activities
|
|
|
(47,813
|
)
|
|
|
153,061
|
|
|
|
48,184
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net increase in cash and cash equivalents
|
|
|
6,490
|
|
|
|
18,888
|
|
|
|
14,662
|
|
Cash and cash equivalents at beginning of year
|
|
|
36,286
|
|
|
|
17,398
|
|
|
|
2,736
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash and cash equivalents at end of year
|
|
$
|
42,776
|
|
|
$
|
36,286
|
|
|
$
|
17,398
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
96
MOLINA
HEALTHCARE, INC.
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
Notes to
Condensed Financial Information of Registrant
|
|
Note A
|
Basis of
Presentation
|
Molina Healthcare, Inc. (Registrant) was incorporated on
July 24, 2002. Prior to that date, Molina Healthcare of
California (formerly known as Molina Medical Centers) operated
as a California HMO and as the parent company for Molina
Healthcare of Utah, Inc. and Molina Healthcare of Michigan, Inc.
In June 2003, the employees and operations of the corporate
entity were transferred from Molina Healthcare of California to
the Registrant.
The Registrants investment in subsidiaries is stated at
cost plus equity in undistributed earnings of subsidiaries since
the date of acquisition. The parent company-only financial
statements should be read in conjunction with the consolidated
financial statements and accompanying notes.
|
|
Note B
|
Transactions
with Subsidiaries
|
The Registrant provides certain centralized medical and
administrative services to its subsidiaries pursuant to
administrative services agreements, including medical affairs
and quality management, health education, credentialing,
management, financial, legal, information systems and human
resources services. Fees are based on the fair market value of
services rendered and are recorded as operating revenue. Payment
is subordinated to the subsidiaries ability to comply with
minimum capital and other restrictive financial requirements of
the states in which they operate. Charges in 2008, 2007, and
2006 for these services totaled $190.4 million,
$154.1 million, and $120.0 million, respectively,
which are included in operating revenue.
The Registrant and its subsidiaries are included in the
consolidated federal and state income tax returns filed by the
Registrant. Income taxes are allocated to each subsidiary in
accordance with an intercompany tax allocation agreement. The
agreement allocates income taxes in an amount generally
equivalent to the amount which would be expensed by the
subsidiary if it filed a separate tax return. Net operating loss
benefits are paid to the subsidiary by the Registrant to the
extent such losses are utilized in the consolidated tax returns.
|
|
Note C
|
Capital
Contribution and Dividends
|
During 2008, 2007, and 2006, the Registrant received dividends
from its subsidiaries totaling $91.5 million,
$39.0 million, and $22.5 million, respectively. Such
amounts have been recorded as a reduction to the investments in
the respective subsidiaries.
During 2008, 2007, and 2006, the Registrant made capital
contributions to certain subsidiaries totaling
$48.6 million, $55.9 million, and $73.8 million,
respectively, primarily to comply with minimum net worth
requirements and to fund contract acquisitions. Such amounts
have been recorded as an increase in investment in the
respective subsidiaries.
|
|
Note D
|
Related
Party Transactions
|
The Registrant has an equity investment in a medical service
provider that provides certain vision services to its members.
The Registrant accounts for this investment under the equity
method of accounting because it has an ownership interest in the
investee in excess of 20%. As of December 31, 2008 and
2007, the Registrants carrying amount for this investment
totaled $3.6 million and $3.5 million, respectively.
During 2007, the Registrant paid this provider a
$0.9 million network access fee that was fully amortized as
of June 30, 2008. During 2008, the Registrant advanced this
provider $1.3 million, of which $417,000 remained
outstanding as of December 31, 2008. We expect to collect
this outstanding advance in the first quarter of 2009. For the
years ended December 31, 2008, 2007, and 2006, the
Registrant paid $15.4 million, $10.9 million, and
$7.9 million, respectively, for medical service fees to
this provider.
The Registrant is a party to a fee-for-service agreement with
Pacific Hospital of Long Beach (Pacific Hospital).
Pacific Hospital is owned by Abrazos Healthcare, Inc., the
shares of which are held as community
97
MOLINA
HEALTHCARE, INC.
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
property by the husband of Dr. Martha Bernadett, the
Registrants Executive Vice President, Research and
Development. Amounts paid under the terms of this
fee-for-service agreement were $242,000, $157,000, and $357,000
for the years ended December 31, 2008, 2007, and 2006,
respectively. The Registrant also has a capitation arrangement
with Pacific Hospital, where the Registrant pays a fixed monthly
fee based on member type. The Registrant paid Pacific Hospital
for capitation services totaling approximately
$3.8 million, $4.8 million and $1.7 million for
the years ended December 31, 2008, 2007, and 2006,
respectively. The Registrant believes that both arrangements
with Pacific Hospital are based on prevailing market rates for
similar services. Also as of December 31, 2008, the
Registrant had an advance outstanding to this provider totaling
$23,000 which will be offset to capitation payments in 2009.
Note 20. Subsequent
Events
In January 2009, the board of directors authorized the
repurchase of up to $25 million in aggregate of either our
common stock or our 3.75% convertible senior notes due 2014. The
repurchase program will be funded with working capital, and
repurchases may be made from time to time on the open market or
through privately negotiated transactions. The repurchase
program extends through June 30, 2009, but we reserve the
right to suspend or discontinue the program at any time.
Under this program, we settled the repurchase of
$13.0 million face amount of our convertible senior notes
on February 18, 2009 (see Note 11, Long-Term
Debt for a description of the Notes). We repurchased the
notes at an average price of $74.25 per $100 principal amount,
for a total of $9.6 million. Including accrued interest of
approximately $186,000, our total payment was $9.8 million.
Also under this program, we repurchased approximately
724,000 shares of our common stock for an aggregate
purchase price of $13.3 million (average cost of
approximately $18.33 per share) during the period beginning
February 27, 2009, through March 13, 2009. As of
March 13, 2009, we had $1.7 million remaining to spend
under this repurchase program. If we were to repurchase shares
at an average cost of $20 per share, for example, this
would result in the repurchase of approximately 85,000
additional shares.
On March 1, 2009 we awarded 364,700 shares of restricted
stock to our officers and employees, primarily in connection
with an annual recognition program. These shares will vest in
equal annual installments over the four-year period following
the date of grant.
98
|
|
Item 9.
|
Changes
in and Disagreements with Accountants on Accounting and
Financial Disclosures
|
None.
|
|
Item 9A.
|
Controls
and Procedures
|
Disclosure Controls and Procedures: Our
management is responsible for establishing and maintaining
effective internal control over financial reporting as defined
in
Rules 13a-15(f)
and
15d-15(f)
under the Securities Exchange Act of 1934 (the Exchange
Act). Our internal control over financial reporting is
designed to provide reasonable assurance to our management and
board of directors regarding the preparation and fair
presentation of published financial statements. We maintain
controls and procedures designed to ensure that we are able to
collect the information we are required to disclose in the
reports we file with the Securities and Exchange Commission, and
to process, summarize and disclose this information within the
time periods specified in the rules of the Securities and
Exchange Commission.
Evaluation of Disclosure Controls and
Procedures: Our management, with the
participation of our Chief Executive Officer and our Chief
Financial Officer, has conducted an evaluation of the design and
operation of our disclosure controls and procedures
(as defined in
Rules 13a-15(e)
and
15d-15(e)
under the Exchange Act. Based on this evaluation, our Chief
Executive Officer and our Chief Financial Officer have concluded
that our disclosure controls and procedures are effective as of
the end of the period covered by this report to ensure that
information required to be disclosed in the reports that we file
or submit under the Exchange Act is recorded, processed,
summarized and reported within the time periods specified in the
Securities and Exchange Commissions rules and forms.
Because of its inherent limitations, internal control over
financial reporting may not prevent or detect misstatements.
Therefore, even those systems determined to be effective can
provide only reasonable assurance with respect to financial
statement preparation and presentation.
Changes in Internal Controls: There were no
changes in our internal control over financial reporting during
the three months ended December 31, 2008 that have
materially affected, or are reasonably likely to materially
affect, our internal controls over financial reporting.
Managements Report on Internal Control over Financial
Reporting: Management of the Company is responsible for
establishing and maintaining adequate internal control over
financial reporting, as such term is defined in
Rule 13a-15(f)
under the Exchange Act. The Companys internal control over
financial reporting is designed to provide reasonable assurance
regarding the reliability of financial reporting and the
preparation of financial statements for external purposes in
accordance with generally accepted accounting principles in the
United States. However, all internal control systems, no matter
how well designed, have inherent limitations. Therefore, even
those systems determined to be effective can provide only
reasonable assurance with respect to financial statement
preparation and reporting.
Management assessed the effectiveness of the Companys
internal control over financial reporting as of
December 31, 2008. In making this assessment, management
used the criteria set forth by the Committee of Sponsoring
Organizations of the Treadway Commission (COSO) in
Internal Control-Integrated Framework. Based
on our assessment, management believes that the Company
maintained effective internal control over financial reporting
as of December 31, 2008, based on those criteria.
The effectiveness of the Companys internal control over
financial reporting has been audited by Ernst & Young
LLP, an independent registered public accounting firm, as stated
in their report appearing on the page immediately following,
which expresses an unqualified opinion on the effectiveness of
the Companys internal control over financial reporting as
of December 31, 2008.
|
|
Item 9B.
|
Other
Information
|
None.
99
REPORT OF
INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
The Board of Directors and Stockholders
of Molina Healthcare, Inc.
We have audited Molina Healthcare, Inc.s (the
Companys) internal control over financial
reporting as of December 31, 2008, based on criteria
established in Internal Control Integrated
Framework issued by the Committee of Sponsoring
Organizations of the Treadway Commission (the COSO criteria).
The Companys management is responsible for maintaining
effective internal control over financial reporting, and for its
assessment of the effectiveness of internal control over
financial reporting included in the accompanying
managements report on internal control over financial
reporting. Our responsibility is to express an opinion on the
Companys internal control over financial reporting based
on our audit.
We conducted our audit in accordance with the standards of the
Public Company Accounting Oversight Board (United States). Those
standards require that we plan and perform the audit to obtain
reasonable assurance about whether effective internal control
over financial reporting was maintained in all material
respects. Our audit included obtaining an understanding of
internal control over financial reporting, assessing the risk
that a material weakness exists, testing and evaluating the
design and operating effectiveness of internal control based on
the assessed risk, and performing such other procedures as we
considered necessary in the circumstances. We believe that our
audit provides a reasonable basis for our opinion.
A companys internal control over financial reporting is a
process designed to provide reasonable assurance regarding the
reliability of financial reporting and the preparation of
financial statements for external purposes in accordance with
generally accepted accounting principles. A companys
internal control over financial reporting includes those
policies and procedures that (1) pertain to the maintenance
of records that, in reasonable detail, accurately and fairly
reflect the transactions and dispositions of the assets of the
company; (2) provide reasonable assurance that transactions
are recorded as necessary to permit preparation of financial
statements in accordance with generally accepted accounting
principles, and that receipts and expenditures of the company
are being made only in accordance with authorizations of
management and directors of the company; and (3) provide
reasonable assurance regarding prevention or timely detection of
unauthorized acquisition, use, or disposition of the
companys assets that could have a material effect on the
financial statements.
Because of its inherent limitations, internal control over
financial reporting may not prevent or detect misstatements.
Also, projections of any evaluation of effectiveness to future
periods are subject to the risk that controls may become
inadequate because of changes in conditions, or that the degree
of compliance with the policies or procedures may deteriorate.
In our opinion, Molina Healthcare, Inc. maintained, in all
material respects, effective internal control over financial
reporting as of December 31, 2008, based on the COSO
criteria.
We also have audited, in accordance with the standards of the
Public Company Accounting Oversight Board (United States), the
consolidated balance sheets of Molina Healthcare, Inc. as of
December 31, 2008 and 2007, and the related consolidated
statements of income, stockholders equity, and cash flows
for each of the three years in the period ended
December 31, 2008 and our report dated March 16, 2008
expressed an unqualified opinion thereon.
Los Angeles, California
March 16, 2009
100
PART III
|
|
Item 10.
|
Directors,
Executive Officers, and Corporate Governance
|
|
|
(a)
|
Directors
of the Registrant
|
Information concerning our directors will appear in our Proxy
Statement for our 2009 Annual Meeting of Stockholders under
Proposal No. 1 Election of Two
Class I Directors. This portion of the Proxy
Statement is incorporated herein by reference.
|
|
(b)
|
Executive
Officers of the Registrant
|
Pursuant to General Instruction G(3) to
Form 10-K
and Instruction 3 to Item 401(b) of
Regulation S-K,
information regarding our executive officers is provided in
Item 4 of Part I of this Annual Report on
Form 10-K
under the caption Executive Officers, and will also
appear in our Proxy Statement for our 2009 Annual Meeting of
Stockholders. Such portion of the Proxy Statement is
incorporated herein by reference.
Information concerning certain corporate governance matters will
appear in our Proxy Statement for our 2009 Annual Meeting of
Stockholders under Corporate Governance,
Corporate Governance and Nominating Committee,
Corporate Governance Guidelines, and Code of
Business Conduct and Ethics. These portions of our Proxy
Statement are incorporated herein by reference.
|
|
(d)
|
Section 16(a) Beneficial
Ownership Reporting Compliance
|
Section 16(a) of the Exchange Act requires our officers and
directors, and persons who own more than 10% of a registered
class of our equity securities, to file reports of ownership and
changes in ownership with the SEC, and to furnish us with copies
of the forms. Purchases and sales of our equity securities by
such persons are published on our website at
www.molinahealthcare.com. Based on our review of the
copies of such reports, on our involvement in assisting our
reporting persons with such filings, and on written
representations from our reporting persons, we believe that,
during 2008, each of our officers, directors, and greater than
ten percent stockholders complied with all such filing
requirements on a timely basis, with the single exception of one
Form 4 for our chief information officer, Amir Desai, which
due to an oversight we filed on August 18, 2008 with
respect to a sale of 645 shares on July 28, 2008.
|
|
Item 11.
|
Executive
Compensation
|
The information which will appear in our Proxy Statement for our
2009 Annual Meeting under the captions Compensation
Committee Interlocks, Non-Employee Director
Compensation, and Compensation Discussion and
Analysis, is incorporated herein by reference. The
information which will appear in our Proxy Statement under the
caption Compensation Committee Report is not
incorporated herein by reference.
|
|
Item 12.
|
Security
Ownership of Certain Beneficial Owners and Management and
Related Stockholder Matters
|
Information concerning the security ownership of certain
beneficial owners and management will appear in our Proxy
Statement for our 2009 Annual Meeting of Stockholders under
Information About Stock Ownership. This portion of
the Proxy Statement is incorporated herein by reference. The
information required by this item regarding our equity
compensation plans is set forth in Part II, Item 5 of
this report and incorporated herein by reference.
|
|
Item 13.
|
Certain
Relationships and Related Transactions, and Director
Independence
|
Information concerning certain relationships and related
transactions will appear in our Proxy Statement for our 2009
Annual Meeting of Stockholders under Related Party
Transactions. Information concerning director
101
independence will appear in our Proxy Statement under
Director Independence. These portions of our Proxy
Statement are incorporated herein by reference.
|
|
Item 14.
|
Principal
Accountant Fees and Services
|
Information concerning principal accountant fees and services
will appear in our Proxy Statement for our 2009 Annual Meeting
of Stockholders under Disclosure of Auditor Fees.
This portion of our Proxy Statement is incorporated herein by
reference.
PART IV
|
|
Item 15.
|
Exhibits
and Financial Statement Schedules
|
(a) The consolidated financial statements and exhibits
listed below are filed as part of this report.
(1) The Companys consolidated financial
statements, the notes thereto and the report of the Independent
Registered Public Accounting Firm are on pages 60 through 98 of
this Annual Report on
Form 10-K
and are incorporated by reference.
|
Report of Independent Registered Public Accounting Firm
|
Consolidated Balance Sheets At December 31,
2008 and 2007
|
Consolidated Statements of Operations Years ended
December 31, 2008, 2007, and 2006
|
Consolidated Statements of Stockholders Equity
Years ended December 31, 2008, 2007, and 2006
|
Consolidated Statements of Cash Flows Years ended
December 31, 2008, 2007, and 2006
|
Notes to Consolidated Financial Statements
|
(2) Financial Statement Schedules
None of the schedules apply, or the information required is
included in the Notes to the Consolidated Financial Statements.
(3) Exhibits
Reference is made to the accompanying Index to Exhibits.
102
SIGNATURES
Pursuant to the requirements of Section 13 or 15(d) of the
Securities Exchange Act of 1934, as amended, the undersigned
registrant has duly caused this report to be signed on its
behalf by the undersigned, thereunto duly authorized, on the
16th day
of March, 2009.
MOLINA HEALTHCARE, INC.
|
|
|
|
By:
|
/s/ Joseph
M. Molina, M.D.
|
Joseph M. Molina, M.D.
Chief Executive Officer
(Principal Executive Officer)
Pursuant to the requirements of the Securities Exchange Act of
1934, as amended, this report has been signed below by the
following persons on behalf of the registrant and in the
capacities and on the dates indicated.
|
|
|
|
|
|
|
Signature
|
|
Title
|
|
Date
|
|
|
|
|
|
|
/s/ Joseph
M. Molina, M.D.
Joseph
M. Molina, M.D.
|
|
Chairman of the Board, Chief Executive Officer, and President
(Principal Executive Officer)
|
|
March 16, 2009
|
|
|
|
|
|
/s/ John
C. Molina, J.D.
John
C. Molina, J.D.
|
|
Director, Chief Financial Officer, and Treasurer (Principal
Financial Officer)
|
|
March 16, 2009
|
|
|
|
|
|
/s/ Joseph
W. White, CPA, MBA
Joseph
W. White, CPA, MBA
|
|
Chief Accounting Officer (Principal Accounting Officer)
|
|
March 16, 2009
|
|
|
|
|
|
/s/ Charles
Z. Fedak, CPA, MBA
Charles
Z. Fedak, CPA, MBA
|
|
Director
|
|
March 16, 2009
|
|
|
|
|
|
/s/ Frank
E. Murray, M.D.
Frank
E. Murray, M.D.
|
|
Director
|
|
March 16, 2009
|
|
|
|
|
|
/s/ Steven
Orlando, CPA
Steven
Orlando, CPA
|
|
Director
|
|
March 16, 2009
|
|
|
|
|
|
/s/ Sally
K. Richardson
Sally
K. Richardson
|
|
Director
|
|
March 16, 2009
|
|
|
|
|
|
/s/ Ronna
Romney
Ronna
Romney
|
|
Director
|
|
March 16, 2009
|
|
|
|
|
|
/s/ John
P. Szabo, Jr.
John
P. Szabo, Jr.
|
|
Director
|
|
March 16, 2009
|
103
INDEX TO
EXHIBITS
|
|
|
|
|
|
|
Number
|
|
Description
|
|
Method of Filing
|
|
|
3
|
.1
|
|
Certificate of Incorporation
|
|
Filed as Exhibit 3.2 to registrants Registration
Statement on
Form S-1
filed December 30, 2002.
|
|
3
|
.2
|
|
Amended and Restated Bylaws
|
|
Filed as Exhibit 3.2 to registrants
Form 8-K
filed February 17, 2009.
|
|
4
|
.1
|
|
Indenture dated as of October 11, 2008
|
|
Filed as Exhibit 4.1 to registrants
Form 8-K
filed October 5, 2008.
|
|
4
|
.2
|
|
First Supplemental Indenture dated as of October 11, 2008
|
|
Filed as Exhibit 4.2 to registrants
Form 8-K
filed October 5, 2008.
|
|
4
|
.3
|
|
Global Form of 3.75% Convertible Senior Note due 2014
|
|
Filed as Exhibit 4.3 to registrants
Form 8-K
filed October 5, 2008.
|
|
10
|
.1
|
|
2000 Omnibus Stock and Incentive Plan
|
|
Filed as Exhibit 10.12 to registrants
Form S-1
filed December 30, 2002.
|
|
10
|
.2
|
|
2002 Equity Incentive Plan
|
|
Filed as Exhibit 10.13 to registrants
Form S-1
filed December 30, 2002.
|
|
10
|
.3
|
|
Form of Stock Option Agreement under 2002 Equity Incentive Plan
|
|
Filed as Exhibit 10.3 to registrants
Form 10-K
filed March 14, 2007.
|
|
10
|
.4
|
|
2002 Employee Stock Purchase Plan
|
|
Filed as Exhibit 10.14 to registrants
Form S-1
filed December 30, 2002.
|
|
10
|
.5
|
|
2005 Molina Deferred Compensation Plan adopted November 6, 2006
|
|
Filed as Exhibit 10.4 to registrants
Form 10-Q
filed November 9, 2006.
|
|
10
|
.6
|
|
2005 Incentive Compensation Plan
|
|
Filed as Appendix A to registrants Proxy Statement
filed March 28, 2005.
|
|
10
|
.7
|
|
Form of Restricted Stock Award Agreement (Executive Officer)
under Molina Healthcare, Inc. 2002 Equity Incentive Plan
|
|
Filed as Exhibit 10.1 to registrants
Form 10-Q
filed August 9, 2005.
|
|
10
|
.8
|
|
Form of Restricted Stock Award Agreement (Outside Director)
under Molina Healthcare, Inc. 2002 Equity Incentive Plan
|
|
Filed as Exhibit 10.1 to registrants
Form 10-Q
filed August 9, 2005.
|
|
10
|
.9
|
|
Form of Restricted Stock Award Agreement (Employee) under Molina
Healthcare, Inc. 2002 Equity Incentive Plan
|
|
Filed as Exhibit 10.1 to registrants
Form 10-Q
filed August 9, 2005.
|
|
10
|
.10
|
|
Employment Agreement with J. Mario Molina, M.D. dated
January 2, 2002
|
|
Filed as Exhibit 10.7 to registrants
Form S-1
filed December 30, 2002.
|
|
10
|
.11
|
|
Amendment to Employment Agreement with J. Mario Molina dated
July 1, 2006
|
|
Filed as Exhibit 10.2 to registrants
Form 10-Q
filed August 8, 2006.
|
|
10
|
.12
|
|
Employment Agreement with John C. Molina dated January 1, 2002
|
|
Filed as Exhibit 10.8 to registrants
Form S-1
filed December 30, 2002.
|
|
10
|
.13
|
|
Employment Agreement with Mark L. Andrews dated December 1, 2001
|
|
Filed as Exhibit 10.9 to registrants
Form S-1
filed December 30, 2002.
|
|
10
|
.14
|
|
Change in Control Agreement dated June 15, 2006 with Terry Bayer
|
|
Filed as Exhibit 10.1 to registrants
Form 8-K
filed June 16, 2006.
|
|
10
|
.15
|
|
Change in Control Agreement dated May 29, 2008 with James W.
Howatt, M.D.
|
|
Filed as Exhibit 10.1 to registrants
Form 8-K
filed May 30, 2007.
|
|
10
|
.16
|
|
Change in Control Agreement dated March 1, 2008 with Joseph White
|
|
Filed as Exhibit 10.15 to registrants
Form 10-K
filed March 17, 2008.
|
|
10
|
.17
|
|
Form of Indemnification Agreement
|
|
Filed as Exhibit 10.14 to registrants
Form 10-K
filed March 14, 2007.
|
|
10
|
.18
|
|
Amended and Restated Credit Agreement, dated as of March 9,
2005, among Molina Healthcare, Inc., as the Borrower, certain
lenders, and Bank of America, N.A., as Administrative Agent
|
|
Filed as Exhibit 10.1 to registrants current report
on
Form 8-K
filed March 10, 2005.
|
|
|
|
|
|
|
|
Number
|
|
Description
|
|
Method of Filing
|
|
|
10
|
.19
|
|
First Amendment and Waiver to the Amended and Restated Credit
Agreement, dated as of October 5, 2005, among Molina Healthcare,
Inc., certain lenders, and Bank of America, N.A., as
Administrative Agent
|
|
Filed as Exhibit 10.1 to registrants current report
on
Form 8-K
filed October 13, 2005.
|
|
10
|
.20
|
|
Second Amendment and Waiver to the Amended and Restated Credit
Agreement, dated as of November 6, 2006, among Molina
Healthcare, Inc., certain lenders, and Bank of America, N.A., as
Administrative Agent
|
|
Filed as Exhibit 10.1 to registrants
Form 10-Q
filed November 9, 2006.
|
|
10
|
.21
|
|
Third Amendment and Waiver to the Amended and Restated Credit
Agreement, dated as of May 25, 2008, among Molina Healthcare,
Inc., certain lenders, and Bank of America, N.A., as
Administrative Agent
|
|
Filed as Exhibit 10.1 to registrants
Form 8-K
filed May 31, 2008.
|
|
10
|
.22
|
|
Office Lease with Pacific Towers Associates for 200 Oceangate
Corporate Headquarters.
|
|
Filed as Exhibit 10.34 to registrants
Form 10-K
filed March 17, 2008.
|
|
12
|
.1
|
|
Computation of Ratio of Earnings to Fixed Charges
|
|
Filed herewith.
|
|
21
|
.1
|
|
List of subsidiaries
|
|
Filed herewith.
|
|
23
|
.1
|
|
Consent of Independent Registered Public Accounting Firm
|
|
Filed herewith.
|
|
31
|
.1
|
|
Section 302 Certification of Chief Executive Officer
|
|
Filed herewith.
|
|
31
|
.2
|
|
Section 302 Certification of Chief Financial Officer
|
|
Filed herewith.
|
|
32
|
.1
|
|
Certificate of Chief Executive Officer pursuant to
18 U.S.C. Section 1350, as adopted pursuant to Section 906
of the Sarbanes-Oxley Act of 2002.
|
|
Filed herewith.
|
|
32
|
.2
|
|
Certificate of Chief Financial Officer pursuant to
18 U.S.C. Section 1350, as adopted pursuant to Section 906
of the Sarbanes-Oxley Act of 2002.
|
|
Filed herewith.
|
exv12w1
Exhibit 12.1
Molina Healthcare, Inc.
Computation of Ratio of Earnings to Fixed Charges
(Dollars in thousands)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended December 31, |
|
|
|
2008 |
|
|
2007 |
|
|
2006 |
|
|
2005 |
|
|
2004 |
|
Earnings: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income before income taxes |
|
$ |
103,891 |
|
|
$ |
93,696 |
|
|
$ |
73,458 |
|
|
$ |
43,851 |
|
|
$ |
87,685 |
|
|
Add fixed charges: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest expense,
including amortization
of debt discount and
exp |
|
|
8,714 |
|
|
|
4,631 |
|
|
|
2,353 |
|
|
|
1,529 |
|
|
|
1,049 |
|
|
Estimated interest
portion of rental
expense |
|
|
4,370 |
|
|
|
3,988 |
|
|
|
2,682 |
|
|
|
2,852 |
|
|
|
2,225 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total fixed charges |
|
|
13,084 |
|
|
|
8,619 |
|
|
|
5,035 |
|
|
|
4,381 |
|
|
|
3,274 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total earnings
available for fixed
charges |
|
$ |
116,975 |
|
|
$ |
102,315 |
|
|
$ |
78,493 |
|
|
$ |
48,232 |
|
|
$ |
90,959 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fixed Charges from above |
|
$ |
13,084 |
|
|
$ |
8,619 |
|
|
$ |
5,035 |
|
|
$ |
4,381 |
|
|
$ |
3,274 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Ratio of Earnings to Fixed
Charges |
|
|
8.9 |
|
|
|
11.9 |
|
|
|
15.6 |
|
|
|
11.0 |
|
|
|
27.8 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total rent expense |
|
$ |
17,481 |
|
|
$ |
18,127 |
|
|
$ |
12,193 |
|
|
$ |
9,505 |
|
|
$ |
7,416 |
|
Interest factor |
|
|
25 |
% |
|
|
22 |
% |
|
|
22 |
% |
|
|
30 |
% |
|
|
30 |
% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest component of rental
expense |
|
$ |
4,370 |
|
|
$ |
3,988 |
|
|
$ |
2,682 |
|
|
$ |
2,852 |
|
|
$ |
2,225 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
exv21w1
Exhibit 21.1
LIST OF SUBSIDIARIES
|
|
|
|
|
Name |
|
Jurisdiction of Incorporation |
Molina Healthcare of California
|
|
|
|
California |
Molina Healthcare of California Partner Plan, Inc.
|
|
|
|
California |
Molina Healthcare of Washington, Inc.
|
|
|
|
Washington |
Molina Healthcare of Michigan, Inc.
|
|
|
|
Michigan |
Molina Healthcare of Utah, Inc.
|
|
|
|
Utah |
Molina Healthcare of New Mexico, Inc.
|
|
|
|
New Mexico |
Molina Healthcare of Ohio, Inc.
|
|
|
|
Ohio |
Molina Healthcare of Texas, Inc.
|
|
|
|
Texas |
Molina Healthcare of Nevada, Inc.
|
|
|
|
Nevada |
Molina Healthcare Insurance Company
|
|
|
|
Ohio |
Alliance for Community Health LLC,
dba Molina Healthcare of Missouri
|
|
|
|
Missouri |
Molina Healthcare of Florida, Inc.
|
|
|
|
Florida |
Molina Healthcare of Virginia, Inc.
|
|
|
|
Virginia |
HCLB, Inc.
|
|
|
|
Michigan |
exv23w1
EXHIBIT 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in the Registration Statements (Forms S-8,
No. 333-108317 and No. 333-138552) pertaining to the Molina Healthcare, Inc. 2000 Omnibus Stock and
Incentive Plan, 2002 Equity Incentive Plan, and 2002 Employee Stock Purchase Plan, and in the
Registration Statement (Form S-3, No. 333-155995) and related Prospectus of Molina Healthcare, Inc.
for the registration of $300,000,000 of its securities, of our reports dated March 16, 2009, with
respect to the consolidated financial statements of Molina Healthcare, Inc., and the effectiveness
of internal control over financial reporting of Molina Healthcare, Inc., included in this Annual
Report (Form 10-K) for the year ended December 31, 2008, filed with the Securities and Exchange
Commission.
/S/ ERNST & YOUNG LLP
Los Angeles, California
March 16, 2009
exv31w1
EXHIBIT 31.1
SECTION 302 CERTIFICATION
I, Joseph M. Molina, M.D., certify that:
1. I have reviewed this annual report on Form 10-K for the fiscal year ended December 31, 2008
of Molina Healthcare, Inc.;
2. Based on my knowledge, this report does not contain any untrue statement of a material fact
or omit to state a material fact necessary to make the statements made, in light of the
circumstances under which such statements were made, not misleading with respect to the period
covered by this report;
3. Based on my knowledge, the financial statements, and other financial information included
in this report, fairly present in all material respects the financial condition, results of
operations and cash flows of the registrant as of, and for, the periods presented in this report;
4. The registrants other certifying officer and I are responsible for establishing and
maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and
15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules
13a-15(f) and 15d-15(f)) for the registrant and have:
(a) Designed such disclosure controls and procedures, or caused such disclosure controls
and procedures to be designed under our supervision, to ensure that material information
relating to the registrant, including its consolidated subsidiaries, is made known to us by
others within those entities, particularly during the period for which this report is being
prepared;
(b) Designed such internal control over financial reporting, or caused such internal
control over financial reporting to be designed under our supervision, to provide reasonable
assurance regarding the reliability of financial reporting and the preparation of financial
statements for external purposes in accordance with generally accepted accounting principles;
(c) Evaluated the effectiveness of the registrants disclosure controls and procedures and
presented in this report our conclusions about the effectiveness of the disclosure controls and
procedures, as of the end of the period covered by this report based on such evaluation; and
(d) Disclosed in this report any change in the registrants internal control over financial
reporting that occurred during the registrants most recent fiscal quarter (the registrants
fourth fiscal quarter in the case of an annual report) that has materially affected, or is
reasonably likely to materially affect, the registrants internal control over financial
reporting; and
5. The registrants other certifying officer and I have disclosed, based on our most recent
evaluation of internal control over financial reporting, to the registrants auditors and the audit
committee of the registrants board of directors (or persons performing the equivalent functions):
(a) All significant deficiencies and material weaknesses in the design or operation of
internal control over financial reporting which are reasonably likely to adversely affect the
registrants ability to record, process, summarize and report information; and
(b) Any fraud, whether or not material, that involves management or other employees who
have a significant role in the registrants internal control over financial reporting.
|
|
|
|
|
|
|
|
|
/s/ Joseph M. Molina
|
|
|
Joseph M. Molina |
|
|
Chief Executive Officer and President |
|
|
March 16, 2009
exv31w2
EXHIBIT 31.2
SECTION 302 CERTIFICATION
I, John C. Molina, certify that:
1. I have reviewed this annual report on Form 10-K for the fiscal year ended December 31,
2008, of Molina Healthcare, Inc.;
2. Based on my knowledge, this report does not contain any untrue statement of a material fact
or omit to state a material fact necessary to make the statements made, in light of the
circumstances under which such statements were made, not misleading with respect to the period
covered by this report;
3. Based on my knowledge, the financial statements, and other financial information included
in this report, fairly present in all material respects the financial condition, results of
operations and cash flows of the registrant as of, and for, the periods presented in this report;
4. The registrants other certifying officer and I are responsible for establishing and
maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and
15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules
13a-15(f) and 15d-15(f)) for the registrant and have:
(a) Designed such disclosure controls and procedures, or caused such disclosure controls
and procedures to be designed under our supervision, to ensure that material information
relating to the registrant, including its consolidated subsidiaries, is made known to us by
others within those entities, particularly during the period for which this report is being
prepared;
(b) Designed such internal control over financial reporting, or caused such internal
control over financial reporting to be designed under our supervision, to provide reasonable
assurance regarding the reliability of financial reporting and the preparation of financial
statements for external purposes in accordance with generally accepted accounting principles;
(c) Evaluated the effectiveness of the registrants disclosure controls and procedures and
presented in this report our conclusions about the effectiveness of the disclosure controls and
procedures, as of the end of the period covered by this report based on such evaluation; and
(d) Disclosed in this report any change in the registrants internal control over financial
reporting that occurred during the registrants most recent fiscal quarter (the registrants
fourth fiscal quarter in the case of an annual report) that has materially affected, or is
reasonably likely to materially affect, the registrants internal control over financial
reporting; and
5. The registrants other certifying officer and I have disclosed, based on our most recent
evaluation of internal control over financial reporting, to the registrants auditors and the audit
committee of the registrants board of directors (or persons performing the equivalent functions):
(a) All significant deficiencies and material weaknesses in the design or operation of
internal control over financial reporting which are reasonably likely to adversely affect the
registrants ability to record, process, summarize and report information; and
(b) Any fraud, whether or not material, that involves management or other employees who
have a significant role in the registrants internal control over financial reporting.
|
|
|
|
|
|
|
|
|
/s/ John C. Molina
|
|
|
John C. Molina, J.D. |
|
|
Chief Financial Officer and Treasurer |
|
|
March 16, 2009
exv32w1
EXHIBIT 32.1
CERTIFICATE PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the annual report of Molina Healthcare, Inc. (the Company) on Form 10-K
for the period ending December 31, 2008 as filed with the Securities and Exchange Commission (the
Report), I, J. Mario Molina, M.D., Chief Executive Officer of the Company, certify, pursuant to
18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:
(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the
Securities Exchange Act of 1934, as amended; and
(2) The information contained in the Report fairly presents, in all material respects, the
financial condition and results of operations of the Company.
|
|
|
|
|
|
|
|
|
/s/
Joseph M. Molina
|
|
|
Joseph M. Molina, M.D. |
|
|
Chief Executive Officer and President |
|
|
March 16, 2009
This certification accompanies this report pursuant to Section 906 of the Sarbanes-Oxley Act
of 2002 and shall not, except to the extent required by the Sarbanes-Oxley Act of 2002, be deemed
filed by the Company for purposes of Section 18 of the Securities Exchange Act of 1934, as amended.
A signed original of this written statement required by Section 906 has been provided to Molina
Healthcare, Inc. and will be retained by Molina Healthcare, Inc. and furnished to the Securities
and Exchange Commission or its staff upon request.
exv32w2
EXHIBIT 32.2
CERTIFICATE PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the annual report of Molina Healthcare, Inc. (the Company) on Form 10-K
for the period ending December 31, 2008 as filed with the Securities and Exchange Commission (the
Report), I, John C. Molina, J.D., Chief Financial Officer of the Company, certify, pursuant to 18
U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:
(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the
Securities Exchange Act of 1934, as amended; and
(2) The information contained in the Report fairly presents, in all material respects, the
financial condition and results of operations of the Company.
|
|
|
|
|
|
|
|
|
/s/
John C. Molina
|
|
|
John C. Molina, J.D. |
|
|
Chief Financial Officer and Treasurer |
|
|
March 16, 2009
This certification accompanies this report pursuant to Section 906 of the Sarbanes-Oxley Act
of 2002 and shall not, except to the extent required by the Sarbanes-Oxley Act of 2002, be deemed
filed by the Company for purposes of Section 18 of the Securities Exchange Act of 1934, as amended.
A signed original of this written statement required by Section 906 has been provided to Molina
Healthcare, Inc. and will be retained by Molina Healthcare, Inc. and furnished to the Securities
and Exchange Commission or its staff upon request.